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 Chapter 1 
Introduction 
 
The treatment of infectious diseases caused by microorganisms has always been a 
particular interest in the medical world. Since penicillin was found by Alexander 
Flemming (1928), the exploration of new antimicrobial agents against various 
pathogenic microorganisms keeps growing. Finding a new active is however not the 
end goal of the battle; the innovation of an appropriate and effective vehicle to deliver 
the drug into the infected site has been the real challenge.  
From all existing infectious diseases known, fungal infection is a long-standing hassle 
because of its long-term therapy and accordingly a low patient compliance. Moderate 
to severe infections demand oral administration since the infected site cannot be 
reached easily by the topical treatment, e.g., nail fungal infection. Onychomycosis, for 
example, needs an oral therapy for at least 6 weeks (for finger nail infection) or up to 
12 months (for toenail infection) [1]. On the other hand, the peroral treatment with 
azole derivatives is overshadowed by either its high hepatotoxicity risk or systemic 
drug interactions with other medications. Considering all these issues, delivering the 
drug (trans)dermally may be a solution in reducing the length of the therapy and 
reducing the amount of unnecessary accumulated drug in the body.  
Transdermal route has been the most favorite among other treatments, e.g., 
parenteral or oral, due to its non-invasive application and high patient’s compliance. In 
accordance to this, a poloxamer 407-based vehicle, later referred to as thermogelling 
formulation was recently developed [2]. This formulation was successful in enhancing 
the permeation rate of 5-aminolevulinic acid (5-ALA) remarkably across human 
stratum corneum [2-4] compared to that from Basicreme DAC and water containing 
hydrophilic ointment, both described in German Drug Code (DAC) and German 
Pharmacopoeia (DAB). The permeation rates of 5-ALA were 7.5-fold and 19.5-fold 
higher compared to both standards, respectively [5]. 5-ALA, a very hydrophilic 
substance with log P of -1.51 cannot satisfactorily be delivered transdermally since 
stratum corneum, the lipophilic barrier of the skin, limits its diffusion into the deeper 
tissues.  
2 Chapter 1 Introduction 
In order to explore and expand the potential of this thermogelling vehicle for 
transdermal delivery purpose, a lipophilic antifungal drug terbinafine HCl with log P of 
3.3 was chosen and incorporated. Terbinafine HCl (TBF), invented by Novartis AG, is 
available in the market now for oral and dermal administration (cream, gel, solution, 
spray) in superficial mycosis therapy under the brand name Lamisil® in Germany and 
several European countries. The thermogelling vehicle is composed of poloxamer 
407, medium chain triglycerides, isopropyl alcohol, dimethyl isosorbide and water. 
This vehicle possesses some characteristics such as a reversible thermogelation [2] 
and an indication of the presence of liquid crystal structure of some formulations with 
ringing effect [6].  
Still in line with the treatment of antifungal diseases, the limitation of human nail plate 
source has hampered the development of the therapy itself. Different from skin, nail 
plate consists of highly keratinized dead cells [7] and behaves as a hydrophilic gel 
membrane [8-10]. Animal hooves are up to now an accepted model to replace human 
nail for studying drug permeation but some significant differences have been reported 
[11]. The work group of Stephan Reichl in our institute has successfully extracted 
keratin alpha from human hair using the so-called Shindai method [12]. This keratin 
was previously intended as substrate for cell culture and tissue engineering purposes. 
Through further processes involving molding and oxidative procedures, a keratin film 
has been built. To test this film for its usefulness as a human nail plate model, physical 
characterization and serial permeation studies employing several markers were 
carried out to explore the properties of this film in comparison with bovine hoof, the 
accepted human nail model.  
Based on previously elaborated results, the present study emphasizes as follows:  
 Incorporation of antifungal drug TBF into the poloxamer 407 based thermogelling 
formulation intended for topical application 
 Physicochemical characterization of the formulations 
 TBF permeation from the formulations across human stratum corneum and 
bovine hooves 
 Stability study of the formulations during storage at 20 °C for up to 6 months 
 Microbiological assay of the formulations 
 Testing the keratin film made of human hair keratin as a human nail plate model  
   
Chapter 2 
General Part 
2.1 Human skin 
Skin is the greatest human organ which carries not only the primary protection 
function but also other tasks such as regulation, immunity, sensory and many 
important synthesis functions [13]. As protector, skin constrains the body from 
environmental assaults as well as water loss [14,15]. To the skin, water confers 
flexibility and facilitates a proper desquamation [13]. A disrupted or perturbed skin 
barrier function is indicated from an increase in transepidermal water loss (TEWL) 
value up to 20-fold [13].  
2.1.1 Anatomy of the skin 
Human skin is stratified into layers and consists of epidermis and dermis. An 
anatomical view of human skin is displayed in Fig. 2.1. The epidermis is composed of 
keratinocytes that undergo differentiation originating from the stem cells in the basal 
layer. Besides keratinocytes, melanocytes, Langerhans cells and Merkel cells exist in 
the epidermis as well. Dermis contains mainly collagen and elastin which are 
responsible for skin tensile strength, besides other macromolecules with high water-
retaining ability. Moreover, dermis is responsible for nutrients supply since this layer is 
rich in blood vessels [16]. Fat globules and part of the blood vessels lie in the 
subcutaneous tissue. 
Keratinocytes make up about 95% of the total epidermis. Layers in epidermis can be 
distinguished as stratum basale/ stratum germinativum, stratum spinosum, stratum 
granulosum and in the uppermost, stratum corneum (SC) [16]. Keratinocytes move 
progressively from stratum basale towards the skin surface until they lose their nuclei; 
these dead cells without nuclei are called corneocytes. An area where keratinocytes 
still retain their nuclei is called stratum lucidum and these cells are referred to as 
transitional cells [16]. Interaction with the matrix protein fillagrin (filament-aggregating 
protein) transforms and aligns keratins into highly ordered and condensed arrays. 
Thereafter, fillagrin aggregates keratin filaments into tight bundles forming a flat shape 
of either hexagonal or pentagonal geometry [15,17].  
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Fig. 2.1 Skin structure and layers of the human epidermis, taken from ref. [15,18] 
 
SC consists of normally about 10 - 16 layers of corneocytes on most anatomical 
locations [19]. During the movement towards the skin surface, keratinocytes secrete 
phospholipids, sphingolipids and plasma membrane constituents which are 
subsequently enzymatically cleaved into free fatty acids and ceramides in SC. All 
these components blend together building continuous lamellar bilayers of SC [13]. 
Adjacent keratinocytes are connected through several junctions for the sake of 
mechanical, biochemical and signaling interactions. From all described junctions, 
desmosomes are probably the most important ones. Desmosomes display the major 
adhesive intercellular junction and bridge cells in epidermis together by affixing keratin 
intermediate filaments to the cell membrane [15,16]. Initializing desquamation, 
desmosomes are broken down by proteolytic, tryptic and chymotryptic enzymes; this 
is followed by shedding off the corneocytes after about 2 weeks [14,15,20]. Illustration 
on how desmosomes connect keratinocytes is shown in Fig. 2.2 (a). In a very dry skin, 
desmosomes cannot be shed completely and this causes shedding in large scales 
rather than as individual cells [15]. The entire turnover time of normal epidermis from 
basal layer to the outmost SC is a sum of three main important processes: proliferative 
phase (13 days), differentiation phase (10-14 days) and final transit of SC (14 days) 
[21]. There are variations in the reported epidermal turnover time and this was 
suggested to be due to the differences in methods, models and assumptions used for 
the calculation [22]. Yet, the epidermal turnover time can be shorter in pathological 
situations such as psoriasis [16].  
SUBCUTANEOUS TISSUE 
Fat globules 
Stratum corneum 
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Corneocytes are covered with a shell called cornified envelope (CE), mainly consisting 
of loricrin (80%) and involucrin (2-5%). CE is cross-linked by sulfhydryl oxidases and 
transglutaminase enzymes (TGases) synthesized in the stratum spinosum [16,23,24]. 
CE formation occurs during the late differentiation where the internal organelles of 
keratinocytes are being degraded and a thick band of protein is deposited on the inner 
aspect of the cell plasma membrane. TGases cross-link these protein bands via 
disulfide and isopeptide bonds, followed by the attachment of lipid at the outer surface, 
forming a cornified envelope [25]. A detailed CE assembly is displayed in Fig. 2.2 (b). 
CE consists of a protein and a lipid envelope conferring biomechanical strength and 
providing a Teflon-like coating to the cell, respectively [24]. CE is the most insoluble 
structure of the corneocyte due to its dense N-(-glutamyl)lysine isopeptide cross-
links and disulfide bonds formation as well [13,23,24]. 
 
(a) (b) 
Fig. 2.2 (a) Human epidermis, keratin filaments are omitted, from ref. [14], (b) Assembly of CE, 
previously proposed by Nemes and Steinert [24], modified by Wickett and Visscher [15] 
 
Water is essential to secure a normal desquamation and all metabolic processes 
[13,15]. Natural moisturizing factor (NMF), which is the hydrolytic product of filaggrin, 
is produced to maintain SC hydration [13,14]. Hydrolysis of filaggrin to NMF will be 
initiated when water content in SC decreases. NMF consists of amino acid mixtures 
and their derivatives (pyrrolidone carboxylic acid, urocanic acid), lactic acid, urea and 
sugars which work as skin humectants [14]. Normal skin contains about 30% water in 
SC (by weight) whereas in a very dry SC the value can drop down to 10%. Water loss 
in SC is a vital signal for returning homeostatic condition. Once the barrier is altered or 
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perturbed, various signaling cascades will be initialized to return the skin back to 
normal function [13].  
2.1.2 Stratum corneum (SC): bricks and mortar model 
As skin most important barrier, SC is accompanied by the nucleated epidermis, cell-
cell junctions and groups of cytoskeletal proteins. SC carries about more than 80% of 
the skin barrier function [26]. All other components such as lipids, acids, hydrolytic 
enzymes and macrophages build an immunological barrier for any environmental 
assault [17]. SC is now no longer described as a passive layer, but in reality is a 
dynamic layer with all its ongoing metabolic activities, particularly lipid synthesis, 
processing, and signaling cascades to the deeper layer as a response to any 
perturbation or stress [13,15]. 
 
Fig. 2.3 Schematic model of "bricks and mortar", taken from ref. [13].  
 
Corneocytes in the SC have been modeled as bricks embedded in a continuous lipid 
matrix (mortar). Corneocytes can be simply seen as piles of highly organized keratin 
macrofibrillar matrix and stabilized via interkeratin and intrakeratin filament disulfide 
bonds. The lipid matrix acts as “glue” sealing the corneocytes. It provides a water 
barrier and crucial protection against insults and injuries [26]. A schematic view of the 
former description “bricks and mortar” is shown in Fig. 2.3. The mortar has gained so 
much attention lately due to its uniqueness being composed of about 50% ceramides, 
10-20% fatty acids, 25% cholesterol and other constituents, including small amounts 
of cholesterol esters and cholesterol sulfate. Among all, cholesterol esters, cholesterol 
sulfate and linoleic acid seem to play an important role for maintaining the skin barrier 
function [13,14]. The straight structure of ceramides enables a tight lateral packing of 
tight junctions and highly ordered gel phase membrane domains. Cholesterol on the 
other hand serves fluidity to the SC structure [14]. Deficiency in essential fatty acid 
Covalently bound lipid     Cornified cell envelope      Intracellular humectants 
(NMF) 
Corneocyte Keratin macrofibrils 
Corneodesmosome 
Intercellular 
lamellar lipids 
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such as linoleic acid may lead to a poor water barrier function of the SC and increase 
in TEWL value [14,27]. The uniqueness of SC lipid content and structure makes this 
the most important barrier of the skin [25]. Lipid removal from the skin, e.g., by means 
of extraction with organic solvent, will increase its permeability. 
2.1.3 SC microstructure 
Barry [28] mentioned up to four endothermic transitions, referred as T1-T4, observed 
by means of differential scanning calorimetry (DSC), when SC is heated up to 120 °C. 
These transitions originate from the changes in SC lipid state, either liquefaction or 
packing rearrangement upon heating. T1 (~40 °C) is devoted to the lipid melting 
possibly from sebaceous lipids or cholesterol side-chain, T2 (~70 °C) is due to the lipid 
melting within the bilayer structure together with some non-polar material, T3 (~85 °C) 
describes the disruption of the association between lipid polar head groups and 
cholesterol-stiffened area (protein-lipid association) and T4 (~100 °C) is ascribed due 
to proteins (keratin) denaturation [28,29]. From all transitions, only T4 is irreversible 
due to protein denaturation. The T1-T4 transitions and the enthalpy involved can be 
identified and measured by means of DSC. As a prerequisite, SC water content must 
be sufficient since the transitions will not be visible when SC water content is below 
15% [29]. Among all, T2 and T3 are the most reliable transitions since T1 and T4 were 
found to be strongly dependent on the skin source and its water content during 
measurement [28].  
 
Fig. 2.4 DSC thermogram of SC untreated and treated with Azone, T1-T3 disappear upon 
treatment with Azone, taken from ref. [30] 
 
Interaction of SC with penetration enhancers alters SC lipid’s mobility and furthermore 
loosens its tight microstructure. This can be later observed as disappearances of one 
or more transitions from DSC thermogram as seen in Fig. 2.4. It shows SC 
thermogram before and after treatment with Azone, a potent transdermal penetration 
Untreated 
With Azone 
T1 
T2 T3 
T4 
T4 
TEMPERATURE (°C) 
8 Chapter 2 General Part 
enhancer. The mechanism thereof, how Azone disrupts SC lamellar packing and 
integrity, is illustrated by Barry in Fig. 2.5. The thermal transitions T1-T4 can be thus 
utilized as an indication for transdermal permeation enhancement. 
 
 
Fig. 2.5 Proposal on how Azone disrupts SC lipid structure, from ref. [28,30] 
 
2.1.4 Drug permeation across skin 
Considering the complex structure of the skin, one can imagine the tortuous pathway 
drugs have to penetrate or permeate upon topical administration. Skin offers three 
main entry routes for drugs: transcellular, intercellular and appendageal (primarily, 
follicular). It seems now that the intercellular pathway for most substances 
predominates over others routes [31]. Any perturbation to SC mortar such as 
fluidization or rearrangement of the lipid bilayer will thus reduce SC barrier function. 
The appendageal route has played hitherto insignificant role in human. In addition, the 
importance of the corneocytes membranes can be excluded as well [30]. 
Among all layers, SC as the outermost skin layer receives an important attention since 
this takes over the first skin barrier function and also provides the rate-limiting step in 
drug penetration process [32,33]. Considering its unique structure, Subedi et al. [33] 
emphasized that only drugs with log P between 1 and 3, MW less than 500 Da, 
melting point below 200 °C and required dose less than 10 mg/day have sufficiently 
high chance as candidates for transdermal administration. 
As shown in Fig. 2.6, the transcellular pathway comprises routes through the protein-
filled corneocytes and the multilamellar lipid matrix alternately meanwhile the 
intercellular pathway allows drugs to penetrate between the cells. Hydrophilic 
substances are likely to penetrate via the transcellular pathway alternately between 
the corneocytes and the lamellar lipid layers whereas the intercellular pathway could 
be more reasonable for the lipophilic drugs [32].  
Partially hydrated tissue After treatment with Azone 
Azone inserts 
between the 
lipids, preventing 
chain 
crystallisation 
Closely packed 
hydrocharbon 
chains 
Non polar material 
Free fatty acid 
Cholesterol 
Triglyceride Ceramide 
 
AZONE 
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Fig. 2.6 Penetration pathways across SC: intercellular and transcellular, taken from ref. [30] 
 
Neubert and Wepf [34] proposed a new insight into the structure of SC and realized 
this through the “hook like” structure of the corneocytes, the existence of the 
corneodesmosomes and the bilayer structure of the SC lipids. According to this new 
understanding, transcellular pathway is rather unlikely since the drug must penetrate 
or permeate through the hydrophilic and lipophilic layers of SC alternately. However, a 
penetration pathway through the corneodesmosomes is possible considering its large 
quantities per corneocyte. Therefore, this has been proposed as the possible route for 
the hydrophilic drugs replacing the previously transcellular pathway.    
2.1.5 Quantitation of drug permeation across skin 
Examining the possible pathways of drug permeation across the skin, SC has been 
the rate-limiting step for the most compounds. This led to the broad use of SC for 
analyzing most cases of transdermal drug delivery. Drug permeation across the skin is 
a diffusion-controlled process which can be quantified with the term flux (J), i.e., the 
amount of drug diffusing over time per unit area. At a steady-state condition, the 
diffusion process follows Fick’s 1st law which is expressed as [35]: 
d
= =
d
K D CM m s oJ
t δ
 
 (Eq. 2.1) 
 
M = the amount of drug diffusing through a unit area of the skin in time t 
Co = drug concentration within the membrane surface/ in the vehicle 
Corneocyte 
Intercellular 
lamellar lipids 
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Km = skin/ vehicle partition coefficient 
Ds = (apparent) diffusion coefficient 
 = the diffusional path length 
 
The applicability of this law is under assumptions that: (a) only a single drug is 
important in the formulation, (b) D must be constant in terms of time and position in 
the formulation layer, (c) only the drug is able to permeate out of the formulation; 
vehicle constituents cannot diffuse or evaporate and (d) the drug is rapidly removed as 
it reaches the receiver compartment (drug concentration ~0 at the receiver-formulation 
boundary for t>0) [36]. Concerning the last assumption, which is better known as sink-
condition, has to be guaranteed that drug diffusion is ongoing since in the in vivo 
situation the permeated drug will be directly transported by the microvasculature, 
which lies beneath the epidermis at a depth of 150-200 µm from the skin surface [35]. 
In addition, Eq. 2.1 is acceptable when the amount of depleted drug from the donor is 
less than 10% from its saturated solubility in the receiver compartment during the 
diffusion process. For lipophilic drugs with limited aqueous solubility, the inclusion of 
solubilizing agents such as alcohol or surfactant in the receiver medium can help 
accomplishing the sink-condition besides maintaining a sufficient stirring rate within 
the receiver compartment [35]. Nevertheless, any of this treatment should not cause 
any significant alteration to the skin during the permeation. 
The skin flux is determined from the slope of a plot of the permeated amounts [g/cm2] 
vs. time [s], taken from the steady state part of the plot in accordance to Fick’s 1st law. 
The lag time, tL, can be determined by extrapolating the steady state line of the 
cumulative drug amount to the axis where drug release = 0 through Eq. 2.2: 
2
L
s
δ
t =
6D
  (Eq. 2.2) 
 
It is common to express KmDs/ from Eq. 2.1 as permeability coefficient, P, so that the 
equation can be rewritten as in Eq. 2.3: 
d
d
M
J = = P Cot
   (Eq. 2.3) 
 
Considering the influence of the viscosity of the formulation on the permeation 
process, this parameter is not the rate limiting step of the percutaneous absorption. 
However, it determines drug diffusion and drug release from the vehicle [37]. 
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According to the Stokes-Einstein equation (Eq. 2.4), the solute diffusion coefficient (D) 
decreases when viscosity of the medium (η) increases. A low D will result in a low flux 
according to Fick’s 1st law. 
6
kT
D
R


 (Eq. 2.4) 
2.2 Human nail 
The nail unit encompasses the nail plate, nail folds, nail matrix, nail bed and 
hyponychium [38]. Besides the protecting function, human nail supports the fine motor 
function and the daily activity, e.g., scratching and grooming [39]. The schematic 
illustration of human nail unit is displayed in Fig. 2.7. 
 
Fig. 2.7 Human nail unit, taken from Ref. [39] 
 
2.2.1 Anatomy and function 
Nail plate, the most demonstrative part of human nail, is the hardest part of the nail 
unit. It is composed of about 80-90 layers of dead, keratinized, flattened squamous 
cells which are tightly arranged to one another [38,39]. -keratin makes up the nail 
with mainly hair-type keratins that are more dominant (>90%) than epidermal-type 
keratins [40]. Nail plate thickness varies according to different authors ranging from 
0.25 to 1.0 mm [41]. Nail plate can be divided into three layers according to its matrix-
origin: ventral, intermediate and dorsal [39,40]. Calcium is abundant in the nail plate 
(0.1%) but the sulfur proteins, and accordingly the disulfide crosslinks, are mainly 
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responsible for its strength [39,40]. In addition, nail plate contains 10-30% water and a 
small amount of lipid at 0.1-1% [38]. Nail bed consists of viable epidermis as in the 
skin except that nail bed is much thinner with less subcutaneous fat [39,42]. Similar to 
hair, nail has been shown to be more permeable than the stratum corneum to water. 
Water is important for nail since it confers elasticity and flexibility [40]. 
2.2.2 Keratin 
Keratin is not a single substance. In fact, it is composed of a complex mixture of 
proteins with molecular mass between 40-70 kDa and variation in isoelectric point (pI) 
[43,44]. Two-dimensional electrophoresis is needed for resolving all keratin proteins, 
according to their molecular weights (MW) and thus isoelectric points. Human keratin 
proteins can be grouped as acidic/ type I with pI 4.9-5.4 and basic/ type II with pI 6.5-
8.5. In bovines, pI values are slightly different being <5.6 for type I and >6.0 for type II. 
In addition, to enable the identification of a specific keratin protein after resolution 
according to MW, immunoblotting assay is needed. K13 is a good example; its size is 
51 kDa in humans and 43 kDa in bovines [43]. 
2.2.3 Availability of human nail for studying drug permeation 
Nail diseases, especially onychomycosis, which contributes to as much as 50% of nail 
disorders [45-47], should be efficiently treated to improve the patients’ quality of life. 
Unlike skin diseases, for which medical treatments are continuously developed, 
treatments of nail diseases hitherto are not satisfying. The main obstacles are our 
limited knowledge of conquering the perfect barrier of the human nail and the limited 
source of human nails as the object of the study itself. Bovine hoof has been accepted 
until now as a substitute for human nail, but significant differences between bovine 
hoof and human nail have been reported [11]. The limitation of animal hoof as a study 
object is its great water uptake during hydration, which could lead to an overestimation 
of drug permeability, when this is translated to human nail. Khengar et al. [11] reported 
that the water uptake by human nail was 27 ± 3% whereas that of horse hoof was 40 ± 
9%. Nail clippings have been used for permeation studies as well, but they are not the 
best model due to the limited nail bed [48] and the available contact surface with 
formulation.  
Both human nail and animal hoof are composed of the same keratin type (i.e., -
keratin). The main difference includes the ratio of the amino acid components besides 
the inner structure, with the latter due to the specific differentiation pathways in vivo 
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[49]. However, both human nail and animal hoof possess  hair-type keratin which is 
well-known for its high sulfur protein content [50].  
Mertin and Lippold [9] investigated the influence of drug lipophilicities and solubilities 
in water on their permeabilities across human nail and hooves. They found that drug 
permeability across both membranes was not dependent on its lipophilicity. Both 
materials were found to behave as a hydrophilic gel membrane rather than a lipophilic 
partition membrane, as in the case of human skin [8-10]. The mechanism of drug 
permeation across hoof resembled that in human nail plate, except that hoof retained 
more water. This was confirmed by a study with serial nicotinic acid esters that 
permeated across human nail and bovine hooves. Hoof permeabilities were found to 
be 10- to 30-fold greater than those across the human nail plate [9]. Nail hydration 
plays an important role in the ungual permeation by providing more space for the 
permeating substance. This has been observed by Walters et al. [10,51] as well, 
where the permeation of homologous alcohols was higher from aqueous solution than 
that from the neat liquids (undiluted). 
2.2.4 The development of a human nail plate model made of human hair 
keratin  
Human hair is abundant in nature, and its keratin type is present in human nail, too 
[43,49,52-54]. Baden et al. [53] studied human keratinized tissues (stratum corneum, 
hair and nail) and found that hair and nail showed many resemblances in their 
physical and chemical properties, despite their different morphological properties. The 
question was whether the extraction of keratin from hair with e.g., the Shindai method 
and its re-assembly into a film would enable its use as a nail plate model.  
Keratin is insoluble in many common solvents, such as dilute acids, alkalines, water 
and organic solvents [43]. A common method to extract keratin involves the use of 
reducing agents because the native form is hard to extract due to its highly cross-
linked state by disulfide bonds. Shindai method, which avoids a detergent, provides a 
sufficient amount of extracted proteins for analysis and can avoid protein hydrolysis 
[55]. Reducing agents such as dithiothreitol and 2-mercaptoethanol work by cleaving 
keratin’s disulfide bonds and thus increasing its solubility [43].  
The Shindai method employs a mixture of Tris pH 8.5, urea, thiourea and 2-
mercaptoethanol to extract hair [55]. A further process is needed to transform the hair 
extract into a film which is stable and water-resistant for permeation study. Reichl [12] 
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improved this method initially for producing substrate material for standard cell 
cultivation. After extraction, the hair extract was dialyzed against water to remove the 
excess of the reagents, producing keratin nanosuspension. Following centrifugation to 
eliminate coarse particles, the still turbid supernatant of this suspension is ready as a 
raw material for manufacturing a keratin film. The suitability of this keratin film as a 
human nail plate model still has to be tested in terms of its mechanical strength, water 
absorption ability and permeability to different markers with different physicochemical 
properties. 
2.3 Superficial fungal infection (mycosis) 
Fungal infections may be divided into two different types, i.e., a deep/ systemic 
infection and a superficial/ local infection. The former develops commonly into a life-
threatening stage whereas the latter is considered to be mild. Superficial fungal 
infection occurs in the outermost layer of the body, such as stratum corneum, hair and 
nails. This kind of disease has not only been found in humans since many cases have 
also been developed in animals, for example in pet skin and animal hoof.  
The microorganisms responsible for mycoses are mainly the dermatophytes. They 
feed on mammalian keratin as their essential nutrient source [56]. Keratin serves not 
only as nutrient, but functions also as the up-regulator for some putative virulence 
factors of the fungi. An example is the over-expression of G-protein subunit alpha in 
an in vitro condition which might play an important role in modulating the virulence 
factors [57].  
Trichophyton rubrum accounts for more than 90% of the chronic dermatophytosis 
apart from other dermatophytes from the genera Microsporum and Epidermophyton 
[56,57]. Other non-dermatophytes have also been credited as the cause of 
onychomycosis or nail fungal infections such as Scopulariopsis brevicaulis, 
Aspergillus versicolor, A. flavus, A. niger, A. fumigatus, Fusarium solani, F. oxysporum 
and Scytalidium spp [58]. Although these non-dermatophyte fungi do not have 
sufficient keratinolytic activity, the external factors can still induce infection. A low 
hygiene level, local trauma, peripheral diseases, immunodeficiency stage and climate 
may elevate the risk factor of mycoses [58].  
The absence of keratin in the deeper layer of the body is the main reason why 
mycosis remains superficial [56,58]. During occupation, dermatophytes produce not 
only keratinolytic enzymes such as keratinases which break down the keratin 
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structure, but also other pathogenic factors such as xanthomeganin (toxin), mannans 
(immunosuppresive agents), haemagglutinins, trigger factors for haemolytic reactions 
and antibiotics to bear the local bacterial colonization [56].  
2.3.1 Host responses  
There is a principal difference between antropophilic and zoophilic/ geophilic 
dermatophytes. The former type causes rather a chronic clinical manifestation 
meanwhile the latter produces a more acute reaction [59]. The invasion of 
dermatophytes into the tissue will trigger humoral and/or cellular immune responses 
as a host defense mechanism. This may prevent infections to get into the deeper 
tissues as well [56,60]. Dermatophytes possess two main antigens, i.e., glycopeptides 
and keratinases. The protein fragment from the former stimulates preferentially cell-
mediated immune response whereas the polysaccharide fragment stimulates the 
humoral one. Keratinases, enzymes produced to invade the keratinous tissues, are 
able to induce a delayed-type hypersensitivity response in an in vitro experiment with 
animals [59,60]. 
During the fungal invasion multiple inflammatory cytokines, interferon and various 
interleukins (IL) such as TNF-alpha, IL-1 beta, IL-8 and IL-16 are released by 
keratinocytes and mononuclear cells [56]. This cell-mediated immune response is 
absent in the ‘dead’ SC and nail plate; this is an additional reason why the invasion 
cannot go into deeper viable tissues of the skin [59]. Nevertheless, people with lack of 
cell-mediated immune response do not develop a systemic dermatophyte infection. 
Complement, a series of plasma proteins that act as mediators of inflammation, 
defenses the body through the interaction of antibody with the microorganisms/ 
antigens (classical pathway) or interaction with certain microbial cell walls/ toxin 
(alternative pathway). The action of the complement will be followed by phagocytosis 
of the fungal cell by neutrophils or macrophages [61]. 
A severe infection is usually experienced by patients with an immune deficiency 
condition, especially AIDS, while in a normal circumstance this infection is not life-
threatening. This fact shows the importance of human immune system in controlling 
the spreading and growth of dermatophytes in the environment [60]. 
2.3.2 Clinical manifestations 
Lesions developing during the infection are known as tinea or ringworm [56]. The 
infection is distinguished according to the Latin term indicating the infected site, e.g., 
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tinea capitis for infection of the scalp, tinea barbae in beard and mustache, tinea 
corporis in glabrous skin, tinea cruris in groin, tinea favosa in favus, tinea manuum in 
hand, tinea pedis/ Athlete’s foot in feet, und tinea unguium in nail. In addition, several 
sites can be infected by a single fungal species and vice versa, different species may 
cause identical lesions [60,62].  
The spreading of dermatophytes on the skin can be recognized from a marked 
erythema, scaling and palpable infiltration of the skin, sometimes accompanied by 
pustules. The inflamed sites often have an arched or circular shape (see Fig. 2.8 (a)); 
explaining the origin of term of ringworm [56]. Dermatophyte infections are often found 
in the skin, especially in the dead layer of stratum corneum, nails, hair follicles and 
hair [56]. Hair follicle has probably been the responsible site for relapses and 
recurrences since these sites are quite protected from topical and systemic therapies. 
Topical treatments usually do not penetrate deep into follicles meanwhile the systemic 
ones are delivered into the skin surface by sweat thus avoiding the follicular canal 
[59]. 
 
 
 Fig. 2.8 Skin rashes (a) and infected nails (b) due to dermatophyte    
Sources: (a) http://www.webmd.com/skin-problems-and-treatments/picture-of-ringworm-of-the-body-
tinea-corporis; (b) http://dermatology.fromyourdoctor.com/ 
 
The visible lesions at the infected sites are due to the biological products of 
dermatophytes which are majorly able to digest keratin and induce inflammation at 
once. Inflammation occurs at the infected site since fungal hyphae are chemotactic to 
the host immune system. Different from skin, nail does not develop any inflammation 
at the infected site due to the absence of viable cells and immune cells (see Fig. 2.8 
(b)). Furthermore, a slow growth rate of nails makes the fungal elimination more 
difficult and many cases develop into chronic infections [56].  
(a) (b) 
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2.3.3 Mycosis therapy and its drawbacks 
Basically, the choice of the therapy is assessed from the malignancy of the infection. 
Meanwhile lesions at early stage can be treated with topical formulations, a more 
severe and widespread infection must be treated perorally [60]. Particularly, tinea 
unguium/ onychomycosis requires peroral therapy in most cases since topical 
treatments do not produce sufficient drug levels at the periphery. Steroid agents such 
as prednisone or betamethasone are often meaningful in the therapy to reduce the 
inflammation. In addition, an antibiotic is sometimes necessary to handle the arising 
secondary infection [1]. Various antifungal aägents have been described for 
dermatophytosis treatment [1,60] : 
 the azole group: miconazole, clotrimazole, econazole, ketoconazole, 
oxiconazole, tioconazole, isoconazole, sulconazole, bifonazole, fenticonazole 
and sertaconazole  
 allylamine group: butenafine, terbinafine and naftitine  
 echinocandin group 
 morpholine derivative:  amorolfine 
 ciclopirox olamine  
 tolnaftate  
 griseofulvin 
 haloprogin  
Topical medications are widely available for mycosis in the form of cream, gel, lotion 
and shampoo. They contain majorly the active from the azole, allylamine and 
morpholine derivatives. Five antifungal drugs are common for systemic therapy, i.e., 
terbinafine, itraconazole, fluconazole, griseofulvin and ketoconazole [1]. The current 
treatments available and approved for dermatophytosis are listed in Table 2.1. 
   
Table 2.1 Available treatment of dermatophytosis 
 Terbinafine Itraconazole Fluconazole Ketoconazole Griseofulvin 
Tinea 
pedis/manuum 
Cream
a
: twice daily, 1-4 
weeks 
1% solution
a
: twice 
daily, 1 week 
Oral: 250 mg/day, 2 
weeks 
Oral: 200 mg, twice 
daily for 1 week 
Oral: 150 mg once 
weekly for 2-6 weeks 
2% cream
a
: once daily 
for 6 weeks 
Oral
a
: 200-400 mg/day 
for more than 4 weeks 
Oral :  
Microsize
a
 1g/day 
Ultramicrosize 660 or 
750 mg/day for 4-8 
weeks 
Tinea corporis/ 
cruris 
Cream
a
: twice daily, 1-4 
weeks 
1% solution
a
: twice daily 
for 1 week 
Oral: 250 mg/day for 2-4 
weeks 
Oral: 200 mg/day for 1 
week 
Oral: 150-300 mg once 
weekly for 2-4 weeks 
2% cream
a
: once daily 
for 2 weeks 
Oral
a
: 200-400 mg/day 
for 4 weeks 
Oral: 
Microsize
a
 500 mg/day 
Ultramicrosize 330-375 
mg/day for 2-4 weeks 
Tinea unguium/ 
Onychomycosis 
Oral: 250 mg/day 
Toenail: 12-16 weeks 
Fingernail: 6 weeks 
Oral: pulse therapy: 200 
mg twice daily for 1 
week followed by 3 
itraconazole free weeks 
Toenail: 3 pulses 
Fingernail only: 2 pulses 
Oral: 150 or 300 mg 
once weekly for 6-12 
months 
Toenail approx. 9-15 
months, fingernail 
approx. 4-9 months 
Oral: 200-400 mg/day 
for 6 months 
(not recommended due 
to hepatotoxicity risk) 
Microfine: 500 mg daily 
for 6-12 months 
Microsize
a
 1g/day 
Ultramicrosize
a
 660 or 
750 mg/day for 4-12 
months 
a
 FDA approved; modified from Gupta, A.K and Cooper, E.A. [1] 
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The length of the treatment is depending on the malignancy of the infection and 
susceptibility of the fungus to the drug. Unfortunately, dermatophytosis treatment is 
not satisfying due to its low mycological cure rate, e.g., in the case of griseofulvin. In 
addition, other problems such as a high relapse rate subsequent to topical application 
and arising incidences of side effects, e.g., hepatotoxicity due to ketoconazole, have 
been reported [60]. Drug interaction with other medication has been reported as well, 
such as with antidiabetic agents, since these drugs share similar hepatic pathways for 
metabolism via the cytrochome P-450 system. Interference in metabolism can shift the 
plasma level of the counter drug to a higher or lower level thus followed by either 
intoxication or therapy failure, respectively. As a consequence, the use of itraconazole 
for example is prohibited for patients with ventricular dysfunction or with a history of 
congestive heart failure and the respective medications [1,63]. 
Special attention should be given to onychomycosis because its treatment is up to 
now still problematic due to the long treatment, thus a limited success because of non-
compliance of the patients. Furthermore, the relapse incidence is high, 3-20 % after 
peroral administration with TBF [64,65]. To reduce relapse, onychomycosis treatment 
is still involving mechanical approaches through trimming, aggressive debridement 
(yet not for children), nail abrasion and nail avulsion (partial or full removal) [1]. 
Although not being convenient, mechanical interventions can reduce the fungal 
burden in the infected nail in most cases and thus accelerate the healing process [66]. 
The length of the treatment has been the major drawback of the therapy. Treatment 
risk is high for patients who receive other treatments which are metabolized through 
the hepatic pathway. Although the topical treatment is the most favorite among others, 
the cure rate is not satisfying even for mild to moderate infections. The cure rates 
were 33% for nail lacquer containing 8% ciclopirox (after 48 weeks) and 60-76% for 
nail lacquer containing 5% amorolfine (after 6-12 months of treatment) [1]. 
2.3.4 Therapy failures  
There are many factors that lead to the failure of dermatophytosis therapy. Major 
factors are poor patient compliance, misdiagnosis, insufficient consideration of 
individual need/ condition of the patient, lack of patient counseling during the 
treatment and variation in host response [66]. Microscopic examination and culture of 
the causative fungi are the deciding factors to treat the infection properly. 
Unfortunately, the rate of false negative culture identification is high; this makes the 
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attempt to distinguish the occurrence of a new infection from relapse more difficult [1]. 
However, an improvement in identifying the fungi via biomolecular methods offers now 
better results, e.g., identification of fungal DNA [1,67]. 
The choice of the treatment is made solely by the physician. A lack of knowledge 
about the causative fungus, the severity stage of the infection and drug resistance 
issues may lead to an improper medication choice. Although topical formulations 
increase the compliance of patients, the cure rate is low. A prolonged oral therapy is 
the golden standard for dermatophytosis in many cases but still, a sufficient 
counseling must be altogether given to improve the compliance of the patients. 
Education about a good hygiene can avoid the spreading of the infection, e.g., to other 
family members. An individual need of each patient must be considered, especially for 
elderly, children, pregnant women and immunocompromised patients. 
The possibility of a tailored therapy has been suggested to increase cure rates and to 
reduce relapses [1,66]. A combination of two antifungal agents with different 
mechanisms may give a synergistic effect, e.g., terbinafine with itraconazole. The 
combination is also possible for topical and oral therapy, e.g., amorolfine or ciclopirox 
nail lacquer with an oral antifungal drug. This suggestion needs however further 
clinical studies to assess the therapy improvement and is not yet currently approved 
[1]. 
2.3.5 Pharmacology and pharmacokinetics of terbinafine (TBF)  
Terbinafine is a relative new synthetic antifungal agent from the allylamine group. 
Terbinafine works by inhibiting the transformation of squalene to squalene 2,3-epoxide 
via the fungal enzyme squalene epoxidase in the ergosterol pathway [68]. This 
inhibition leads to the accumulation of squalene and a decrease in metabolites such 
as ergosterol and lanosterol, the essential components of the fungal cell membrane 
[63,68-70]. Fuglseth et al. [68] suggested that the antifungal activity of TBF originated 
from its steric and electronic effects which are important for the squalene epoxidase 
inhibition. Furthermore, their results indicated that the nitrogen basicity of TBF is 
essential for the binding with this enzyme. 
TBF acts fungicidal to dermatophytes and fungistatic to yeasts group of fungi such as 
Candida spp. The cidal action was associated with the high concentration of squalene 
within the fungal cell meanwhile the fungistatic action appears due to the deficiency in 
ergosterol [69]. Thus, the death of the dermatophyte cell is rather due to the 
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accumulation of squalene whereas in yeast cells, the growth inhibition runs parallel to 
the drop in ergosterol content [71]. The highly lipophilic squalene in a high amount 
within fungal cells acts as a lipid sponge, extracting the essential lipid components of 
the fungal cell membranes thus weakening its membrane integrity. Disintegration of 
the vacuolar membrane will then release lytic enzymes which is lethal to the cell [69]. 
The relation between TBF minimum inhibitory concentration (MIC) for complete 
suppression of the fungal growth and sterol biosynthesis can be seen in Table 2.2. In 
addition, the values shown in Table 2.2 reflect the different strengths of TBF to 
filamentous and yeast fungi. A low MIC value implies a great impairment to the sterol 
biosynthesis which is indicated as low IC50 and IC95 values, respectively. 
 
Table 2.2 TBF: Relation between MIC [µg/ml] and sterol biosynthesis 
Fungus MIC 
Sterol biosynthesis 
IC50 IC95 
Trichophyton rubrum 
T. mentagrophytes 
Aspergillus fumigatus 
Candida parapsilosis 
C. albicans 124 (yeast) 
C. albicans 126 (yeast) 
C. albicans 126 (mycelial) 
C. glabrata 
0.003 
0.003 
0.8 
0.4 
3.1 
12.5 
1.5 
100 
0.0005 
0.002 
0.07 
0.006 
0.008 
0.014 
0.013 
0.04 
0.02 
0.04 
1.2 
0.3 
0.2 
0.63 
0.22 
0.9 
IC50, IC95 = drug concentration that produces 50% and 95% inhibition (n = 3); reproduced from ref. [69]. 
 
The allylamine group offers a higher selectivity compared to the azole group in terms 
of the work mechanism. Almost every step in the host steroid hormone synthesis can 
be affected by azoles but not by allylamines [70]. TBF does not impair the work of the 
human liver enzyme since its target, squalene epoxidase, does not belong to the 
cytochrome P-450 family [69]. Therefore, TBF acts only as a substrate for a fraction of 
cytochrome P-450 and it will be rapidly degraded to several less lipophilic metabolites. 
This action is different from the azole group which is involved in every step of the 
human cholesterol synthesis in the liver via a direct binding with the haem group of 
almost all cytochrome P-450 [70].  
TBF shows a rapid absorption within two hours and is rapidly enzymatically 
metabolized in the liver. The hepatic cytochrome P-450 plays an important role for the 
metabolism of TBF. The metabolism process involves side chain oxidation at the t-
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butyl group, dealkylation and aromatic oxidation. Despite its high selectivity, care must 
be taken for patients with liver impairments. Its lipophilic character drives a high 
distribution into tissues, especially adipose tissue and skin, thus the plasma level 
remains low. This unique distribution to the periphery is an advantage for the 
treatment [70].  
2.3.6 Physicochemical properties of TBF 
Terbinafine HCl (C21H25N·HCl), the salt form of terbinafine with log P of 3.3 [72], is an 
allylamine/ benzylamine derivative together with other antifungal agents butenafine 
and naftitine. TBF structure is shown in Fig. 2.9. TBF salt is preferably used instead of 
its base form since the salt form gives a higher stability and aqueous solubility [73]. 
TBF melting point, after being recrystallized from 2-propanol, ranges from 204-208 °C 
[74,75]. TBF solubility in several pharmaceutical-related solvents is listed in Table 2.3. 
TBF has a rather limited aqueous solubility despite its salt form and its fairly high 
solubilities in alcohols.  
N
CH3
C(CH3)3
.HCl
 
Fig. 2.9 Chemical structure of terbinafine HCl  
 
2.3.7 TBF stability in bulk and in formulation 
Several TBF degradation products may be found in formulations after several months 
of storage. They may also originate from impurities in the bulk material. 1-
methylaminomethylnaphtalene (MAMN) is an impurity as well as a degradation 
product from the synthesis process. Further impurities from the synthesis are 4-
methyl-terbinafine and -terbinafine derived from -MAMN as an impurity of the 
precursor MAMN. Z-terbinafine is proposed to be a potential degradation product of 
TBF [76]. The chemical structure from each compound is displayed in Fig. 2.10.  
Ahmad et al. reported that no degradation products were found after storing TBF 
tablets and cream for 6 months in an accelerated condition at 40 °C and 75% RH [77]. 
Matysová et al. recommended the storage of TBF solution in acetonitrile at a low 
temperature of 4 °C. This solution was only stable up to 48 h, corresponding to 
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maximum of 1% TBF decrease (from the initial concentration). Furthermore, they 
found 0.253% MAMN, corresponding to the TBF amount, from a TBF cream after 
being stored for 6 months at 40 °C and 60% RH. In all cases, omitting light during the 
storage is recommended [76,78,79].  
Table 2.3 TBF solubility in some pharmaceutical-related solvents   
Solvent Solubility [g/L] 
Anhydrous ethanola 
Methanol 
Isopropyl alcohol 
Isobutyl alcohol 
Water 
Acetone 
freely soluble 
freely soluble 
120 
21 
8 
less than 0.5 
a
 from ref. [78] 
Solubility determination: ~0.5 g TBF was boiled with 5 ml solvent, kept for 24 h at room temperature 
and filtered, solubility was calculated from the difference of  the filtrate and total weight; modified from 
ref. [75] 
 
H
N
CH3
 
MAMN      -terbinafine 
CH3
N
CH3
.HCl
C(CH3)3
 
4-methyl-terbinafine    Z-terbinafine 
Fig. 2.10 Impurities and possible degradation products of TBF 
 
2.4 Development of formulation for topical administration 
There are several approaches to enhance drug permeation rate across the skin. The 
most conventional one is the incorporation of chemical penetration enhancers, but the 
safety issues and irreversible damages caused by, limit their use. Other alternatives 
N
CH3
C(CH3)3
N C(CH3)3
.HCl
CH3
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such as modifying drug’s thermodynamic activity and vehicles still remain to be 
explored. 
2.4.1 Chemical penetration enhancers 
The lipid-protein-partitioning theory suggested by Barry [30] proposes three main 
mechanisms of the chemical penetration enhancers, i.e., alteration of the intercellular 
lipid or the protein domains of SC, drug partition enhancement into the skin or the 
combination of both mechanisms. A new study utilizing an FTIR approach found that 
lipophilic penetration enhancers rather fluidize the arrangement of the ceramides so 
that the spaces between them increase. On the other side, hydrophilic enhancers 
decrease the strength of hydrogen bonds between the polar head groups of the 
ceramides [80]. Both types of enhancers perturb SC arrangement thus facilitating drug 
entry into the skin. Chemical penetration enhancers offer a broad choice in order to 
increase drug diffusion across the skin. Water, not to be neglected, is also a 
penetration enhancer working via an increase in hydration. Thus, the solute mobility is 
higher in the loosened SC lamellar arrangement [28]. Other groups from different 
chemical classes such as hydrocarbons, alkanols and alkenols, fatty acids, alkyl 
amino esters, amides, amines, sulfoxides, cyclic carbohydrates, terpenes and 
pyrrolidines have been acknowledged and reviewed extensively as transdermal 
penetration enhancers for various substances as well [33]. 
2.4.2 Drug’s thermodynamic activity in the vehicle 
The drug release rate from the formulation depends on drug’s thermodynamic activity 
[81]. Thermodynamic activity has been described as the driving force of the drug to 
leave the vehicle and penetrate across SC [82,83]. A saturated drug concentration in 
the vehicle exhibits the highest thermodynamic activity, i.e., it reaches unity. Drug 
solution below its saturated concentration exhibits thermodynamic activity of less than 
unity and therefore its release rate is slower than that of the saturated drug 
concentration. A saturated drug concentration in different vehicles will exhibit similar 
release rates, accordingly similar penetration rates, since in this state the release rate 
will be independent of the vehicle [82,84]. The dependency of drug’s penetration rate 
on its thermodynamic activity has been proposed by Higuchi in Eq. 2.5 as follow: 
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dq D A
dt L
 


 (Eq. 2.5) 
 
dq/dt = the steady state rate of penetration 
 = thermodynamic activity of the drug in its vehicle 
 = effective activity coefficient of the agent in the skin barrier phase 
D = the effective average diffusivity of the agent in the barrier phase 
A = the effective cross section area 
L = the effective thickness of the barrier phase 
 
Following Higuchi, Ishii et al. [84], expanded Fick’s 1st law and Nernst-Planck equation 
and resumed that under a constant temperature, steady-state flux of a drug (J) is a 
function of only drug’s activity (Av’). A suspension exhibits a unity-independent activity 
of different vehicles and thus the skin permeation rate is also independent of the 
vehicles. Vice versa, different vehicles with similar drug concentrations, yet different 
thermodynamic activity of the drug, can be expected to give different release rates. 
Following release from the vehicle, drug partition and permeation across SC is 
afterwards determined by the drug lipophilicity and melting point [81]. 
2.4.3 Liquid crystal phases as drug carrier 
The current development in drug formulation and delivery seeks alternatives where 
the carrier/ vehicle is designed in such a way so that a drug can be delivered more 
readily across the skin. In some extent, the vehicle should even be able to modify the 
barrier function of SC or its integrity without causing any irreversible damage. For 
granting this need, liquid crystal as a carrier could enhance drug penetration across 
SC due to its low surface tension at oil/water interface; this can promote a higher drug 
partition into SC. Furthermore, this type of vehicle may enable higher drug loading 
compared to other conventional bases [85].  
Different liquid crystal phases namely lamellar, hexagonal and cubic systems made of 
Pluronic® 105/ water mixtures have been reported to enhance permeations of some 
drugs across rabbit ear skin [85]. The enhancing effect was found to be specific for 
each drug, e.g., diclofenac sodium and paracetamol permeated faster from the 
hexagonal phase meanwhile propanolol and -tocopherol were faster from the 
lamellar phase, all compared to other examined phases. A cubic phase, made of lauric 
acid, monolaurin and simulated endogenous intestinal fluid, was able to solubilize 
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cinnarizin, a lipophilic drug with log P of ~5.8 and aqueous solubility less than 1 
µg/mL, to a 2·105-fold greater  extent than its solubility in buffer pH 6.5 [86]. Brinon et 
al. [87] reported that the diffusion coefficient (D) of the hydrophilic sunscreen 
benzophenone-4 was the highest in the cubic phase, made of surfactant mixtures Brij® 
30 and Brij® 35, whereas the lipophilic sunscreen octyl methoxycinnamate’s D was the 
highest in the lamellar system containing similar ingredients. The corresponding liquid 
crystal bases without drug were used as diffusion receivers in those experiments; both 
being separated with a filter cellulose membrane as barrier. Unfortunately, the 
permeation enhancement across pig skin from these systems was not significantly 
higher than that from a control, hinting at the rate-limiting step of the skin for this 
process. Since entering of large aggregates of the liquid crystal into SC is rather 
unlikely, it has been hypothesized that the single constituent of the vehicle, e.g., 
surfactant monomer, is able to penetrate and thus improves drug penetration [87].  
2.4.4 Thermogelling formulation 
A novel vehicle for topical application based on poloxamer 407 had been developed 
which was denoted as thermogel. This formulation was composed of poloxamer 407 
(Lutrol® F127), isopropyl alcohol, dimethyl isosorbide, Miglyol® 840 and water. In 
addition, this vehicle exhibited a reversible thermogelation property, it was semisolid at 
room temperature and liquid below 13 °C, e.g., in the refrigerator [4,5]. Thermogel 
containing 5-ALA, a hydrophilic drug with log P -1.51, showed a higher permeation 
rate across SC compared to other creams described in German Pharmacopoeia, i.e., 
7.5-fold and 19.5-fold higher permeation rates than those from Basiscreme DAC and 
water containing hydrophilic ointment, respectively [5]. A synergistic work of all 
components was suggested to be responsible for this permeation enhancement since 
the absence of a single component decreased the permeation flux. In addition, DSC 
measurement displayed a stronger interaction between the vehicle and SC; this was 
evident from its highest endothermic shift transitions of T2 and T3, respectively, and 
its lowest enthalpy involved among other formulations [2,5].  
The original thermogel vehicle was composed of 25% mixture of poloxamer 407/POX 
and Miglyol® 840/MIG (fixed at 4:1), 25 % mixture of isopropyl alcohol/IPA and 
dimethyl isosorbide/DMIS (fixed at 1:1) and 50 % of water. By varying the composition 
of the constituents, different appearances and physical properties were achieved. 
Interesting for dermal application would be the semisolid systems such as cream- and 
gel-like, located in the area with the composition of 20-60 % POX/MIG, 0-30 % 
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IPA/DMIS and 20-75 % water (all w/w) [4]. Outside this area the systems were not 
appropriate for topical application: they were paste-like, liquid or instable subsequent 
to the manufacture. 
Thermogel featured a thermoreversible gelation upon heating and cooling. Gelation 
occurs upon heating via dehydration of the lipophilic blocks of propylene oxide groups, 
followed by dehydration of the hydrophilic blocks of the ethylene oxide groups. 
Thereafter, the transition from sol to gel occurs. The process is reversible and can be 
repeated by changing the heating/ cooling direction. Generally, gelation temperature 
increased with decreasing POX and IPA/DMIS contents [88]. 
Although the majority of the formulations were isotropic, few formulations were 
anisotropic, especially in the area rich in POX/MIG with water content less than 10%. 
The border between isotropic and anisotropic systems could be thus drawn at 10% 
water content. Only systems without water were anisotropic when POX/MIG<50%. 
From the measurement by means of wide angle X-ray diffraction, the birefringence of 
the systems originated from the incomplete solubilization of POX in the system; this 
was concluded from the appearances of POX crystalline reflections at about 2Θ of 19° 
and 23° [4].  
Formulations located in the area with 25-70% POX/MIG, 0-30% IPA/DMIS and 20-
75% water feature a so-called ringing effect upon knocking the jar to a hard surface. 
The manifestation of this phenomenon is suggested due to the existence of a cubic 
liquid crystal. Vice versa, in some cases ringing effect can be a hint for the presence 
of this structure [89,90]. Since the cubic structure is isotropic, an additional analysis by 
means of small angle x-ray diffraction (SAXD) is needed. This technique determines 
the spacing order of a highly ordered system such as a crystal or liquid crystal. The 
hint at a cubic liquid crystal was also supported by the high viscosity of the 
formulations. So far, three types of the cubic structure from this area have been 
identified, i.e., space groups of Fm3m, Pn3m and lm3m, respectively [6]. Referring 
back to the original composition of the thermogel, according to SAXD measurement, 
this composition possesses Pn3m cubic structure. Whether this cubic liquid crystal is 
also responsible for 5-ALA high permeation rate, further investigations are needed.    
Subsequent to one year of storage in a climatized room at 20 °C, three kinds of 
instabilities had been observed for these thermogelling formulations. Microbiological 
growth was detected in formulations with low POX/MIG in absence of IPA/DMIS, 
liquefaction of gel-like formulations with POX/MIG less than 50% and inhomogeneity 
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in some liquid formulations. Furthermore, crystal growth was observed in anisotropic 
formulations [91]. Resuming these findings, IPA/DMIS plays an important role in 
preserving the formulation. Considering that the crystal growth originates from POX 
incomplete dissolution, anisotropic systems should then be no longer considered for 
dermal application. The same is also suggested for liquid systems which showed 
phase separation during storage.  
2.4.5 Strategies in developing topical formulations containing TBF 
The HCl salt of terbinafine offers a better stability and no doubt a higher aqueous 
solubility compared to the base form [73]. The existence of double and triple bonds in 
TBF rises however the concern of its vulnerable stability against possible chemical 
reaction such as oxidation. TBF base with a low melting point at around 43 °C and 
boiling point at 140 °C at 0.3 mbar receives a special attention compared to its salt 
form [73]. This consideration is also valid for the purification and manufacturing 
processes which involve heat. The HCl form and the base form are included in 
marketed formulations under the brand of Lamisil® Creme and Lamisil® DermGel, 
respectively.  
So far, the HCl salt form is the only available raw material in the market. For the sake 
of mycosis treatment, a good drug delivery and a high drug deposit in the SC would be 
advantageous to enhance the cure rate. This would also reduce peroral 
administration, especially for moderate to severe infections. In accordance to mycosis 
therapy with TBF, a novel topical product should thus be able to: 
 deliver TBF readily into SC  
 enhance TBF deposit in SC 
Various formulations containing TBF intended for topical application are available in 
the market as cream, gel, solution and spray under the brand name Lamisil® as well 
as the generic form. These topical dosage forms are recommended for mild infection 
only or as adjuvant for the oral therapy. The topical application is not a choice at all for 
nail infection. As alternative, iontophoresis has been introduced to improve TBF 
delivery into the skin. Sachdeva et al. [92] reported that TBF delivered into SC of 
hairless rat skin following iontophoresis from a glycerin-based solution was yet not 
significantly higher than that of passive diffusion. However, a significantly higher TBF 
amount beneath the skin after the application of anodal iontophoresis was evident 
over cathodal iontophoresis or passive diffusion [92]. 
Chapter 2 General Part 29 
Regarding the lipophilic nature of TBF, the main focus in developing a formulation for 
topical application may be an effective loading of the vehicle with drug. A hydrophilic 
vehicle offers a limited advantage due to its poor solubilization ability. A lipophilic 
vehicle has a high affinity to TBF, but may thus eventually hamper its release. A 
vehicle offering a high drug loading capacity and ability of enhancing TBF partition rate 
into SC would be advantageous. 
 Chapter 3 
Materials and Methods 
3.1 Materials 
 Terbinafine HCl (C21H26ClN, MW 327.9) or (2E)-N,6,6-Trimethyl-N-(naphtalin-1-
ylmethyl)hept-2-en-4-in-1-amine hydrochloride (BAN)) was purchased from 
Suzhou Leader Chemical Co., Ltd, China and was used as received. It is an 
odorless powder with a white to off-white appearance. The purity was determined 
to be 100-101% (potentiometry) according to the monograph in Ph. Eur. 6.0 [78]. 
The melting point was found to be at 211.9 °C measured with a differential 
scanning calorimetry (DSC 220C with disk station SSC 5200, Seiko Instrument, 
JP-Tokyo). In the following sections terbinafine HCl will be abbreviated as TBF. 
 Poloxamer 407 (Pluronic® F127, Lutrol® F127) is an ABA type block copolymer 
composed of a central, hydrophobic block of polypropylene oxide (PPO) flanked 
by two hydrophilic blocks of polyethylene oxide (PEO). The average molecular 
weight is 12,200 and the hydrophilic part contributes to about 73% of the 
molecular weight [93].  
CHCH2O
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Fig. 3.1 Chemical structure of poloxamer 407, from Ref. [5] 
 
The rich proportion in PEO makes poloxamer 407 readily soluble in water. The 
poloxamer 407 gel possesses a thermoreversible gelation property and exhibits 
a sol-gel transition upon heating and cooling. Poloxamer 407 has been used as a 
carrier for many routes of drug applications (oral, topical, intranasal, rectal, 
vaginal, ocular and parenteral) [94]. The substance was kindly donated by BASF 
(Ludwigshafen, Germany) and featured free-flowing prilled granules. In the 
further section poloxamer 407 will be abbreviated as POX. 
 Miglyol® 812N (MCT), a medium chain triglyceride (caprylic/ capric triglyceride 
(INCI)), was purchased from Sasol GmbH (Witten, Germany). It is a neutral oil, 
clear, colorless with a neutral odor and taste. The oil is composed of saturated 
triglycerides of fatty acids C8 and C10 with glycerol from fractionated plant oils 
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(coconut and palm kernel) [95]. MCT is used for many pharmaceutical purposes 
as carrier, solvent, dispersing agent, permeation enhancer in oral, topical and 
parenteral preparations [96].  
 Dimethyl isosorbide (DMIS) was kindly donated by Dolorgiet (St. Agustin-Bonn, 
Germany). DMIS is a clear liquid with an odor and taste similar to isopropyl 
alcohol. It is hydrophilic and used as a solvent, drug solubilizer and penetration 
enhancer for topical preparations [96].  
O
O
O
CH3
O
H3C  
Fig. 3.2 Chemical structure of dimethyl isosorbide, from Ref. [5] 
 
 Isopropyl alcohol (IPA) was purchased from VWR Int. (Leuven, Belgium). IPA 
has been used as a preservative and transdermal penetration enhancer. 
 Phosphate buffer pH 5.8 (PB) (Eur. Ph. 6.0, 4002100) was prepared from 
disodium hydrogen phosphate dihydrate and potassium dihydrogen phosphate 
according to Ph. Eur. 6.0 [78]. The pH value of the solution was verified before 
use and if necessary, adjusted. Both materials were purchased from Merck 
KGaA (Darmstadt, Germany).  
 Lamisil® Creme and Lamisil® DermGel were purchased from a local pharmacy. 
Both are intended for topical therapy of skin fungal infections such as tinea pedis 
and tinea corporis. Lamisil® Creme is a semisolid formulation containing 1% 
terbinafine HCl, purified water, isopropyl myristate, polysorbate 60, stearyl 
alcohol, cetyl alcohol, cetyl palmitate, sorbitan stearate, benzyl alcohol and 
sodium hydroxide, meanwhile Lamisil® DermGel contains 1% terbinafine base, 
purified water, ethanol 96%, isopropyl myristate, polysorbate 20, carbomer, 
sorbitan laurate, benzyl alcohol, sodium hydroxide and butylhydroxytoluene.   
 Basiscreme DAC was purchased from Caelo (Hilden, Germany). Basiscreme 
DAC is composed of glycerol monostearate 60 (4%), cetyl alcohol (6%), medium 
chain triglycerides (7.5%), white soft paraffin (25.5%), macrogol-20-glycerol 
monostearate (7%), propylene glycol (10%) and purified water (40%) [97].  
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 For the manufacture of keratin film, blond hairs were obtained from a local 
hairdresser. Bovine hooves were purchased from an online pet shop 
(Edingershops, Germany) and healthy nail clippings were donated from 
volunteers in the university surroundings. Shindai solution was prepared from 
urea, thiourea (Carl Roth GmbH, Karlsruhe, Germany), 2-mercaptoethanol and 
Tris base (Sigma, USA) according to a previous method [55]. A Spectra/Por 
membrane (MWCO: 6-8,000 Da Spectrum Laboratories, Inc. Rancho 
Dominiguez, Canada) was used as dialysis tubing. Sodium fluorescein (SF) was 
purchased from Fluka (Steinheim, Germany), rhodamine B (RB) from Fluka 
(Sweden), thioglycolic acid (TA) from Merck (Hohenbrunn, Germany), fluorescein 
isothiocyanate-dextran MW 4000 (FD4) and papain (from papaya latex) from 
Sigma-Aldrich (Steinheim, Germany). Chemical structures of the markers are 
shown in Fig. 3.3. 
Phosphate buffered saline pH 7.4 (PBS) was prepared according to Eur. Ph. 6.0. 
Disodium hydrogen phosphate anhydrous and sodium chloride were obtained 
from Merck (Darmstadt, Germany) and potassium dihydrogen phosphate was 
from Carl Roth GmbH (Karlsruhe, Germany). Sodium hydroxide (NaOH) was 
supplied from BASF (Darmstadt, Germany). Acrylamide (30% solution), 
N,N,N’,N’- tetramethylethylenediamine and ammonium persulfate were obtained 
from Sigma-Aldrich, sodium dodecyl sulfate from Acros Organics (Geel, 
Belgium), glycine from ICN Biomedicals, Inc. (Aurora, Ohio, USA) and Serva 
Blue G (dye based on Coomassie® brilliant blue G-250) from Serva 
Electrophoresis GmbH (Heidelberg, Germany). SpectraTM multicolor broad range 
protein ladder #SM 1841 (10 – 260 kDa) from Fermentas GmbH (St. Leon, Rot, 
Germany) was used as the size marker for electrophoresis. 
 Water was used in double distilled quality, except for HPLC analysis. For this 
purpose water was processed with an EASYpureTM LF from Barnstead 
(Dubuque, USA) to produce type I reagent-grade water with low organic content 
and high resistivity up to 18.3 MΩ-cm. 
 Miscellaneous materials used for any specific method will be introduced and 
defined in the corresponding section. 
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Fig. 3.3 Chemical structure of fluorescein (a), rhodamine B (b) and fluorescein isothiocyanate-
dextran MW 4000 (c); source Ref. [98,99] 
 
3.2 Methods 
3.2.1 Manufacture of the POX-based formulations [100]  
Formulations were given codes according to the drug content and the collective 
content of POX/MCT and IPA/DMIS in the vehicle alone. The ratios of POX/MCT and 
IPA/DMIS in all cases were fixed in accordance to Grüning and Müller-Goymann [5] at 
4:1 and 1:1, respectively. For example, 1P5025 contained 1% TBF, while the vehicle 
itself was composed of 50% of POX/MCT, 25% of IPA/DMIS and 25% of water (all 
w/w). An example is given in Table 3.1. Formulations were produced according to the 
pseudoternary phase diagram presented in Fig. 4.1. All materials, including TBF for 
formulations containing drug, were weighed in a special jar designed for Cito Unguator 
2000 Konietzko GmbH (Bamberg, Germany) and were mixed at 1450 rpm for 1.5 min. 
The composition of the vehicle constituents was varied depending on the 
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characterization requirement. TBF, POX/MCT and IPA/DMIS ranged from 0 – 4%, 25 
– 75% and 10 – 70% (all w/w), respectively.  
Table 3.1 Composition of 1P5025 as example 
Components Amount [g/ 100 g] 
Poloxamer 407 
Isopropyl alcohol 
Dimethyl isosorbide 
Medium chain triglycerides 
Terbinafine HCl (TBF) 
Water 
39.6 
12.38 
12.38 
9.9 
1.0 
24.75 
 
3.2.2 Physicochemical characterization of POX-based formulations [100] 
Physicochemical characterization was carried out after 24 h to allow for sufficient 
equilibration of the microstructure. The characterization was performed visually in 
terms of appearance and ringing effect, as well as microscopically in terms of isotropy 
and TBF concentration at saturation. The ringing effect was examined by knocking the 
jar to a hard surface. A “ringing” gel responded to agitation with a particular back-
resonance. Isotropy and TBF concentration at saturation were examined under a 
polarizing microscope Leica LMDM equipped with camera Olympus DP12 (Hamburg, 
Germany). The lowest TBF concentration representing detectable crystals was 
defined as the saturation/ solubility concentration. 
3.2.2.1 Rheometrical measurement [100] 
Rheometrical measurements were performed in an oscillation mode using a controlled 
stress rheometer CVO 50 from Bohlin (Bamberg, Germany) with a conical disk plate of 
an angle of 1° (Ø 20 mm). Gelation temperatures and complex viscosities were 
measured within the linear viscoelastic regions of the formulations, which were 
previously determined with an amplitude sweep at a fixed frequency of 0.5 Hz 
according to Ref. [5]. This low frequency was chosen to prohibit any major change in 
the microstructure during the subsequent measurements, especially during gelation 
point detection [101]. Complex viscosities (η*) were measured at 32 °C to make sure 
that the formulation was in its viscoelastic state, i.e. storage modulus G’>loss modulus 
G”. Gelation temperatures were determined within the temperature range of 5 to 30 °C 
using a temperature gradient program with a rate of 2 °C/min. Samples of 
approximately 1 g were applied and renewed prior to the proximate measurement. 
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The cone/ plate rheometer including the sample were placed under a protecting cover 
during the measurements to prevent any excessive evaporation of volatile ingredients. 
The gelation temperature was considered to be the temperature, where G’ and G” 
crossed over (G’=G”) [101] or when the phase angle δ = 45° or tan δ = G”/G’ =1 [102].  
3.2.2.2 Small angle X-ray diffraction (SAXD) 
Small angle X-ray measurements were carried out using a compact Kratky camera 
(Hecus Braun X-ray systems, Graz, Austria) connected to a Roentgen generator Iso-
Debyeflex 3003 60 kV (Seifert-FPM, Freiberg, Germany). Samples were measured at 
room temperature for 600 s and detected with a position sensitive detector PSD-50M 
(M. Braun, Garching, Germany). Distance to sample was 27.7 cm meanwhile the 
length of the channel was 54 µm. Sample was placed in a paste carrier from Hecus 
Braun X-ray systems (Graz, Austria). The measured curves were desmeared and 
smoothed to obtain the final diffractograms. 
 
Table 3.2 Bragg reflection ratios and Miller indices for cubic lattice structures 
Cubic lattice Bragg reflection ratio Miller index {hkl} 
lm3m (primitive cubic, 
bcc) 
2, 4, 6, 8, 10  {110}, {111}, {200}, {211}, 
{220}, {221} and {310} 
Pn3m (double diamond) 2, 3, 4, 6, 8, 9, 10   {110}, {200}, {211}, {220} and 
{310} 
la3d (gyroid cubic) 6, 8, 14, 16, 20  {211}, {220}, {321}, {400} and 
{420} 
 
Since the examined formulation P2525, P4020 and P5015 displayed ringing effects 
and were not birefringent, a cubic lattice structure was expected. The influence of TBF 
(0-3%) and heating (20 and 40 °C) on P2525 structure were investigated. The 
scattering pattern of a system possessing a cubic structure will follow any of the Bragg 
reflection ratios. Some possible Bragg ratios are listed in Table 3.2. These reflections 
can also be indexed into diffraction planes according to Miller indices. 
3.2.3 Stability of terbinafine HCl 
3.2.3.1 TBF stability in aqueous media 
TBF was dissolved in water, PB and phosphate buffer saline pH 7.4 (PBS), 
respectively. Each sample containing 10 mL solution was stored in a sealed, air tight 
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glass and was protected from light during storage. Sampling at every determined point 
of time was performed using a syringe to reduce the contact with the environment.  
3.2.3.2 Influence of pH on TBF stability in aqueous media 
UV spectra of 0.1% TBF solutions in PB and PBS were recorded at 0, 2, 5, 24, 48 and 
144 h by means of Spectrophotometer UV Specord®  200 from Analytik Jena AG 
(Jena, Germany) equipped with the software WinASPECT® PLUS. Measurements 
were carried out within the wavelength range of 200-400 nm at ambient temperature. 
This measurement was aimed to investigate the influence of two different pH values 
on TBF stability.    
3.2.3.3 Influence of temperature on TBF stability in aqueous media 
TBF solutions of 50 µg/mL in water, PB and PBS were stored at different 
temperatures: 20 °C and 32 °C for 72 h. Changes in TBF concentration during storage 
were monitored by means of HPLC measurements. 
3.2.4 TBF stability in formulations during storage at 20 °C 
3.2.4.1 Macroscopical examination 
Samples were manufactured according to the pseudoternary phase diagram in Fig. 
3.4 and stored in a climatized room at 20 °C for up to six months. Samples were 
placed in their original jar (Unguator Kruke) to simulate the real storage condition. 
Examinations were carried out after 1, 3 and 6 months. Examinations included 
physical appearance, color change and phase alteration. 
3.2.4.2 Changes in TBF concentration 
Formulations from Fig. 3.4 were manufactured, divided and placed in several airtight 
glass vials. They were sealed and stored in a climatized room at 20 °C for up to three 
months. Samples were taken at 0, 1 and 3 months. TBF was extracted from the 
formulation and its concentration was determined by means of HPLC.  
3.2.4.3 TBF extraction from the formulation 
An amount of ~50 mg formulation was weighed in a volumetric flask of 10 mL volume 
and was given up to 10 mL methanol. Following shaking, the formulation was 
completely soluble in methanol. 40 µL of this mixture was injected into the column and 
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analyzed using the HPLC system as in section 3.2.6.6. The extraction was done in 
triplicate for each formulation. Calibration curves were performed in methanol within 
the range of 0.1-50 µg/mL (r2>0.9999) with LOD and LOQ at 0.014 and 1.654 µg/mL, 
respectively. The recovery of this extraction process was found to be more than 99 %. 
The obtained TBF concentrations were recalculated based on the recovery result from 
each formulation. 
3.2.5 Instability of TBF in the formulation 
3.2.5.1 Finding the instability trigger 
After one month of storage in the climatized room (section 3.2.4.1), some formulations 
containing TBF turned yellow. This color change initially occurred in formulations with 
IPA/DMIS contents of more than 40%. Upon storage the color change gradually 
continued with other formulations which contained less IPA/DMIS. In order to find the 
trigger of this phenomenon, several binary and multiple mixtures were prepared 
according to the composition of 2P2570. They were stored for one month in airtight 
glass vials in similar condition as for the stability study.  
3.2.5.2 Thin layer chromatography (TLC) 
TLC is a fast and reliable method to detect and separate degradation products from 
the parent compound. As the stationary phase, an HPTLC plate Kieselgel 60F (20 cm 
x 10 cm) with UV fluorescence at 254 nm from Merck (Darmstadt, Germany) was 
used. The mobile phase was composed of chloroform, methanol and 25% aqueous 
ammonia solution (12: 0.1: 0.1) [79]. The chamber was previously saturated for two 
hours with the mobile phase before running the sample.  
Several samples which had turned yellow after one month of storage were examined, 
i.e., 1P2570, 2P2570, 1P2560, 1P3050, 1P3060 and 1P4050. One-month-old 
formulations without TBF were analyzed as well, i.e., P2530, P2550, P2560 and 
P2570. A freshly prepared 1% TBF solution in methanol was used as reference. Prior 
to TLC, all formulations were diluted 1:1 with methanol. 10µL of the solution (including 
the reference) was then applied on the plate using an Eppendorf pipette with 
distances between point-shaped samples of 1.5 cm. Samples were dried (~30 min 
under a fume hood) and developed in a TLC chamber at ambient temperature (20 ± 2 
°C). Afterwards, the plate was dried under a fume hood and finally examined under a 
UV lamp at  254 nm to observe the spots. 
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The retardation factor (RF) from each visible spot can be calculated as follows [103]:  
F
distance travelled by the center of the spot
distance simultaneously travelled by the mobile phase
R   (Eq. 3.1) 
 
3.2.6 Permeation of TBF across human stratum corneum (SC) and bovine 
hooves 
3.2.6.1 Isolation of human SC [100] 
Isolated human SC was used for the permeation studies. Skin was donated from 
plastic surgery of the abdominal region of 38- and 55-year-old women with consent of 
the patients and ethical approval according to the Declaration of Helsinki of the World 
Medical Association. After removing the fat tissue, the skin was immediately frozen 
with liquid nitrogen and stored at – 20 °C. The isolation of the SC was performed using 
the trypsination method described by Kligman and Christophers [104]. Briefly, the vital 
layers of the skin are removed manually using a scalpel. After 48h of incubation with 
0.5 mg/mL trypsin solution (Trypsin 2500 USP Unit/mg from Carl Roth GmbH, 
Karlsruhe, Germany) at 37 °C, SC can be separated from the rest of the skin layers. 
The SC is further introduced to 0.4 mg/mL trypsin inhibitor solution (Type II-O: chicken 
egg white from Sigma-Aldrich Chemie, Steinheim, Germany) to stop the enzymatic 
process. Finally it is rinsed twice with excessive water. This ready-to-use SC was put 
on a Teflon sieve and kept in a desiccator prior to use to protect it from humidity. The 
isolated SC was used within two months to avoid any skin lipid degradation. Stability 
has been reported in the literature for up to four months [105,106].  
3.2.6.2 Bovine hooves preparation 
Only the sole part of the bovine hooves was used for this study. Soles were first cut in 
squares (2 cm x 2 cm) and submerged overnight in water before being sliced with a 
rotational microtome MICROM HM 355S (Walldorf, Germany) to a thickness of 100 
µm. For the permeation study, these membranes were then punched out (15 mm 
diameter). 
3.2.6.3 Examined formulations 
1P2525 vs. other semisolid vehicles containing 1% TBF 
A concentration of 1% TBF was chosen to be incorporated in P2525, the original 
thermogelling formulation from a previous publication [5] since the marketed product 
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Lamisil® Creme contains a similar drug concentration. Other formulations such as 
1P3030, 1P4030 and Basiscreme DAC containing 1% TBF were prepared as well. 
Considering that onychomycosis may occur in nail, it is valuable to measure the 
permeation rate of TBF across bovine hoof, an accepted human nail model. 
Furthermore, semisolid formulations obtained from variation of the composition of the 
thermogelling vehicle enable a good applicability and a sufficient adhesive property for 
the treatment of nail infection. Lamisil® DermGel, a marketed product, was chosen as 
a standard of comparison for the permeation across hooves regarding the vehicle’s 
rather hydrophilic properties.  
 
Variation of the thermogelling formulations 
Several formulations from the semisolid area of the pseudoternary phase diagram 
were chosen for permeation experiments across human SC and hooves. For only 
examining the influence of a single “component” on the permeation, two other 
“components” were kept constant at 1:1. An overview to the examined formulations is 
shown in Fig. 3.4. As example, in order to examine the influence of POX/MCT on TBF 
permeation rate, the ratio of IPA/DMIS to water was kept constant at 1:1. This is 
depicted as the line with empty triangles from 1P2836 up to 1P5025. Each line 
comprises four formulations with 1P3333 as the intersection point. A detailed 
composition of each formulation can be further seen in Table 3.3. 
 
Thermogelling formulations containing more than 1% TBF 
The influence of TBF content on the permeation rate across SC was assessed by 
including 2P2525, 2P3030 and 4P4030 in this study. All prepared formulations were 
given 24 h equilibration time after manufacture. An examination by means of 
polarizing microscope showed that TBF was soluble in all tested formulations for the 
permeation study. Considering the permeation from formulations with more than 1% 
TBF, an enhancement factor from each formulation could be calculated as follows:  
flux from the formulation containingmore than1% drug
Enhancement factor =
flux from the formulation containing1% drug
 (Eq. 3.2) 
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Fig. 3.4 Position of all examined formulations in the pseudoternary phase diagram for the 
permeation study 
 
Table 3.3 Composition of the examined formulations for the permeation study 
Group of formulations % POX/MCT % IPA/DMIS % water % TBF 
POX/MCT: water (1:1)  
1P3040 
1P3333a 
1P3824 
1P4412 
 
29.70 
32.97 
37.62 
43.56 
 
39.60 
32.97 
23.76 
11.88 
 
29.70 
32.97 
37.62 
43.56 
 
1 
1 
1 
1 
IPA/DMIS : water (1:1) 
1P2836 
1P4030 
1P5025 
 
27.72 
39.60 
49.50 
 
35.64 
29.70 
24.75 
 
35.64 
29.70 
24.75 
 
1 
1 
1 
POX/MCT: IPA/DMIS (1:1) 
1P2525 
1P3030 
1P4040 
 
24.75 
29.70 
39.60 
 
24.75 
29.70 
39.60 
 
49.50 
39.60 
19.80 
 
1 
1 
1 
a 
1P3333 was the intersection point of the three examined lines 
3.2.6.4 TBF solubility in the receiver solution  
According to the literature, PB was chosen as a receiver solution in permeation 
experiments. TBF solubility in PB and water (as a comparison) was determined as 
follows.  An excess of TBF was given into 5 mL of each examined solvent. The 
mixtures were placed and sealed in air-tight glass vials and then stirred at 300 rpm, 32 
°C for 24 h to mimic the in vitro permeation condition. The insoluble drug was removed 
by filtration using a cellulose acetate filter with pore size of 0.2 µm from Sartorius AG 
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(Göttingen, Germany). The filtrate was analyzed with HPLC. The samples were diluted 
100-fold with the corresponding solvent prior to analysis. The standard solutions for 
the HPLC analysis were prepared in the corresponding solvents, i.e., water or PB, 
respectively. TBF solubility in water and PB at 32 °C was 0.698% and 1.360%, 
respectively. The solubility in PB was sufficient to maintain the sink condition during 
the permeation experiment. 
3.2.6.5 Permeation study [100] 
Both rims of the diffusion cell compartments were given a thin layer of silicone paste 
(Baysilone-paste medium viscous, Bayer AG, Bad Berleburg-Raumland, Germany) to 
aid adhesion. After a fully hydration of SC in water, it was mounted on a TMTP (pore 
size 5 µm) polycarbonate filter IsoporeTM Millipore (Ireland) to support its mechanical 
stability and clamped between donor and receiver compartments. This filter did not 
represent any diffusion barrier. Since the intersubject skin variability of permeation 
studies was found to be larger than the intrasubject variability [107], the results of the 
permeation studies were always compared to those from the same donor. Bovine 
hooves were equilibrated in the buffer for 1 h before being mounted between both 
compartments. 
Prior to permeation, the intactness of the membrane was checked by its trans 
epithelial electric resistance/ TEER using an EVOM instrument (World Precision 
Instruments, US-Sarasota) with a measurement range up to 20 kΩ. This method was 
developed by Fokuhl and Müller-Goymann [108]. An intact membrane shows a high 
resistance represented by a TEER value of >20 kΩ (the maximum measurable value 
of the instrument). A damaged membrane shows a TEER value less than 20 kΩ. 
Modified Franz diffusion cells with membrane areas between 0.418 and 0.534 cm2 
were used for the permeation studies. The volumes of the receiver compartments 
varied between 5.18 and 6.37 mL and were filled with phosphate buffer pH 5.8 (PB). 
The pH value of 5.8 was chosen in accordance to previous TBF stability reports from 
Lebo et al., Özcan et al. and Sachdeva et al. [92,109,110]. This buffer was also 
sufficient to maintain the sink condition for TBF partitioning, i.e., TBF concentration in 
the receiver compartment during permeation study did not exceed 10% of the initial 
concentration in the donor compartment. TBF solubility in PB was determined in the 
section 3.2.6.4 to confirm this. Approximately 2 g of the formulation was filled into the 
donor compartment.  
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The diffusion cells were thermostated at 32 °C and the receiver compartments were 
stirred at 300 rpm. Receiver solutions from SC permeation were probed (250 µL) for 
over 40 h and replaced by the same amount of fresh buffer. The samples were taken 
in the beginning after 4 h and 10 h followed by an interval of 3-4 h (night break: 11 h) 
up to 48 h. This sampling time was extended for some formulations up to 72 h. 
Receiver solutions from hooves permeation were probed at the 2nd, 4th, 6th, 9th and 
12th h. 
The samples were kept in a refrigerator (6-8 °C) and analyzed within 48 h without any 
additional dilution. The flux value of TBF was obtained from the slope of a plot of the 
permeated amount [g/cm2] vs. time [s]. The slope was taken from the steady state part 
of the plot in accordance to Fick’s 1st law [111]. 
3.2.6.6 Analytical measurement by means of high performance liquid 
chromatography (HPLC) [100] 
Samples from permeation experiments were analyzed with an HPLC which consisted 
of a pump 515, autosampler 717 plus and a UV tunable absorbance detector 486 from 
Waters (Milford, USA). Mobile phase was modified from Cardoso and Schapoval [112] 
being composed of methanol : water (95:5) with an addition of 10 mM triethylamine 
(694 µL for 1 L mixture). Flow rate was set at 1.5 mL/min with detection at wavelength 
of 254 nm. Samples were eluted through a column Zorbax SB-C18 (Agilent, USA) with 
particle size of 5 µm and dimension 4.6 x 250 mm for 5 min with retention time at 4.1 
min. Peaks were integrated and evaluated using software Clarity V. 2.6.3.313. Sample 
injection volume was 40 µL. Calibration was performed in PB from 0.1-50 µg/mL with 
r2 of more than 0.999. Limit of detection (LOD) and limit of quantification (LOQ) were 
determined according to the ICH Guideline [113] and the values were 0.122 and 3.446 
µg/mL, respectively.  
3.2.6.7 Quantification of TBF retained in SC and hooves [100] 
SC and hooves were isolated directly after terminating the permeation at 48th and 12th 
hours, respectively. Excess formulation was cleaned by wiping off the surfaces with 
cotton swabs followed by tissue paper. This was done to assure that there would be 
no rest of the formulation left on the surface. The residual humidity was absorbed 
once more with tissue paper and the membranes were finally placed in reaction 
vessels of 1.5 mL volume (Roth, Karlsruhe-Germany). These vessels were stored 
without lids in a refrigerator (6-8 °C) for 48 h. The dried membranes were afterwards 
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transferred into fresh vessels, extracted with 1 mL methanol and agitated with an 
orbital shaker (IKA Vibrax-VXR) at 150 rpm for 24 h. The amount of TBF extracted 
was determined by injecting the extract into HPLC with the same parameter as in 
earlier section. Calibration curves were performed in methanol within the range of 0.1-
50 µg/mL (r2>0.9999) with LOD and LOQ at 0.014 and 1.654 µg/mL, respectively. 
3.2.6.8 Recovery of the extraction process [100] 
SC and hooves with the size of 1 cm x 1 cm (n = 6) were given about 10 µL drop of a 
defined concentration of TBF solution in methanol and then weighed. The solution 
concentrations (cstandard) for SC were 4.88 and 0.488 mg/mL. Blank was dropped with 
methanol only. Drying and extraction process were carried out in the same manner as 
in section 3.2.6.7. Neither cleaning nor wiping process was necessary to clean the 
surface for the extraction process since TBF is freely soluble in methanol. The 
recovery of the extraction process was calculated as follows: 
[
[
detected concentration µg/mL]
%recovery = 100%
actual concentration µg/mL]

 (Eq. 3.3) 
 
The detected concentration was obtained by HPLC measurement, meanwhile the 
actual concentration was calculated as follows: 
[
6weight of the solution [g] c [g/mL] 10
standardactual conc. [µg/mL] = 
density of the solution g/mL] 1[mL]
 

 (Eq. 3.4) 
 
3.2.7 SC measurement by means of differential scanning calorimetry (DSC) 
[100]  
Any changes in the SC due to its interaction with the formulation component can be 
well recorded by means of DSC, which enables the detection of heat transitions and 
even measures the amount of enthalpy involved quantitatively. SC was first hydrated 
to gain water content of 20% in a desiccator filled with saturated sodium chloride 
solution in water for at least 48 h at ambient temperature. A size of 1.5 cm x 1.5 cm 
was eligible for each measurement. The formulation to be tested was equilibrated at 
37 °C before the SC was inserted for incubation at 37 °C for 30 min. After incubation, 
an excess of the formulation was wiped off by means of tissue paper and weighed in a 
hermetically closed aluminum crucible of 40 µL volume (ME-27331, Mettler Toledo). 
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Sample was directly measured from 20 to 120 °C with a heat rate of 5 K/min using 
DSC 1 Stare System (Mettler Toledo, Schwerzenbach, Switzerland). An empty 
aluminum crucible was used as reference. Care was taken to assure a uniform contact 
time between SC and formulation and to perform the DSC measurement immediately 
after incubation. Up to four endothermic thermal transitions could be recorded, 
denoted as T1 – T4, but only the middle transitions (T2 and T3) were reliable for 
further interpretation. The transition temperatures were determined and evaluated 
using software STARe DB V9.20. 
3.2.8 Development of human nail plate model made of human hair keratin 
[114] 
Keratin film made of human hair keratin was produced and its suitability was tested for 
the permeation study purpose. The permeability of the keratin film was investigated 
using three markers with different properties as well as several ungual penetration 
enhancers with different mechanism of action. In addition, water absorption of the 
keratin film as well as its SDS-PAGE profile were compared to bovine hoof and human 
nail. 
3.2.8.1 Keratin film (KF) manufacture 
Keratin from hair was extracted under reducing conditions with the so-called Shindai 
method [12,55]. The hair was pulverized using a ball mill MM301 Retsch (Haan, 
Germany) at 29 Hz for 10 min. An amount of 25 g of hair powder was mixed with 500 
mL Shindai solution containing 25 mM Tris pH 8.5, 2.6 M thiourea, 5 M urea and 5% 
(v/v) 2-mercaptoethanol and was extracted at 50 °C for 72 h. The mixture was filtered 
with medical gauze and further with filter paper with a 2.5 µm pore size to remove the 
insoluble hair. The extract was centrifuged at 4,500 x g for 15 min; the supernatant 
could be stored at -20 °C and thawed, if required. Dialysis against demineralized water 
was conducted to remove the rest of the Shindai components using Spectrapore® 
tubing, MWCO 6,000 – 8,000 Da, for 48 h at ambient temperature. The dialysate was 
further centrifuged at 10,000 x g for 30 min to remove coarse aggregates and 
immediately used for KF manufacture. The dialysate’s protein content was determined 
using the Bradford colorimetric method [115] using bovine serum albumin as standard. 
Prior to film manufacturing, 1% (w/w) glycerol was added to the dialysate as film 
plasticizer. A volume of 2 mL of this mixture was optimum to produce about 100 µm 
thick KFs. This volume was added stepwise (2 x 1 mL within 4 h) into molding rings, 
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which were made of polytetrafluoroethylene (PTFE/Teflon) with 2 cm inner diameter in 
our studio, and dried at 40 °C for 24 h. A siliconized polyethylene terepthalate (PET) 
foil from LTS Lohmann (Andernach, Germany) was used as base. The produced soft 
films were punched out (diameter 1.5 cm) before curing. Curing at 110 °C for 3 h was 
essential to oxidize the disulfide bridges between keratin molecules, producing stable, 
water-insoluble films. The thicknesses of the prepared KF and hoof membrane were 
measured with a micrometer screw gauge after a complete hydration in PBS for 1 h. 
3.2.8.2 Water absorption profile of keratinous material under study 
All the studied keratinous materials, i.e., hoof membranes, KFs and human nail 
clippings were submerged in double distilled water and repeatedly weighed until a 
constant weight was obtained. Prior to weighing, the water on the surface was wiped 
off with tissue paper. The amount of water absorbed was compared to the dry weight. 
3.2.8.3  SDS-polyacrylamide gel electrophoresis (SDS-PAGE) 
SDS-PAGE was performed according to Laemmli [116] to separate the protein 
components of the keratinous materials under study according to their molecular 
weights. The aqueous dialysate and the hair extract in the Shindai solution were 
previously diluted 5-fold with water. The other keratinous samples were previously 
extracted with the Shindai solution. Nail clippings (2.5% (w/w)) were extracted and 
agitated overnight, whereas KF and hoof (5% and 2.5% (w/w), respectively) were 
extracted for 72 h at 50 °C. All the samples were finally diluted 2-fold with Laemmli 
buffer (Sigma, Deisenhofen, Germany) and boiled for 5 min before running SDS-
PAGE. The sample volume for the separation was 5 µl, except for hoof extract and 
marker, which was 7.5 and 10 µl, respectively. A vertical slab gel electrophoretic 
system (EC 120, 80 x 100 mm, EC Apparatus Corp., Holbrook, US) with a 4% 
stacking gel and 12% separation gel was used. The system was run at 180 V, 80 mA 
and 25 W. After running, the gel was stained with 0.1% (w/v) coomassie brilliant blue 
in a mixture of methanol: acetic acid: water (4:1:10) and further destained with this 
acidic methanol mixture for 30 min. 
3.2.8.4 Permeability of the keratin film: finding the thickness analogue  
The permeability of KF was examined by using several markers and ungual 
penetration enhancers. Because of similarities between bovine hoof and human nail, 
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bovine hoof was chosen for comparison. Moreover, bovine hoof is available in the 
market and can be obtained for screening purposes in great quantities whereas the 
availability of human nail is limited and costly. Three markers were chosen to 
represent drugs with different physicochemical properties. Sodium fluorescein (MW 
376, log P -1.52), rhodamine B (MW 443, log P 2.38) [117] and fluorescein 
isothiocyanate-dextran (MW 4400, log P -2.0) [118] were chosen as water soluble, 
lipid soluble and large molecule model drugs, respectively. The slight differences in 
size between sodium fluorescein and rhodamine B were not taken as considerable.  
The thickness analogue of KF, in terms of permeability and marker retaining ability, 
was compared with 100 µm thick bovine hoof. KFs with thicknesses of 110, 120 and 
130 µm were examined. Permeation experiments were carried out using modified 
Franz diffusion cells [119] at 32 °C. The cell opening areas were between 0.418 and 
0.534 cm2 and the volumes of the receiver compartments varied between 5.18 and 
6.37 mL. Bovine hoof membranes and KF were equilibrated for 1 h with PBS and were 
then mounted between donor and receiver compartments. The receiver compartments 
were filled with PBS, whereas the donor compartments were filled with marker 
solutions in PBS with the concentration of 500 µg/mL for SF, 250 µg/mL for RB and 
1000 µg/mL for FD4 (all w/v). Samples of 100 µl were taken from the receiver for 40 h 
and replaced by the same amount of fresh buffer. The first sample was taken at 10 h; 
afterwards, 3- to 4-h intervals were employed over the remaining time. The samples 
were placed in a 96-well plate from Corning (Roskilde, Denmark) and the fluorescence 
intensities were directly measured after terminating the permeation using a 
fluorescence plate reader, Tecan Genios (Switzerland), with  excitation at 485 nm,  
emission at 535 nm (filters) for SF and FD4, and  excitation at 535 nm,  emission at 
590 nm for RB. Calibrations for the markers were performed in PBS within the range 
of 0.1-5 µg/mL for SF and RB, and 1-10 µg/mL for FD4 with r2 more than 0.999.  
3.2.8.5 The application of ungual penetration enhancer (PE) 
Three acknowledged nail penetration enhancers with different mechanism of action 
were chosen, i.e., urea, thioglycolic acid and papain from papaya latex to provide 
more information about the usefulness of keratin film made of human hair as a human 
nail plate substitute. Urea works by increasing nail hydration [120], thioglycolic acid by 
cleaving the disulfide bonds between keratin molecules [72,121], and papain, an 
endopeptidase enzyme that contains a highly reactive sulfhydryl group, by hydrolyzing 
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peptide bonds, thus promoting the formation of pores between nail corneocytes 
[122,123]. 
PEs were not mixed into the marker solutions to avoid any interaction between the PE 
and the marker. After assembling the diffusion cells, the receivers and the donors 
were filled with PBS and PE solution, respectively. All PEs were dissolved in water, 
except for papain which was dissolved in PBS (pH 7.4 is the optimum papain pH), with 
the concentration of 40% for urea, 5% for TA and 2% for papain (all w/w). The pH 
values of the aqueous PE solutions were 9.23, 1.63 and 2.93 for urea, TA and TA-
urea combination, respectively. The treatment lengths were 3 days for urea and 15 h 
for TA and papain. Combinations (15 h) and serial treatments (3 days urea + 15 h TA) 
were examined as well. The treated KF or hoof was kept at ambient temperature 
during treatment, except for papain, which was equilibrated in a water bath at 32 °C. 
Afterwards, both compartments were rinsed twice with double distilled water (donor) or 
PBS (receiver) after the treatment. After the treatment with papain, both compartments 
were rinsed twice with PBS. The receivers were ultimately filled with fresh PBS and 
the donor with the marker solution. Samples of 100 µl were taken from the receiver for 
7-40 h (depending on the treatment) and replaced by the same volume of fresh buffer. 
Sampling time was adjusted for every PE. The use of TA, its mixture and serial 
application allowed for a sampling time of only up to 7 h before the KF was damaged. 
Therefore the sampling was performed hourly for all markers in the presence of TA. 
This was also the case for papain and urea (7h), except for FD4 the sampling interval 
was employed as in section 3.2.8.4 (40h). The fluorescence intensities of the samples 
were measured using a fluorescence plate reader with the same parameters as in 
section 3.2.8.4. 
3.2.8.6 Marker extraction from membranes 
Hooves and KFs (without PEs) were isolated directly after terminating the permeation. 
The membranes were rinsed with double distilled water twice to remove the rest of the 
donor solution. The residual humidity was absorbed with tissue paper and the 
membranes were finally placed in reaction vessels of 1.5 mL volume (Roth, Karlsruhe, 
Germany). These vessels were stored without lids in a desiccator for 48 h. The dried 
membranes were extracted using 1 mL aqueous solution of 2% (w/v) NaOH. These 
membranes were agitated overnight (3 days for RB) with an orbital shaker IKA Vibrax-
VXR (Staufen, Germany) at 150 rpm. The fluorescence intensities were measured 
48  Chapter 3 Materials and Methods 
afterwards, as in section 3.2.8.4. Calibration curves were performed in 2% NaOH 
aqueous solution within the same concentration ranges as in the permeation study 
with r2 values greater than 0.999.  
3.2.8.7 Determination of the extraction recovery in hoof and KF 
Hoof of 100 µm thickness and KF of 120 µm thickness (each n = 6) were given about 
10 µl drop of a defined concentration of marker solution (cstandard) in PBS and then 
weighed. The marker concentration was similar as in section 3.2.8.4. Blanks for both 
membranes were dropped with PBS only. Afterwards, drying and extraction process 
were carried out as in section 3.2.8.6. The recovery of the extraction process was 
calculated using Eq. 3.2. The detected concentration was obtained through the 
fluorescence measurement; the actual concentration was calculated using Eq. 3.3. 
The amount of the accumulated marker in the membrane from section 3.2.8.6 was 
adjusted according to the recovery result of the individual marker. 
3.2.9 Microbiological assay 
The thermogelling formulation was tested in terms of its efficacy against dermatophyte 
Trichophyton rubrum, the main cause of human tinea. TBF needs to diffuse from the 
formulation across hooves and keratin film (both as permeation barriers) to inhibit the 
growth of T. rubrum. The efficacy of the formulation is a function of the zone of 
inhibition width. An effective formulation will show a wide zone of inhibition and vice 
versa. Since hooves and keratin film were used as human nail plate models, this 
assay simulated an infected nail bed, one clinical manifestation of onychomycosis.   
3.2.9.1 Fungi strain and medium 
T. rubrum strain DSM 19959 was obtained from DSMZ (Deutsche Sammlung von 
Mikroorganismen und Zellkulturen GmbH Braunschweig, Germany) as an active 
culture. The culture was delivered and rejuvenated on an agar slant with a malt 
extract-charcoal medium at 30 °C. The medium was composed of 3% malt extract 
(Fluka Analytical, Steinheim-Germany), 0.3% medical charcoal (Caelo, Hilden-
Germany), 1.65% agar (agar-agar, Danish) from Carl Roth GmbH (Karlsruhe, 
Germany) and distilled water up to 1000 mL. Prior to use, the medium was autoclaved 
at 121 °C for 10 min. Rejuvenation of the fungal culture was done on the agar slant for 
9 days. For the assay, the medium was placed on disposable Petri dishes (92 x 16) 
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with cams (Sarstedt AG, Nümbrecht-Germany). The culture tube for the agar slant and 
the Petri dish for the assay were filled with 12 mL and 20 mL medium, respectively. 
3.2.9.2 Efficacy test of the formulation 
Preparation of the membranes 
Hooves and keratin films were prepared as for the permeation study. The thickness of 
the membranes for this assay was uniformly 100 µm. These membranes were 
autoclaved in a chemical flask filled with PB at 121 °C for 10 min. The sterile 
membranes were used within 24 h to assure a uniform hydration. 
 
Membrane treatment with the formulation 
Prior to use, all the equipment needed to be sterilized either in an autoclave (121 °C, 
10 min) or with a dry heat method in an oven at 170 °C for 1 h. First of all, membrane 
surfaces were wiped with tissue paper to remove the residual humidity. The rim of the 
donor part of the modified Franz diffusion cell was given a sufficient amount of silicone 
paste to assure close contact between the donor compartment and the membrane. 
This donor part was then filled with the sample. The underlying side of the membrane 
was backed with filter paper to avoid a direct contact with the interior of the incubation 
chamber. This assembly was then transported into a sterile box serving as an 
incubation chamber and incubated at 32 °C up to the determined time points. The 
procedure of this assay is illustrated in Fig. 3.5 (1). For a preliminary orientation, the 
membrane was treated with 1P3030 for 1, 5, 15 and 24 h (n = 3 for each hoof or KF). 
1P2525 and 1P4412 were also involved for 24 h incubation on both membranes (n = 
3). 
 
Transfer of the membrane onto the inoculated plate  
Agar plates were inoculated with a 2-weeks-old T. rubrum culture using a sterile cotton 
swab (Carl Roth, Karlsruhe-Germany). A sterile cotton swab was dipped onto the slant 
agar culture and afterwards the Petri dish containing medium was streaked evenly 
over the entire surface in three directions. The plate was allowed to dry for 15 min 
before being used in the assay.  
 
50  Chapter 3 Materials and Methods 
 
Fig. 3.5 Microbiological assay procedure for testing the efficacy of the formulation 
 
The previously treated membrane was isolated from the donor of the diffusion cell and 
the remainings from the formulation were wiped off with sterile cotton swabs. The 
cleaning process is a crucial step to avoid the spreading of the formulation residues 
over the membrane during the subsequent incubation. A spread formulation would 
cause a wider zone of inhibition due to a higher TBF amount. An untreated and sterile 
membrane was used as the positive control for this assay. 
The membrane was transferred in such a way that the upper side which was 
previously in contact with the formulation stayed on top (see Fig. 3.5 (2)). In other 
words, TBF needed to permeate across the membrane to inhibit the growth of T. 
rubrum. The permeation rate was expected to be different from each formulation 
depending on its composition. The Petri dishes containing these assemblies were 
subsequently incubated at 30 °C for 9 days. After 9 days, the diameter of inhibition 
was measured which  is defined as the diameter where no fungal growth could be 
observed. 
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3.2.10 Statistical analysis 
3.2.10.1 Statistical analysis for the permeation study  
All data were presented as means ± standard deviations. Statistical analysis was 
performed with the software program PASW Statistics 18. The Kolmogorov-Smirnov 
or the Shapiro-Wilk test was applied to assess the normality of the data. When the 
data were normally distributed, F-test was performed to examine the variances 
between the groups, continued with the Student’s t-test (two tails,  = 0.05) for testing 
the significance of the differences between the means. p values of <0.05 and <0.01 
are considered as significant and highly statistically significant, respectively. ANOVA 
can also be applied to test the differences of the means between groups (more than 
two groups).  
When the variances of the samples were unequal, Welch’s test or Brown-Forsythe’s 
test was used to test the difference of the means. A post-hoc test can also be applied 
to track the group which gives the significant difference to the result. As example, 
Games-Howell’s post-hoc test is used when the variances of the sample as well as the 
number of the samples are not equal.  
3.2.10.2 Statistical analysis for the stability test of TBF 
Means of the concentrations from each group of the stability test data were compared 
with one way ANOVA test at 0.05 level followed by a post-hoc Gabriel test. Gabriel 
test was performed since the samples of the stability test were not equal (ranging from 
3 to 5). 
 
  
Chapter 4 
Results and Discussion 
4.1 Physicochemical characterization of the formulations  
The formulations were characterized macroscopically and microscopically. Complex 
viscosity and gelation temperature were determined for some selected formulations. 
Small angle X-ray diffraction was employed as well to detect the presence of a liquid 
crystal structure. 
4.1.1 Appearance and consistency of the formulation [100] 
The produced 5-component-systems resulted in a broad range of consistencies and 
appearances, from liquid to paste-like consistencies. The semisolid area of the 
pseudoternary phase diagram could be distinguished as cream-, gel- and paste-like, 
meanwhile the liquid area included milky/white and transparent appearances. The 
liquid formulations could be further characterized as homogeneous and 
inhomogeneous.  
As can be seen from Fig. 4.1 (a) the border between the liquid and semisolid area was 
mainly determined by IPA/DMIS content. More than 35% of IPA/DMIS resulted in 
liquid formulations; except for low POX/MCT, a liquid formulation was already 
achieved with 30% IPA/DMIS. Some liquids with POX/MCT<35% were 
inhomogeneous. An area of transparent mixtures, possibly microemulsions, could be 
found within these liquids as well. Semisolid formulations existed in a region with low 
content of IPA/DMIS (<40%), while appearances and consistencies varied. The 
consistency rather increased with increasing amount of POX/MCT whereas the 
appearance changed from cream-like (25-50% POX/MCT) to highly viscous gel-like 
(50-70% POX/MCT) and then paste-like (≥70%). The addition of 2% TBF into these 
bases extended the liquid area and transformed the appearances of some 
formulations, e.g. from transparent to milky-inhomogeneous as shown in Fig. 4.1 (b).  
From the pseudoternary phase diagram in Fig. 4.1, it can be seen that water and 
IPA/DMIS play an important role in terms of consistencies and appearances of the 
formulations. Appearances and consistencies depend on the degree of POX swelling 
especially by water, considering that POX swells better with water than with organic 
solvents. A lack of water and an excessive amount of IPA/DMIS lead to 
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inhomogeneous systems. On the other hand, IPA/DMIS enables a complete 
solubilization of POX and the oily component (MCT); this was evident from the liquid 
area with transparent appearance. An optimum composition of all components 
resulted in stable formulations, e.g. cream-like or milky-white (macro)emulsions.  
 
 
 
Fig. 4.1 (a) Appearances in pseudo ternary phase diagram without and (b) with 2% TBF; the 
line in the middle separates liquid from semisolid systems [100] 
 
The enlargement of the liquid area upon addition of 2% TBF hints at the participation 
of TBF in POX micellization. TBF, a lipophilic drug with log P of 3.3, would preferably 
reside close to POX hydrophobic part/ PPO; any interaction with this block will hamper 
the dehydration process, the origin of the gelation process [124]. As a consequence, 
the liquid area was larger compared to that without TBF. The observed appearances 
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and consistencies were the same as in the case when Miglyol® 840 was used [3]. This 
indicated that the oil substitution did not affect the resulting appearances. 
4.1.2 Ringing effect and isotropy [100] 
A special feature of semisolid drug-free systems with creamy appearance was the 
existence of a so called “ringing effect”, which was noticeable upon slight mechanical 
agitation. This phenomenon is however not specific for POX containing formulations, 
but mostly occurs in systems of liquid crystalline cubic phases [89,125] which are 
highly elastic with shear modulus between 104-106 Pa [126]. Formulations with ringing 
effect were located in a particular area with 30-60% water, 25-50% POX/MCT and 10-
30% IPA/DMIS (Fig. 4.2). The addition of 2% TBF shifted this area slightly to the 
upper level of the phase diagram, now ranging from 30%-60% POX/MCT. The 
addition of 2% TBF to the formulations moved the area to the upper part only, whilst 
the area broadness was kept. Compared to formulations containing Miglyol® 840, 
Miglyol® 812N did not change the location of the systems with ringing effect at all, but 
the anisotropic area became somewhat narrower [3].  
 
Fig. 4.2 Ringing effect of formulations with and without 2% TBF [100] 
 
The anisotropic formulations could only be found in the area with high content of POX/ 
MCT. The addition of 2% TBF also enlarged the anisotropic area as shown in Fig. 4.3 
from ≥70% POX/MCT to ≥60% POX/MCT. The anisotropic formulations resulted from 
a POX solubility decrease within the systems. The crystalline characteristics of POX 
were confirmed by the appearance of a characteristic POX reflection in the wide-angle 
X-ray diffractograms [3]. In this present study, TBF extended the anisotropic area and 
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this can be explained through the water competition between POX and TBF, regarding 
that TBF is also partially soluble in water. Thereafter, POX crystallizes out easier, 
which is birefringent under the polarizing microscope. 
 
Fig. 4.3 Isotropy of formulations with and without 2% TBF [100] 
 
 
Fig. 4.4 TBF concentrations at saturation (a) and an example of TBF crystals under polarizing 
microscope (b); □ < 2%, ● 2%, ■ 3%, ▲ 4% [100] 
 
4.1.3 TBF solubility in the formulation [100] 
TBF solubility up to 4% was achieved for several formulations and these formulations 
resided just next to the border between semisolid and liquid area (Fig. 4.4 (a)). An 
example of insoluble TBF in the formulation examined under polarizing microscope is 
shown in Fig. 4.4 (b). Since TBF solubility up to 4% has already been achieved with 
the semisolid formulations, the liquid area (where POX/MCT<25% and 
0 20 40 60 80 100
0
20
40
60
80
100 0
20
40
60
80
100
 isotropic
 anisotropic (without TBF)
 anisotropic (with 2% TBF)
P
O
X
/M
C
T
 (4
:1
)
W
A
T
E
R
IPA/DMIS (1:1)
0 20 40 60 80 100
0
20
40
60
80
100 0
20
40
60
80
100
P
O
X
/M
C
T
 (4
:1
)
W
A
T
E
R
IPA/DMIS (1:1)
(a) (b) 
56 Chapter 4 Results and Discussion 
 
IPA/DMIS40%) was no longer taken into account for topical application in this study. 
On the other hand, only up to 1% TBF was soluble in the Basiscreme DAC and an 
attempt to incorporate more TBF in Lamisil® Creme up to 1.5% was not successful 
either. These results could be used as an orientation to assess TBF’s thermodynamic 
activity in the formulations. For comparative purposes a POX hydrogel containing 20% 
POX and 80% water was also prepared and supplemented with 1% TBF. This 
formulation resulted in a transparent, semisolid (at 20 °C) and not ringing formulation. 
TBF was completely dissolved in the system. 
4.1.4 Rheometrical measurement: complex viscosity and gelation temperature 
[100] 
Several formulations containing TBF from the semisolid area of the pseudoternary 
phase diagram were rheometrically characterized, in terms of their complex viscosities 
and gelation points. As depicted in Fig. 4.5 and Fig. 4.6, TBF had a stronger influence 
on gelation points than on complex viscosities. The incorporation of TBF up to 2% 
resulted in only slight changes in complex viscosities. The mean values oscillated with 
an upwards trend towards higher POX/MCT contents. A drop in complex viscosity was 
observed initially at 3% TBF for the formulation with low content of POX/MCT, e.g. 
P2525 (see Fig. 4.5). In contrast, gelation points increased remarkably upon TBF 
addition. Changes were dramatic with increases in POX/MCT. TBF addition from 2% 
to 3% increased gelation point temperatures from below 5 °C (lower temperature limit 
applied) to 25 °C for P3535, whereas P3030 changed its gelation point only from 8 to 
15 °C for equal TBF concentrations. A linear correlation between TBF content and 
gelation point increase could be drawn for P3030, but this was not the case for other 
formulations.  
Formulations with higher POX content needed apparently more stress to enable the 
gelation point detection. All examined formulations could be tested rheometrically at 
shearing stress of 100 Pa, except for the gelation point detection of P3535. Its gelation 
point could only be measured at TBF contents of 3% and 4% under a shearing stress 
of 200 Pa. Further formulations with even higher POX/MCT contents (≥35%) were no 
longer measurable, with respect to gelation points, even with increasing shearing 
stress up to 400 Pa. Since gelation points of 1P3030, 1P3535 and 2P3535 could not 
be detected by rheometer within the temperature range applied (30 °C – 5 °C), they 
were not plotted on the graph (Fig. 4.6). 
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TBF showed a stronger influence on the gelation process than on the complex 
viscosities of the formulations (at least up to 2% TBF addition). The measurement of 
the complex viscosity had to be done at 32 °C which guaranteed for the viscoelastic 
state needed. However, this temperature was apparently not appropriate to detect any 
influence of TBF on the complex viscosity. Furthermore, all the formulations examined 
showed gelation temperatures below 32 °C; above the gelation temperature, no sharp 
change in viscosity can be observed. 
 
Fig. 4.5 Complex viscosity of several semisolid formulations (n = 3) [100] 
 
 
Fig. 4.6 Gelation point of several semisolid formulations (n = 3); All measurements were 
carried out at 100 Pa, except for POX3535 at 200 Pa [100] 
 
Other substances, which increased POX gelation temperature, have been 
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and also vice versa, substances which decreased it: vitamin B12, sorbitol, 5-ALA and 
NaCl [5,127-129]. All those substances have the ability to modify particularly PPO 
block solubility in water, thus delaying or accelerating POX micellization process. The 
increase in gelation temperature upon TBF incorporation was however not in line with 
the expected effect of chlorine salts, which generally accelerate micellization due to 
their ability in reducing water activity/ salting out [130] or what has recently been 
described as water-structure-shaper [130-132]. Therefore, terbinafine cation must 
have a major role in affecting POX gelation process compared to its chloride anion. 
This phenomenon has also been observed from lithium chloride [132].  
4.1.5 Small angle X-ray diffraction (SAXD) 
SAXD enables to identify the presence of a liquid crystal structure through the 
scattered X-ray by an ordered crystal lattice. The hint at the liquid crystal structure has 
been signalized through the presence of a ringing effect in several thermogelling 
formulations, especially from P2525, the original thermogelling formulation. The early 
hypothesis led to the cubic structure since these thermogelling formulations featured a 
high viscosity, isotropy and ringing effect; these are characteristics of the cubic 
structure [87]. However, this assumption has not yet been further examined by 
Grüning before [2]. 
Small angle X-ray diffraction of the formulations with ringing effects hinted at the 
presence of the cubic structure Pn3m, which is displayed in Table 3.2 and Fig. 4.7 as 
“kub 2”. This structure was evident particularly from P2525, which reflections followed 
the order of Pn3m structure, i.e., according to Bragg ratio: 1:
: : : : : :2 3 4 6 8 9 10 . The addition of TBF and the application of heat modified 
the peak intensities.  
Fig. 4.7 presents the structure of P2525 upon addition with TBF and heating to 40 °C. 
At a constant temperature of 20 °C, the structure was still distinct upon incorporation 
of 1% TBF (black line). With 3% TBF at similar temperature (blue line), the intensity 
weakened and the spacing order could not be recognized clearly. Heating to 40 °C 
amplified the peak intensities so that 3P2525, which was not visible at 20 °C, became 
distinct (orange line). This was also the case for 1P2525, which intensity increased 
upon heating to 40 °C. 
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Fig. 4.7 SAXD results of P2525 with varied TBF content (0%, 1% and 3%) and upon heating 
(20 and 40 °C)  
 
 
Fig. 4.8 SAXD results of P2525, 1P2525, 1P4020 and 1P5015 at 20 °C; sheet for the cubic 
structure estimation and calculation had been developed by van Hemelrijck [6]. 
 
In contrast to the SAXD result from P2525, SAXD results from 1P4020 and 1P5015 
(Fig. 4.8) could not be  interpreted due to their high intensities. However, the following 
two peaks (pointed with black arrows) were similar to P2525’ spacing order. The 
assumption that 1P4020 and 1P5015 may possess a cubic structure is not completely 
excluded since both formulations feature the ringing effect. The structure which may 
be displayed by 1P4020 and 1P5015 might though be different from P2525 structure. 
0.25 0.50 0.75 1.00 1.25 1.50
2000
4000
6000
8000
 P2525 20 °C
 1P2525 20 °C
 1P2525 40 °C
 3P2525 20 °C
 3P2525 40 °C
h [nm
-1
]
In
te
n
s
it
y
 [
a
.u
.]
 kub1
 kub2
 kub3
 kub4
0.25 0.50 0.75 1.00 1.25 1.50
0
2000
4000
6000
8000
10000
 kub1
 kub2
 kub3
 kub4
In
te
n
s
it
y
 [
a
.u
.]
h [nm
-1
]
 P2525
 1P2525
 1P4020
 1P5015
60 Chapter 4 Results and Discussion 
 
Liu and Chu [133] reported the transformation of the cubic structure, i.e., from face-
centered cubic (fcc) within the concentration range of 20-40% to body-centered cubic 
(bcc), which was observed when the concentration of POX 407 aqueous hydrogel 
increased to 50%.  
The SAXD results showed at least that the isotropic formulations with ringing effects 
are likely to be cubic liquid crystals although the data presented here are still limited 
for characterization in detail. P2525 retained its cubic structure upon addition of 1% 
TBF whereas the reflections disappeared after the incorporation of 3% TBF (20 °C). 
Since the cubic structure is a consequence of the micellization process, TBF addition 
will also influence the gelation temperature of the formulation; this is in agreement with 
the rheology result in the previous section. Briefly, TBF was shown to be a POX-
structure breaker, both from rheology and SAXD measurements. Heating, on the other 
hand, amplifies SAXD intensity thus makes the order more visible. Increasing the 
temperature turns POX more hydrophobic due to the progressive PPO dehydration 
and at a definite point, gelation occurs [134]. TBF as a structure breaker shifts POX 
gelation point to a higher temperature only; this indicates that the formulation can gel. 
The reappearance of 3P2525 peaks upon heating to 40 °C hinted at the gelation of the 
formulation. Such a gelation had not happened at 20 °C. 
4.2 TBF stability in aqueous media 
As TBF is a relatively new drug in the market, no stability data of TBF have been 
reported so far. Regarding the use of aqueous media in some experiments of this 
study, TBF stability under the influence of different pH values and temperatures was 
evaluated. 
4.2.1 Influence of pH on TBF stability 
Lebo et al. [109] reported TBF stability in aqueous solution up to 72 h when buffered 
at the pH of 5.8. The degradation in aqueous solution occurred even after the addition 
of antioxidants, e.g., ascorbic acid and sodium metabisulfite [109]. Unfortunately, the 
report of TBF stability from Lebo et al. [109] did not include the information on the 
initial TBF concentration. TBF degradation occurred as well when methanol and 
acetonitrile were used as solvent [76,77]. Hitherto, the degradation mechanism of TBF 
has not been reported. TBF degradation apparently deals with hydrolysis since TBF in 
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a dry state, e.g., tablet was reported to be stable up to six months in a stress condition 
(40 °C, 75% RH) [77].  
Two buffers at pH 5.8 (PB) and pH 7.4 (PBS) were employed in the present study to 
examine TBF stability for 144 h. UV spectra from both pH values can be seen in Fig. 
4.9. 
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Fig. 4.9 UV spectrograms of 0.1% TBF solution in PB 5.8 and PBS 7.4 for up to 144 h 
 
No changes were observed up to 48 h from TBF solution in PB. After 144 h, the peak 
at 251 nm split into two peaks. Apart from that, the maximum peak occurred at 283.5 
nm and the profiles remained unchanged during the examination. In contrast to PB, 
the absorbance profiles in PBS changed dramatically after 24 h, marked by the 
disappearance of the first peak at 202.5 nm. Yet, the main peak at 223.5 nm remained 
unchanged. From this observation, pH 5.8 is sufficient to maintain TBF stability for the 
permeation study within 48 h. Changes in absorbance of TBF at 251 nm were 
displayed in Table 4.1. A further discussion to this finding will be given in the next 
section 4.2.2.  
Table 4.1 Absorbance (A) of TBF in PB at ambient temperature 
Time [h] A at 251 nm 
0 
2 
24 
48 
144 
0.394 
0.429 
0.400 
0.418 
0.374 
 
The different UV spectra of TBF under different pH values corresponded well with the 
work reported by Egle [135]. Depending on the pH value applied, TBF chromatograms 
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showed different patterns and peaks measured by means of HPLC with a UV detector 
[135]. 
4.2.2 Influence of temperature on TBF stability 
Besides the influence of pH value, the influence of temperature on TBF stability was 
examined as well since permeation study is commonly carried out at higher 
temperatures than 20 °C to mimic the skin surface temperature (32 °C) or the body 
temperature of 37 °C. 
 
20 °C 32 °C 
 Fig. 4.10 TBF concentration in PB, water or PBS up to 72 h at 20 °C and 32 °C 
 
Changes in TBF concentrations at two different temperatures and in 3 different media 
during storage are displayed in Fig. 4.10. Surprisingly, PB increased TBF 
concentration to 120% for both temperatures after 24 h. Solvent evaporation seemed 
to be impossible since all the samples were packed in gas-tight vials. Therefore, an 
increase in TBF molar absorptivity (ε) at both temperatures in PB (hyperchromic shifts) 
was suggested. A slight increase in TBF absorbance during the early storage period in 
section 4.2.1 was observed as well from the first 2 h in PB (see Table 4.1). Afterwards, 
TBF absorbances remained about constant and decreased after 48 h. 
The hyperchromic shift of TBF in an acidic milieu was possibly a result of a 
conjugation extension of TBF’s double bonds or -stacking interaction which 
commonly occurs between aromatic rings [136]. Unfortunately, there is no report 
associated with TBF so far. A similar finding has been reported by Peters from 
estradiol aqueous solution [137]. The concentration of estradiol solution increased 
steeply during storage from day 7 to 17, whereas the degradation product estron was 
first detected after day 17. The concentration of estradiol increased overall from 5 to 8 
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µg/mL during these 10 days. Furthermore an additional peak with earlier retention time 
had been detected after 8 days which was considered as “ghost peak”. In contrast to 
estradiol, no ghost peak was detected either from the HPLC chromatograms or from 
the UV spectra as seen in Fig. 4.9. This increase in concentration was specific only for 
PB and was not observed in water and PBS. TBF solution in PB was also measured 
by means of photon correlation spectroscopy (ZetaSizer Nano Series ZS ZEN 3600 
from Malvern Instrument Ltd.) to detect any aggregate that might have been formed in 
pH 5.8. However, no aggregation could be detected and thus still no further 
explanation to this phenomenon. Some possible explanation to this phenomenon 
could be -stacking formation of TBF aromatic rings which elevated TBF molar 
absorptivity thus its absorbance or the formation of (a) degradation product(s) that 
exhibited similar absorption maxima as TBF did. A further investigation is needed to 
elucidate this phenomenon in detail. 
TBF concentrations decreased readily in other media, i.e., water and PBS. The 
degradation rate was higher with increasing temperature. Nevertheless, TBF was 
more stable in water than in PBS. TBF content in water was reduced by 10% and 15% 
after 48 h at 20 °C and 32 °C, respectively. In PBS TBF deterioration was more 
dramatic; 45% within 48 h at 20 °C and about the same within 24 h at 32 °C. The fact 
that TBF degraded faster in PBS rather than in water hinted at a strong influence of 
electrolytes to the degradation process. In an acidic milieu of pH 5.8, however, TBF 
stability was sufficiently maintained for the permeation study.  
4.3 TBF stability in the formulations 
This study was carried out to examine TBF stability in the formulations during storage 
at 20 °C in a climatized room. A stability study is important since the formulation may 
exhibit unexpected changes during storage. Alterations which may occur encompass 
larvated incompatibilities and drug degradation due to the storage conditions, such as: 
temperature, humidity and packing material. Macroscopical changes of the 
formulations and TBF content were followed for six months and three months, 
respectively. The macroscopical observations comprised changes in appearance, 
physical state and phase separation meanwhile TBF contents in the formulations were 
determined by means of HPLC subsequent to extractions. 
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4.3.1 Macroscopical changes of the formulations 
After one month of storage, there were no significant changes in physical appearance 
of the formulations containing 1% TBF except for few formulations which turned 
yellow. This alteration occurred to almost all formulations with IPA/DMIS of ≥40% and 
POX/MCT between 25-50%. After three months, the area in the phase diagram 
representing systems with yellow color grew; now occupying an area with POX/MCT 
between 25-60% including one formulation that contained 30% IPA/DMIS. After six 
months, almost all formulations with IPA/DMIS of ≥25% and POX/MCT between 25-
60% underwent this alteration. All these changes are depicted in Fig. 4.11. In addition, 
the color intensity increased along with the increase in IPA/DMIS contents in the 
formulations as well as with the increase in storage duration. TBF loading of the 
formulations also increased the yellow color intensity.  
Besides the yellow color alteration, there was also a fairly dynamic macroscopical 
change observed especially in the liquid area. After three months, all transparent 
mixtures in the study turned turbid/ white or inhomogeneous and one liquid formulation 
(1P2530) turned creamy. After six months, some liquid formulations were again 
observed as transparent but they were surely not exactly the same transparent 
formulations as in the initial state. Alteration in the semisolid area became noticeable 
as well after six months where the gel-like and paste-like area broadened. This was 
likely caused by the evaporation of volatile compounds such as IPA and water since 
air-tightness of the packaging was not fully guaranteed. Overall, the liquid formulation 
was apparently very sensitive towards storage, especially when the packaging used 
did not ensure air-tightness.  
Since all the formulations affected by the yellow color alteration were liquid, this color 
change occurred somehow faster within the first three months than after the 3rd month 
when the semisolid formulations also started to turn yellow. Formulations without TBF 
did not turn yellow even after one year of storage; this was confirmed by van 
Hemelrijck and Müller-Goymann [91]. The alterations of the bases which have been 
reported before were liquefaction, microbial growth and phase separation after one 
year of storage in a similar storage condition [91]. Since the alteration rate was faster 
in liquid formulations, the high content of IPA/DMIS was suspected to be responsible 
for this. In addition, a low viscosity and a liquid state favor chemical reaction. Such an 
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alteration could also originate from a larvated incompatibility between the constituents 
which will be elaborated in the next section. 
 
 
Fig. 4.11 Macroscopical changes of thermogelling formulations containing 1% TBF during 
storage at 20 °C after one (a), three (b) and six (c) months 
   
4.3.2 Finding the instability and/or incompatibility trigger  
Following the result of the previous section where alteration occurred during storage, it 
was then necessary to identify the trigger of the alteration. By having some reactive 
functional groups, i.e., double bonds and tertiary amine, TBF may undergo a chemical 
reaction with any of the formulation components (incompatibility) or degrade due to 
hydrolysis in the presence of water.  
After one month of storage, the reason for the alteration was identified. As can be 
seen from Table 4.2, all the mixtures containing DMIS turned yellow. This did not 
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occur in other mixtures. This result hinted at a particular chemical reaction between 
TBF and DMIS or its major impurities since the base itself did not undergo this 
alteration. Since the product is observable (yellow) under visible light, it is suggested 
that a product with higher molecular weight was formed.  
Table 4.2 Binary and multiple mixtures to identify the trigger of alteration in the formulations  
Mixture TBF POX MCT IPA DMIS Water Result 
1 X  X    n.a. 
2 X   X   n.a. 
3 X    X  yellow 
4 X     X n.a. 
5 X X X    n.a. 
6 X X  X   n.a. 
7 X X   X  yellow 
8 X X    X n.a. 
9 X X  X X  yellow 
10 X X  X  X n.a. 
11 X X  X X X yellow 
 0.2 g 1.96 g 0.49 g 3.43 g 3.43 g 0.49 g total: 10 g 
     n.a.: no alteration was observed 
 
4.3.3 Changes in TBF concentrations during storage  
TBF concentrations in the formulations after three months of storage are displayed in 
Fig. 4.12 and Table 4.3. After one month, the concentration decreased by about 5% 
and after three months, TBF final concentrations were outside the permitted area 95-
105%, i.e., between 71–79%.  
After one month, almost all formulations were still within the permitted concentration 
except 1P3040 and 1P4040 which were distinctly lower than 95%, and 1P2836 and 
1P2525 which were just below 95%. The least degradation was given by 1P4412 
(3.22%) and the maximum one was shown by 1P4040 (8.57%). After three months, 
the minimum degradation was surprisingly shown by 1P3040 with 22.56% and the 
highest one was given again by 1P4040 with 30.67%. Statistical analysis ANOVA 
revealed that TBF changes after one and three months were significantly different 
(p<0.05) from the initial TBF concentration C0. Among all formulations, 1P4412 was 
the one with the significantly highest stability (p<0.05) with only 3.22% degradation 
after one month. As a note, 1P4412 was also the formulation with the least IPA/DMIS 
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content. TBF decreases were particularly high from formulations with high contents of 
IPA/DMIS, with 1P3040 and 1P4040 as examples. A high content of IPA/DMIS in the 
formulation produced a low viscosity, and accordingly liquid formulations, which may 
accelerate the degradation process.  
 
Fig. 4.12 TBF concentrations in formulations within three months of storage at 20 °C (n = 3) 
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Table 4.3 Changes in TBF concentration [%] from selected formulations during storage  
Formulation 
Initial 
concentration 
(C0) 
C after 1 
month (C1) 
C after 3 
months (C3) 
C1 – C0 C3 – C0 
1P3040 99.51 ± 0.51 93.79 ± 0.70 76.95 ± 0.63 -5.71 -22.56’ 
1P3333 102.93 ± 2.68 96.82 ± 1.46 78.32 ± 1.09 -6.11 -24.62 
1P3824 103.43 ± 1.27 95.74 ± 1.32 79.06 ± 1.25 -7.69 -24.38 
1P4412 102.31 ± 0.73 99.09 ± 0.73 77.21 ± 0.40 -3.22*’ -25.09 
1P5025 103.45 ± 1.77 96.74 ± 1.29 79.03 ± 0.40 -6.71 -24.42 
1P2836 101.00 ± 3.04 94.57 ± 1.53 78.26 ± 1.81 -6.43 -22.75 
1P4030 101.49 ± 4.54 97.19 ± 0.37 77.15 ± 0.90 -4.30 -24.35 
1P2525 102.23 ± 0.08 94.73 ± 1.01 77.39 ± 0.61 -7.50 -24.84 
1P3030 105.02 ± 1.12 96.78 ± 2.28 77.81 ± 0.30 -8.24 -27.21 
1P4040 102.16 ± 1.13 93.58 ± 0.89 71.49 ± 0.28 -8.57” -30.67” 
*p<0.05 (one way ANOVA with Gabriel post-hoc test at the 0.05 level); n = 3-5; ‘the least TBF 
degradation; “the highest TBF degradation 
 
 
Fig. 4.13 TBF concentrations of the thermogelling formulations stored in unguator jars at 20 
°C for up to three months (n = 3) 
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from the formulation occurred. As expected, TBF contents rose during the storage as 
depicted in Fig. 4.13. In this manner, TBF concentrations after one month increased 
remarkably to over 125%. After three months, TBF concentrations even reached 
160%, a value which was not realistic. Thereafter, these results hinted at the 
importance of a proper packaging for the stability study although the unguator jars 
reflect the common packaging of semisolid formulations.  
Referring to pharmacopoeial requirements in terms of the drug content in the 
formulation established, this shall generally amount to 95–105%. This requirement 
could be fulfilled by the thermogelling formulations containing 1% TBF up to one 
month only. 1P3040 and 1P4040 failed to meet this requirement. In accordance to 
this, the POX-based thermogelling formulations would still be suitable as vehicles for 
extemporaneous preparations containing TBF for up to one month at a storage 
temperature of 20 °C. 
4.3.4 Thin layer chromatography (TLC) 
TLC can separate substances from a mixture according to their polarities and affinities 
to either stationary or mobile phase. The stationary phase used in this study was silica 
gel that was immobilized on a glass plate. Silica gel is considered as polar. The mobile 
phase used was rich in chloroform and was considered as non-polar. In such a 
system, a polar substance will show a higher affinity to the polar stationary phase so 
that the spot will be visible earlier with a low RF value. This is vice versa for a relatively 
non-polar substance. In other words, substance separation by means of TLC is a 
competitive process between the stationary and the mobile phase.  
The result of separation from the examined formulations by means of TLC is displayed 
in Fig. 4.14. Generally, all formulations containing TBF showed spots at RF 0.66-0.74. 
According to the reference standard (1% TBF in methanol), those spots belonged to 
TBF. Additionally, extra spots at lower RF of 0.09-0.11 were shown by formulations 
containing TBF which have been stored for one month. The spot at lower RF was not 
evident from the freshly prepared TBF solution in methanol nor from the bases without 
TBF (e.g., P2570, P2530, P2550 and P2560). The intensity of the spot at this low RF 
was found to be dependent on TBF concentration in the formulation. As expected, the 
spot intensity was stronger from formulations with higher content of TBF and 
formulations after storage. Referring back to the system used, the spot with low RF 
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value should be a polar substance. Furthermore, this spot should be much more polar 
than TBF and was tightly bound to the stationary phase. 
 
Fig. 4.14 Separation of one-month-old formulations with 1% TBF solution in methanol as 
reference 
 
From the previous section, it may be concluded, that the alteration occurred due to a 
“larvated incompatibility” of TBF with DMIS and this new spot could be the product of 
this interaction. For further identification of the substance of this new spot, isolation 
and a further elucidation by means of other analytical methods are required. 
TBF spots from the freshly prepared solution and from the formulations were slightly 
different in their RF  values. The RF value of TBF spot from the freshly prepared 
solution was slightly lower compared to those from the formulations. Different 
environments of both samples can cause this phenomenon. TBF can behave 
differently in environments with different pH values or upon the presence of other 
substances. However, since TBF appeared as a single spot, this slight difference in RF 
values can be considered as insignificant.  
4.3.5 Resume of TBF stability study  
TBF stability was proven to be pH dependent. As reported by Lebo et al. [109], pH 5.8 
was found to be the most suitable pH for TBF aqueous solution since TBF degraded 
faster in water and PBS (pH 7.4). In this study, UV spectrograms remained unchanged 
for up to 48 h (Fig. 4.9). Changes occurred in PBS even earlier after 24 h. TBF 
degradation rate increased as the storage temperature increased from 20 °C to 32 °C. 
The ranking of TBF degradation rate in various aqueous media was PBS>water>PB. It 
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is interesting that TBF absorbance in PB increased by 20% and this remained for 48 
h. Since evaporation of the solvent from the packing was rather impossible, a 
hyperchromic shift due to the elongation of TBF’s double bonds conjugation or -
stacking interaction which commonly occurs between aromatic rings might be 
responsible for this phenomenon. Of course the formation of (a) degradation 
product(s) with similar absorption maxima to TBF is possible as well. Unfortunately 
this cannot be detected from either UV spectogram or HPLC chromatogram. 
Therefore, a further investigation is needed to elucidate this phenomenon in detail. 
Changes in appearances were observed from the thermogelling formulations with and 
without TBF. While the alteration of the bases was in line with the report of van 
Hemelrijck and Müller-Goymann [91], the formulations containing TBF turned yellow 
during storage. The color change started earlier in formulations with high content of 
IPA/DMIS than in formulations with low IPA/DMIS content.  
TBF was more stable in most of the formulations than in the aqueous solution. TBF 
concentrations from all examined formulations were over 95% after one month storage 
at 20 °C. A faster TBF degradation was observed for formulations with high content of 
IPA/DMIS. After three months, all TBF concentrations in the formulations were less 
than 95%. In other words, these thermogelling formulations containing TBF were only 
stable up to one month at 20 °C. The decrease in TBF amount correlated well with an 
increase in yellow color intensity happening first in formulations with high IPA/DMIS. 
Thereby and in accordance with observations from the binary and multiple mixtures, it 
was concluded that the TBF instability was triggered by a larvated incompatibility 
between TBF and DMIS. The presence of a degradation product was visible from TLC 
separation. All formulations undergoing color changes exhibited an extra spot at lower 
RF. Since the eluent used was non-polar and the stationary phase was polar, this 
additional spot was suggested to be polar. 
4.4 Permeation study across human SC [100]  
Skin is the site where dermatophytosis occurs frequently. In accordance to this, the 
performance of POX-based formulation containing 1% TBF was examined across 
human SC compared with other vehicles containing 1% TBF as well. In addition, some 
formulations with higher TBF amounts (2% and 4%) were evaluated as well.  
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4.4.1 Thermogelling formulations vs. other vehicles  
A formulation containing 1% TBF was chosen, i.e. 1P2525, and its permeation flux 
across SC was compared with Basiscreme DAC and Lamisil® Creme, with respect to 
their comparable creamy consistencies. A steady state flux could be achieved as 
shown in Fig. 4.15 for all the formulations with slight differences in their lag times. The 
permeated amounts were ranked 1P2525>Lamisil® Creme>Basiscreme DAC while 
the ranking of the fluxes was 1P2525>Basiscreme DAC>Lamisil® Creme (see Fig. 
4.16). 1P2525 flux was around 1.4-fold higher compared to Lamisil® Creme and 
Basiscreme DAC. However, all fluxes were not significantly different (p>0.05). This 
was also the case for the lag times which were comparable as well (see Fig. 4.17).   
 
Fig. 4.15 Permeation of TBF from 1P2525, Lamisil® Creme and Basiscreme DAC across SC 
(n = 4-9); donor: ♀, 38-year-old [100] 
 
 
Fig. 4.16 TBF fluxes (mean ± SD) across SC from 1P2525, Lamisil® Creme and Basiscreme 
DAC (n = 4-9) [100] 
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Fig. 4.17 TBF lag times (mean ± SD) across SC from 1P2525, Lamisil® Creme and 
Basiscreme DAC (n = 4-9) [100] 
 
TBF was completely soluble in all the tested formulations for the permeation study, 
including Lamisil® Creme and the Basiscreme DAC containing 1% drug. 1P2525 
contained more water than Basiscreme DAC (50% vs. 40%) and this could be an 
advantage for the permeation. The water content of Lamisil® Creme is unfortunately 
not known for comparing this result, but its flux was similar to that from Basiscreme 
DAC. The ability of water in increasing drug diffusion across skin has been assigned 
to its interaction with the SC’s lipid polar head groups thus loosening the lipid packing 
and providing more space for diffusion [28,29].  
Up to 2% TBF was dissolved in P2525, meanwhile in the Basiscreme DAC drug 
dissolution was only possible up to 1%. This showed that the thermodynamic activity 
of 1P2525 was actually lower than that in the Basiscreme DAC, whilst the drug activity 
in the Basiscreme DAC was close to maximum. TBF thermodynamic activity in 
Lamisil® Creme was close to maximum as well since the vehicle did not enable TBF 
loading up to 1.5%. If the permeation was only depending on the thermodynamic 
activity of the formulation, then Basiscreme DAC and Lamisil® Creme should have 
given a higher flux value than 1P2525 did, but this was not the case. The nature of the 
vehicle and its interaction with TBF might thus play also a major role. 
Differences in vehicle type, construction of a gel network and its tortuosity will affect 
TBF binding with the vehicle and thus TBF release rate. For example, Gendy et al. 
[138] found that flurbiprofen release from carbomer gel was higher than from POX 407 
gel. They suggested that this was due to the different microstructure and release 
mechanism from both gelling agents. Despite similar appearances of P2525, 
Basiscreme DAC and Lamisil® Creme, POX vehicle contains more hydrophilic 
ingredients than other creams so that TBF binding with this vehicle is apparently 
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weaker. A strong influence to the skin lipids such as their fluidization or disruption of 
lamellar sheets could enhance drug permeation rate as well and measurements by 
means of DSC could help in visualizing this (see section 4.7).  
4.4.2 TBF permeation from thermogelling formulations containing more than 
1% TBF  
The enhancement factors from formulations with more than 1% TBF are listed in Table 
4.4. Increasing TBF concentration in the formulation led to an increase in TBF 
permeation flux. The enhancement factor was significantly different (p<0.05) only for 
P4030 containing 4% TBF whereas for all formulations tested with 1% TBF the fluxes 
were similar. Due to high standard deviations of 2P2525 and 2P3030, a significantly 
different enhancement could not be deduced. Permeation profiles of formulations 
containing more than 1% TBF can be seen in Fig. 4.18 - Fig. 4.20. 
Table 4.4 TBF fluxes (mean ± SD) and enhancement factors from thermogelling formulations 
containing TBF of more than 1% 
Formulation [% TBF] 
Flux at steady state  
x 10-11 [g/cm2s] 
Enhancement factor  
[-fold] 
1P2525 
2P2525 
1 
2 
4.56 ± 0.84 
15.00 ± 12.60  
 
3.3 
1P3030 
2P3030 
1 
2 
3.38 ± 0.89   
8.11 ± 4.14   
 
2.4 
1P4030 
4P4030 
1 
4 
4.72 ± 0.98  
 17.33 ± 2.77   
 
3.7* 
*p<0.05, n = 3, donor: ♀, 55-year-old 
 
1P2525, 1P3030 and 1P4030 were not yet saturated with TBF and higher permeation 
fluxes were obtained by increasing TBF amount (see Table 4.4). The enhancement 
factors from P4030 and P2525 were almost similar, although the latter referred to a 
drug content increase from 1 to 2%. This could be assigned to a difference in drug 
release from the vehicle depending on the composition. The dependency of POX 407 
concentration and drug release has already been reported by Gilbert et al. [139] where 
the increase in POX concentration was followed by a decrease in the apparent 
diffusion coefficient (Dapp) of the examined solutes benzoic acid and p-hydroxybenzoic 
acid. This was also the case for piroxicam, where its release was dependent on the 
POX 407 concentration in the examined gels. The permeation rate of piroxicam across 
synthetic cellulose membranes and rat skin decreased as the concentration of POX 
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increased [140]. It has been hypothesized that the growth of the micelle size due to 
the increase in POX content could reduce the water channels of the gel matrix and 
thus simultaneously increases the tortuosity. A higher tortuosity would be followed by 
a decrease of Dapp from a gel with a high POX concentration [141]. Nevertheless, the 
drug release from a POX gel was also determined by the gel dissolution upon contact 
with water [142]. 
 
Fig. 4.18 Permeation of 1% and 2% TBF from P2525 across SC (n = 3); donor: ♀, 55-year-old 
 
Fig. 4.19 Permeation of 1% and 2% TBF from P3030 across SC (n = 3); donor: ♀, 55-year-old 
 
Fig. 4.20 Permeation of 1% and 4% TBF from P4030 across SC (n = 3); donor: ♀, 55-year-
old; *significant difference (p<0.05) 
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In comparison to the flux value achieved by 5-ALA [5] which was incorporated into 
P2525 at an amount of 10% (w/w), the increase in TBF fluxes in the present study 
were not pronounced. Compared to Basiscreme DAC, the permeation enhancement 
across skin from P2525 was 7.5-fold for 5-ALA and 1.4-fold for TBF only (with 1% 
incorporated drug). TBF possibly resided inside the micelles, meanwhile the 
hydrophilic 5-ALA filled the aqueous channels between the micelles. The latter is the 
region from which the solute is directly available for release from a POX system [139]. 
When TBF is located inside the micelles, this could enlarge micelle size as well. As a 
consequence, drug diffusion should also decrease due to similar reasons as explained 
above.  
The lag time exhibited by 1P2525 was not significantly different from other non-POX 
formulations suggesting that all formulations needed about the same time to penetrate 
and permeate across the SC. Furthermore, this implies that lag times were quite 
independent of the formulation ingredients, at least from 1P2525.   
4.5 Permeation across hooves 
Besides human skin, nail is also the site where dermatophytosis commonly occurs. 
Onychomycosis accounts for about 50% of all the nail disorders [143]. Since human 
nails were not available for this study, bovine hooves (100 µm thickness) were 
employed as a human nail model. Lamisil® DermGel was included in this study, 
instead of Lamisil® Creme, due to its hydrophilic characteristic which should be an 
advantage for the ungual permeation.     
Steady state conditions could be achieved for TBF permeation across hooves as 
shown in Fig. 4.21. Different from TBF permeations across SC, those across hooves 
did not show any pronounced lag time, hinting at a spontaneous penetration of TBF 
into hooves with subsequent permeation. A lag time could only be calculated from 
extrapolation of the flux of the steady state part of the permeation curve. 
1P2525 and POX hydrogel 20% with 1% TBF showed superior flux values over other 
non-POX formulations as seen in Fig. 4.22. Basiscreme DAC showed yet a flux twice 
as high as that of Lamisil® DermGel. The ranking of the lag times was slightly different 
from the fluxes being POX hydrogel<1P2525<Lamisil® DermGel<Basiscreme DAC 
(see Fig. 4.23). Nevertheless, all the formulations did not show any significant 
differences (p>0.05) in lag times compared to Lamisil® DermGel. 
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Fig. 4.21 Permeation of TBF across hooves (n = 3-5), TBF amount permeated was calculated 
as base since Lamisil® DermGel contains TBF base  
 
1P2525 flux was about 2.5-fold higher than that from POX hydrogel hinting at a 
synergistic effect of the ingredients. 1P2525 flux was even 18-fold higher than that 
from Lamisil® DermGel and 10-fold from Basiscreme DAC. It is interesting to note that 
both enhancers (IPA and DMIS) in 1P2525 have not been acknowledged as ungual 
penetration enhancers yet although their penetration enhancement action in this study 
was evident.  
 
Fig. 4.22 Fluxes of TBF base (mean ± SD) across hooves (n = 3-5); *significant compared to 
Lamisil® DermGel (p<0.05) 
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Fig. 4.23 Lag times of TBF base (mean ± SD) across hooves (n = 3-5) 
 
Since water acts as a nail plasticizer and ungual penetration enhancer, POX hydrogel 
with almost 80% water content (the highest amongst all) was expected to give the 
highest flux. This is however not the case. The role of water in enhancing ungual 
penetration has been reported with ketoconazole as permeant from the work of Gunt 
and Kasting [144]. Ciclopirox permeated also faster through nails from a Carbomer® 
gel formulation than from a non-aqueous nail lacquer [145].  
TBF fluxes across hooves were generally around 10-fold higher compared to those 
across skin (magnitude 10-10 vs. 10-11). The lipophilic SC controlled TBF permeation 
more strictly than hooves did. This was even more evident since SC (~10 µm, dry) is 
actually much thinner than hoof (100 µm). However, in the real practice, TBF will have 
to permeate further along a higher distance to reach an infected nail bed. As a note, 
similar to the permeation across SC, TBF in 1P2525 possessed still a lower 
thermodynamic activity compared to other comparative standards. TBF fluxes from 
1P2525 were yet still higher over the comparisons.    
4.6 TBF amount retained in SC and hooves  
The validation of TBF extraction process from SC and hooves resulted in recovery 
values of 75% and 100%, respectively. SC binds TBF stronger than hooves do; as 
was mirrored from the recovery results. Extending the extraction time or extraction 
frequency did not improve the recovery result significantly.  
TBF amount extracted from both membranes after terminating the permeation 
experiments with different formulations was adjusted according to the recovery 
validation. As can be seen from Table 4.5, the ranking of the amount retained in SC is 
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1P2525>Basiscreme DAC>Lamisil® Creme although the difference between 1P2525 
and Basiscreme DAC was not significant. A different ranking was observed in hooves: 
POX hydrogel>1P2525>Basiscreme DAC>Lamisil® DermGel. In this case the 
difference between Basiscreme DAC and Lamisil® DermGel was not significant either.  
Table 4.5 The amount of TBF retained [µg/cm2] in SC and hooves (mean ± SD)  
Formulation Stratum corneum Hooves 
Basiscreme DAC 
POX hydrogel 
1P2525 
Lamisil® Creme/ DermGel 
15.60 ± 2.33** 
n.d. 
19.83 ± 3.18** 
8.93 ± 2.11 
7.81 ± 0.34 
94.78 ± 12.60** 
23.07 ± 1.66** 
7.16 ± 1.18 
**significant compared to Lamisil
®
 (p<0.01), n = 3-6; n.d. = not determined; skin donor: ♀, 38-year-old 
 
In terms of 1P2525 showing the highest TBF amount retained in SC amongst all, the 
ranking of the TBF retained corresponded nicely with that of the fluxes. This finding 
indicated a higher and faster drug partition rate from the vehicle of 1P2525 into the 
SC.   
In contrast to the permeation through skin, the water content apparently plays an 
important role in determining the amount of TBF retained in hooves. The high water 
content of POX hydrogel (~80%) compared to 1P2525 (~50%) provoked an about 4-
fold TBF amount retained in hooves. Water improves hooves hydration and this 
provides more sites for TBF binding within the keratin molecules. Basiscreme DAC 
with an even lower water content of 40% also exhibited a TBF amount retained far 
below that of POX-based formulations although a water content difference by 10% 
compared to 1P2525 was not likely to account for one third TBF amount retained in 
hooves. TBF amounts retained from Basiscreme DAC and Lamisil® DermGel were 
quite similar, hinting at a better partition of TBF into hooves from the POX-based 
formulations.    
4.7 DSC study [100] 
DSC enables the visualization of the microstructural changes within SC upon contact 
with formulation. From Fig. 4.24, it can be seen that every formulation had its own 
style in affecting the lipid mobility of the SC. 1P2525 showed the weakest transitions, 
corresponding to the lowest transition enthalpies, i.e., T2 and T3 only, while Lamisil® 
Creme exhibited three transitions (T2-T4) and Basiscreme DAC exhibited an 
additional endothermic transition at about 45 °C belonging to residues of Basiscreme 
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itself on the SC. The transitions were reproducible for every tested formulation with 
standard deviations of maximum 1.1 °C from triple measurements. The resume from 
all transitions shifts can be seen in Fig. 4.25. Albeit close to the standard deviation, the 
ranking for T2 shifts were 1P2525>Basiscreme DAC>Lamisil® Creme. T3 shifts were 
about the same for 1P2525 and Basiscreme DAC, being slightly greater than Lamisil® 
Creme’s T3 shift. However, T2 and T3 from all examined formulations were not 
significantly different from each other (p>0.05).  
Barry [28] mentioned up to four endothermic transitions T1-T4 observed by means of 
DSC, when SC is heated up to 120 °C. While T1 (~40 °C) and T4 (~100 °C) are 
unfortunately not always visible, the presence of T2 (~70 °C) and T3 (~85 °C) are 
more reliable. T1 and T4 were found to be strongly dependent on the skin source and 
its water content during measurement [28]. Interaction of SC with a penetration 
enhancer is responsible for loosening its tight microstructure, thus the lipid mobility 
increases. This increase aids drug penetration and yields higher flux. The endothermal 
transition shifts, measured by means of DSC, due to the increase in lipid fluidity were 
also demonstrated by Glombitza and Müller-Goymann using an in vitro model of the 
skin lipid matrix [146].  
 
Fig. 4.24 Skin thermograms of skin reference/ hydrated to water content of 20% (1); treated 
with: 1P2525 (2), Basiscreme DAC containing 1% TBF (3), Lamisil® Creme (4) [100] 
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Fig. 4.25 Resume of endothermic transitions T2 and T3 as well as enthalpies ΔH (sum of T2 
and T3) from SC (mean ± SD); donor: ♀, 38-year-old [100] 
 
1P2525 produced the highest endothermic transition shifts (T2 -6.3 °C; T3 -8.5 °C) 
and the lowest enthalpy of the SC lipid matrix compared to other formulations. 
Although the difference was not statistically significant, the least negative enthalpy 
produced by 1P2525 indicated a relative stronger influence of the vehicle to the SC 
towards an increase in lipid fluidity. This influence was comparable for Basiscreme 
DAC and Lamisil® Creme. An additional endothermic peak given by Basiscreme DAC 
at 45 °C resulted from one of the vehicle components since T1 happens earlier at 
about 37 °C [29] whereas three endothermic peaks exhibited by Lamisil® Creme were 
consecutive peaks of T2-T4. Comparing both, Basiscreme DAC is likely to be 
relatively more effective in disrupting the SC lipid than the commercial formulation, 
although their TBF permeation fluxes were in the same order of magnitude. According 
to the DSC result, the interaction between the POX-based vehicle and SC matrix was 
not powerful enough in explaining the higher permeation rate of TBF. Thus the nature 
and the structure of the thermogelling formulation was suggested to play a more 
important role in enhancing TBF permeation rate despite TBF’s lower thermodynamic 
activity in the vehicle. 
Referring to the previous work of Grüning and Müller-Goymann [5], DSC 
measurement following SC treatment with P2525 containing 5-ALA, the decrease in 
endothermic shifts of T2 and T3 was greater than that for treatment with Basiscreme 
DAC (i.e. T2/4.6 °C, T3/4.3 °C for P2525 vs. T2/2.0 °C, T3/0.2 °C for Basiscreme 
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DAC). The incorporation of a lipophilic drug such as TBF into the thermogelling vehicle 
apparently modifies the vehicle ability in interacting with the skin lipid matrix. 
Thermodynamic activity of 5-ALA in this vehicle has not been determined due to its 
high aqueous solubility but it was evident that the vehicle interaction with skin lipid 
matrix played an important role for 5-ALA’s remarkable penetration enhancement. 
4.8 TBF permeation from formulations with different compositions 
across SC 
The composition of the thermogelling formulation was varied to examine the influence 
of the ingredients on TBF permeation rate across SC. In order to investigate this 
systematically, two ‘components’ of the pseudoternary phase diagram were kept 
constant at the ratio 1:1. Thus, it was expected that the influence of the third 
‘component’ on TBF permeation rate would be more visible while diminishing the 
interference from the other ‘components’. An overview of the position of the selected 
formulations for this purpose is displayed in the pseudoternary phase diagram of Fig. 
3.4. 
4.8.1 Characteristics of the chosen formulations for the permeation study 
The characteristics of the chosen formulations with different compositions for the 
permeation study can be seen in Table 4.6. In the first group, where the ratio of 
POX/MCT to water was kept constant at 1:1, from 1P3040 to 1P4412, the content of 
POX/MCT and water increased meanwhile IPA/DMIS decreased. Complex viscosity 
increased upon increasing the amount of POX and water; consistencies changed from 
liquid (1P3040) to semisolid (1P4412). With regard to 1P3040, networking of POX 
micelles was likely to be insufficient for gelation, i.e., a semisolid consistency. This 
may be due to the low amount of POX and water (30% each) and the rather high 
IPA/DMIS content of 40%. The white to off-white appearance of both liquid and 
semisolid formulations of this group was typical for dispersions, i.e., emulsion type 
systems.  
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Table 4.6 Properties of the examined formulations for the permeation study 
 
Formulation 
 
Appearance
1 
Ringing 
(20 °C) 
Complex 
viscosity 
[Pa·s]
2
 
Changes in 
composition 
(downwards) 
POX/MCT: water (1:1)  
1P3040 
1P3333 
1P3824 
1P4412 
 
Liquid, heterogeneous, off-white 
Liquid, highly viscous, off-white 
Semisolid, creamy, white 
Semisolid, creamy, white 
 
- 
- 
+ 
+ 
 
968 ± 30 
5778 ± 103 
8953 ± 306 
12523 ± 530 
 
POX/MCT ↑ 
IPA/DMIS ↓ 
Water ↑ 
IPA/DMIS : water (1:1) 
1P2836 
1P3333 
1P4030 
1P5025 
 
Liquid, heterogeneous, off-white
3
 
Liquid, highly viscous, off-white 
Semisolid, gel-like, hazy 
Semisolid, gel-like, hazy 
 
- 
- 
+ 
- 
 
2595 ± 97 
5778 ± 103 
8078 ± 242 
7830 ± 164 
 
POX/MCT ↑ 
IPA/DMIS ↓ 
Water ↓ 
POX/MCT: IPA/DMIS (1:1) 
1P2525 
1P3030 
1P3333 
1P4040 
 
Liquid, highly viscous, white
4
 
Liquid, highly viscous, off-white
4
 
Liquid, highly viscous, off-white 
Liquid, fairly viscous, off-white 
 
- 
- 
- 
- 
 
5183 ± 85 
5852 ± 146 
5778 ± 103 
255 ± 22 
 
POX/MCT ↑ 
IPA/DMIS ↑ 
Water ↓ 
POX hydrogel20% 
containing 1% TBF 
Semisolid, gel-like, clear  - 1878 ± 43  
1 
24 hours after manufacture at 20 °C 
2 
n = 3 (32 °C); 1P3333 is the intersection of the three examined lines 
3 
after stirring and elevation of the temperature to 32 °C (during the permeation study), 1P2836 
remained homogeneous 
4 
semisolid at 32 °C 
 
In the second group where the ratio of IPA/DMIS to water was kept constant at 1:1, 
from 1P2836 to 1P5025, POX/MCT content increased meanwhile IPA/DMIS and water 
contents decreased. Appearances of the formulations changed from an off-white liquid 
to gel-like formulations. The complex viscosity increased gradually from 1P2836 to 
1P5025. Formulations with gel-like appearance were only found in this group.  
In the third group where the ratio of POX/MCT to IPA/DMIS was kept constant at 1:1, 
from 1P2525 to 1P4040, the amount of POX/MCT and IPA/DMIS increased 
meanwhile the amount of water decreased. A low content of water in 1P4040 led to a 
sudden drop in complex viscosity and the formation of a liquid system. This occurred 
likely due to an insufficient amount of water (20%) for POX hydration in the presence 
of high IPA/DMIS content of 40% and thus no gelation occurred as in the case of 
1P3040 in the first group. It should be emphasized that 1P2525 and 1P3030 were 
semisolid at 32 °C during the permeation study.  
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POX hydrogel 20% containing 1% TBF was included in this study to observe the 
behavior of a simple mixture of POX and water only, in terms of TBF permeation rate. 
TBF was completely dissolved in POX hydrogel 20% as was obvious from its 
macroscopically clear and isotropic appearance under the polarizing microscope. POX 
hydrogel 20% complex viscosity was considered low when compared to 1P2525 
viscosity; both formulations contained the same POX amount of 20%. This implicitly 
showed that the additional ingredients in 1P2525 built a different structure with a 
higher complex viscosity value (5183 vs. 1878 Pa.s). 
POX acts as a nonionic surfactant, being able to form and stabilize emulsions [147]. 
POX content in almost all formulations was sufficient to stabilize both the oily and the 
aqueous phases so that no phase separations had been observed, except for 1P3040 
which was still heterogeneous even after re-stirring and at elevated temperature of 32 
°C. A high water content in the formulation allowed sufficient POX swelling so that 
formulations with highly dispersed oily phases and thus creamy appearance were 
obtained. A POX content ≥40% together with sufficient IPA/DMIS in the formulation 
could solubilize the whole oil phase (MCT); the system turned clear and produced a 
gel-like appearance (1P4030, 1P5025). IPA/DMIS contents of 40% or higher led to the 
formation of liquid systems, despite an elevated POX content. The complex viscosities 
were below 1000 Pa·s as in the case of 1P3040 and 1P4040.  
From all formulations prepared for the permeation study, only three compositions 
exhibited ringing effects. Those were 1P3824, 1P4412 and 1P4030. Their ringing 
characteristics were still in line with the previous section for the bases without TBF 
because the formulations selected for the present permeation studies originated partly 
from the area of the ringing formulations. Again, it is noticeable that these ringing 
formulations possessed relatively high complex viscosity compared to other non-
ringing formulations. 
4.8.2 Permeation across SC from the series with POX/MCT : water (1:1) 
Increase in POX/MCT and decrease in IPA/DMIS from 1P3040 to 1P4412 in this 
group, exhibiting an increase in complex viscosities, led to a decrease in fluxes (Fig. 
4.26) and lag times (Table 4.7). All the formulations reached steady state after 20 h 
with distinct lag times except for Lamisil® Creme as depicted in Fig. 4.26. The highest 
flux exhibited by 1P3040 apparently originated from its low viscosity due to its high 
IPA/DMIS content. The second highest flux from 1P3824 was not significantly different 
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compared to 1P3333 or 1P4412. All fluxes from this group were higher than those 
from Lamisil® Creme. The change in consistency from liquid (1P3040) to semisolid 
(1P4412) was in agreement with an expected TBF lower release rate. POX hydrogel 
containing 1% TBF with only a slightly higher complex viscosity than that of 1P3040 
gave about a similar flux value. 
4.8.3 Permeation across SC from the series with IPA/DMIS : water (1:1) 
Again within this group, a steady state could be obtained from each formulation as 
shown in Fig. 4.27. 1P2836 exhibited the highest TBF permeation rate and the 
shortest lag time within this group. In contrast to the first group, an increase in 
POX/MCT content was followed by a pronounced increase in lag time (Table 4.7). The 
change in consistency from liquid (1P2836) to a highly viscous gel (1P5025) seemed 
to hamper TBF permeation; this could be due to the high complex viscosity produced 
by this gel-like system. However, although being not significantly different, all fluxes 
from thermogelling formulations were higher than those from Lamisil® Creme except 
for 1P5025 which was significantly lower than that of Lamisil® Creme. A high standard 
deviation from 1P2836 obscured TBF high flux over other systems. Again, POX 
hydrogel containing 1% TBF with only a slightly lower complex viscosity compared to 
1P2836 showed about a similar flux. 
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Fig. 4.26 Permeation profiles, fluxes and complex viscosities of formulations (mean ± SD) 
from the series of POX/MCT : water (1:1) across SC; n = 3-5; *p<0.05, compared to Lamisil® 
Creme; donor: ♀, 55-year-old 
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Fig. 4.27 Permeation profiles, fluxes and complex viscosities of formulations (mean ± SD) 
from the series of IPA/DMIS : water (1:1) across SC; n = 3-6; *p<0.05, compared to Lamisil® 
Creme; donor: ♀, 55-year-old 
 
4.8.4 Permeation across SC from the series with POX/MCT : IPA/DMIS (1:1) 
Steady states were also achieved by the third group and almost all formulations 
showed a direct release since the beginning of the permeation (see the permeation 
profiles in Fig. 4.28). Upon increasing POX/MCT the complex viscosities of the 
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increasing suddenly at 1P4040. Water amount was not sufficient for establishing the 
networking of POX micelles in 1P4040 so that the complex viscosity dropped. It has 
been well known from the previous groups that decreases in viscosities were followed 
by increases in fluxes. This was also the case for this third group. Again, almost all 
fluxes were greater than Lamisil® Creme’s value except for 1P3333 which was 
approximately similar.   
 
 
Fig. 4.28 Permeation profiles, fluxes and complex viscosities of formulations (mean ± SD) 
from the series of POX/MCT : IPA/DMIS (1:1) across SC; n = 3-5; *p<0.05, compared to 
Lamisil® Creme; donor: ♀, 55-year-old 
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Compared to 1P2525 with the same POX content of 20%, POX hydrogel containing 
1% TBF exhibited higher flux of about 2-fold. The absence of other components in 
POX hydrogel may indeed have increased drug partition into SC so that the 
permeation rate increased. On the other hand, the low viscosity of POX hydrogel, 
which was about 2.8-fold lower than 1P2525, could also be the driving force for the 
higher drug permeation. A dependency between viscosity and flux has been though 
observed from other groups previously. To clarify this, a relation between complex 
viscosities and fluxes will be elaborated in the next section. 
4.8.5 Compilation of permeation across SC 
POX and water were observed to be responsible for building up the viscosity of the 
formulation meanwhile IPA/DMIS tended to decrease it. A nice relation between fluxes 
and the reciprocal viscosities was shown by most formulations. Formulations with 
similar viscosities exhibited fluxes in the same order of magnitude, with 1P2525; 
1P3030; 1P3333 or 1P3824; 1P4030 as examples. A closer look is given in Fig. 4.29. 
However, this rule did not apply if IPA/DMIS content was ≥40% as in the case of 
1P4040, which revealed about the same flux as 1P3824 and 1P4030 although its 
viscosity was far apart from those of 1P3824 and 1P4030. 
 
Fig. 4.29 Compilation of fluxes and complex viscosities from thermogelling formulations (mean 
± SD) with different compositions across SC; n = 3-6; *p<0.05, compared to Lamisil® Creme; 
donor: ♀, 55-year-old 
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TBF fluxes from the thermogelling formulations were generally higher than Lamisil® 
Creme, except from 1P5025 (p<0.05). TBF flux from POX hydrogel 20% containing 
1% TBF was relatively high compared to other thermogelling formulations, yet about 
comparable with formulations possessing low viscosities.  
Lag times of TBF from this group are listed in Table 4.7. Lag times tended to decrease 
as the water content in the formulations increased. There is apparently no direct 
relation between POX/MCT or IPA/DMIS contents with changes in lag times. How 
water affects the lag time can for example be observed in the first group, i.e., while 
water increased from 1P3040 to 1P4412, the lag times decreased. This was also the 
case for other groups, with 1P4040 as exception.  
Table 4.7 Resume of permeation data (mean ± SD) of thermogelling formulations with 
different compositions across SC and the amount of TBF retained in SC after 48 h of 
permeation; n = 3-6; *p<0.05 compared to Lamisil® Creme 
 
Formulation 
Flux 
[x10-11 g/cm²·s] 
Lag time 
[min] 
TBF amount 
retained1 
[µg/cm2] 
POX/MCT: water (1:1)  
1P3040 
1P3333 
1P3824 
1P4412 
 
  12.86 ± 4.95* 
2.28 ± 0.92 
4.44 ± 1.78* 
2.83 ± 0.58 
 
867 
572 
483 
193 
 
17.09 ± 2.76 
20.31 ± 7.26 
  8.93 ± 1.59 
  6.21 ± 0.57 
IPA/DMIS : water (1:1) 
1P2836 
1P3333 
1P4030 
1P5025 
 
6.43 ± 5.82 
2.28 ± 0.92 
3.83 ± 1.76 
0.42 ± 1.02* 
 
351 
572 
511 
1347 
 
16.85 ± 4.72 
20.31 ± 7.26 
14.08 ± 4.61 
  6.69 ± 1.85 
POX/MCT: IPA/DMIS (1:1) 
1P2525 
1P3030 
1P3333 
1P4040 
 
4.00 ± 2.02 
3.11 ± 1.17 
2.28 ± 0.92 
5.06 ± 0.92* 
 
12 
285 
572 
0 
 
15.07 ± 3.31 
  9.48 ± 2.73 
20.31 ± 7.26 
15.98 ± 6.72 
Lamisil® Creme 2.08 ± 0.22 0 10.75 ± 3.63 
POX hydrogel 20% 9.25 ± 4.57 225 32.92 ± 3.33* 
1 
data was corrected according to the recovery of the extraction procedure (75%); 1P3333 is highlighted 
as the intersection point from all groups 
 
There was, however, no unlimited permeation enhancement from the three examined 
lines. Nevertheless, a local maximum flux from each group was evident and this was 
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strongly dependent on the composition of the formulation. The permeation data in the 
previous section signalized a dependency between TBF fluxes and the reciprocal  
complex viscosities. Therefore, both parameters were plotted in Fig. 4.30. 
 
Fig. 4.30 Relation of fluxes - complex viscosities from thermogelling formulations with different 
compositions across SC 
 
Plotting all data in one graph, a fairly linear relation between fluxes and complex 
viscosities could be drawn within the viscosity range from 1000 to 8000 Pa·s only. 
Outside this range, fluxes seemed to be independent of the complex viscosities with a 
tendency to a higher flux value when POX was about or exceeded 40%, as shown by 
1P4030, 1P3824 and 1P4412. In contrast, the flux shown by 1P4040 was apparently 
lower than expected. POX hydrogel containing 1% TBF followed this linear relation. 
Within the viscosity range from 1000-8000 Pa·s, the permeation rate was inversely 
dependent on the complex viscosity of the formulation. It might be hypothesized that 
the release seemed to control the permeation because the lower the viscosity was, the 
higher the release rate from the formulation would be. Outside 1000-8000 Pa·s, other 
factors played an additional role so that TBF permeation did not follow the linear 
relation with the reciprocal viscosities anymore. At lower viscosity, i.e., less than 1000 
Pa·s, the high content of IPA/DMIS made POX swell insufficiently so that the gel 
matrix was not built at all. When the complex viscosity exceeded 8000 Pa·s, a highly 
ordered structure could have been built thus the matrix might have turned more 
complex or the tortuosity of the matrix could simply have increased. 
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Three formulations with noticeable high viscosities -1P4030, 1P3824 and 1P4412- 
were particularly interesting since their fluxes were higher than those from other 
formulations with lower viscosities. It is a coincidence that these three formulations 
also featured a ringing effect. The existence of the ringing effect could be an indication 
for the presence of a cubic structure and this could also be the reason why their fluxes 
were higher as their expected values.  
The application of lyotropic liquid crystal phases (LLC) as drug vehicle for transdermal 
delivery has been reported before and the permeation enhancement was rather 
specific for a particular drug. As example, the hexagonal phase has been reported to 
increase the permeation rate of diclofenac sodium and paracetamol whereas 
propanolol permeated better from the lamellar phase [85]. Last but not least, in order 
to draw a relation between the high fluxes from the three formulations mentioned 
above with the possible existence of the LLC, a further elucidation of the LLC structure 
is needed.  
4.8.6 TBF amount retained in SC 
The amount of TBF retained in SC was determined after terminating the permeation 
and the overview from all formulations can be seen in Fig. 4.31. All data presented 
have been corrected by the recovery of the extraction process. The amounts of TBF 
retained from the thermogelling formulations were about comparable and mostly 
higher yet not significantly higher than the amount retained from Lamisil® Creme. POX 
hydrogel 20% showed a significantly higher amount retained compared to Lamisil® 
Creme. Thermogelling formulations with low amount retained have been identified as 
those with relatively high viscosities, as shown by 1P4412 and 1P5025. Furthermore, 
there was no peculiarity of formulations with ringing effect with regard to their amount 
retained (1P3824, 1P4412 and 1P4030). 
Assuming that a high drug permeation rate originates from a high drug partition rate 
into SC, there was, however, no correlation at all between TBF fluxes and the 
amounts of TBF retained in SC. On the contrary, a fairly linear reverse correlation was 
found between the amount of TBF retained in SC and the complex viscosity of the 
formulation as shown in Fig. 4.32 with r2=0.5123. As was hypothesized for fluxes and 
complex viscosities, the increase in complex viscosity could reduce TBF partition into 
SC and thus subsequently both the penetration and permeation. However, TBF 
amount retained from POX hydrogel was much higher and outside the linear 
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correlation. A high water content or possibly the absence of other ingredients 
apparently increased TBF binding to SC.  
 
Fig. 4.31 Amount of TBF retained (mean ± SD) in SC after 48 h permeation; n = 3-6; *p<0.05, 
compared to Lamisil® Creme; donor: ♀, 55-year-old 
 
 
Fig. 4.32 Relation of TBF amount retained in SC and complex viscosity of the formulation 
 
Referring to the influence of a single component or a mixture of components on the 
TBF amount retained, there is also no apparent correlation between composition and 
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component mixture was varied in concentration while the ratio of the other 
components was kept constant (Table 4.7)). The content of POX, IPA/DMIS or even 
water did not give a pronounced correlation with the amount retained in SC. Resuming 
all, TBF binding with SC seems to be a multiple process which cannot be predicted 
from a single component of the formulation. However, the complex viscosity – which is 
the product of the entire constituents – gives at least an explanation for this case. 
4.9 TBF permeation from formulations with different compositions 
across hooves 
Permeation experiments across hooves revealed fluxes with high standard deviations 
in some cases. This could be due to the high variability of hooves themselves or due 
to an irregular drug release from the formulation. For data analysis, mean and median 
of fluxes from each formulation were displayed together. But, medians were used 
instead of means for further analysis. Fluxes from Lamisil® DermGel were not included 
in the upcoming section since it has previously been shown that TBF permeated 
lesser (p<0.05) from Lamisil® DermGel than from 1P2525 (see Fig. 4.22). To assist 
interpretation, TBF fluxes across hooves were displayed using box plot as shown in 
Fig. 4.33. Therefore, all the important values (five-number summary) such as the 
minimum, 25th percentile (Q1), median (Q2), 75th percentile (Q3) and the maximum 
can be depicted all at once. 
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Fig. 4.33 Box plot 
4.9.1 Permeation across hooves from the series with POX/MCT : water (1:1) 
By increasing POX/MCT and water content in the formulation, complex viscosities of 
the formulations rose, as known from the previous section. Medians of the fluxes 
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remained constant from 1P3040 to 1P3333 and then dropped at 1P3824 and 1P4412 
(Fig. 4.34). By observing the data distribution from each formulation, it can be seen 
that fluxes tended to decrease when POX/MCT contents increased. Among all 
formulations, 1P4412 exhibited the lowest mean and median. One-way ANOVA could 
not be used to test any difference between the means of the samples since their 
variances were unequal (Levene’s test, p<0.05). Furthermore, as summarized in 
Table 4.8, Welch’s test and Brown-Forsythe’s test were used instead. Post-hoc test 
Games-Howell was applied to track the formulation which gave significantly different 
result. Unfortunately, for this group, Welch’s test and Brown-Forsythe’s test gave 
contradictory results: Yet, Games-Howell’s test showed no differences between the 
fluxes. High standard deviations from 1P3040, 1P3333 and 1P3824 were responsible 
for this result.  
Increase in complex viscosity did not result in a significant change in TBF fluxes as 
seen in Fig. 4.34. Interestingly to note that 1P4412 with the highest water content 
(44%) showed no TBF permeation at all. IPA/DMIS content decreased from 1P3040 to 
1P4412 while the complex viscosity increased along with POX/MCT increase.   
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Fig. 4.34 TBF fluxes across hooves and complex viscosities of formulations with POX/MCT : 
water (1:1) across hooves; n = 4-8 
 
4.9.2 Permeation across hooves from the series with IPA/DMIS : water (1:1) 
As depicted in Fig. 4.35, complex viscosities increased from 1P2836 to 1P4030 and 
were then followed by a slight drop at 1P5025. Fluxes were about 1 x 10-8 g/cm2·s for 
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1P2836 and 1P3333 and then steeply dropped at 1P4030 and 1P5025. 1P3333 
produced the maximum fluxes although the lowest complex viscosity was shown by 
1P2836. Similar to section 4.9.1, one-way ANOVA could not be carried out since 
variances of the samples were unequal (Levene’s test, p<0.05). Again, Welch’s test 
and Brown-Forsythe’s test showed different conclusions as summarized in Table 4.8. 
Yet, the post-hoc test according to Games-Howell indicated that 1P2836 revealed 
significantly different fluxes from the other three formulations. According to this, the 
assumption of significant differences between formulations could be drawn.  
Fluxes in Fig. 4.35 corresponded well with the reciprocal complex viscosities of the 
formulations. Especially when 1P3333 high deviation is not considered, fluxes 
decrease from 1P2836 to 1P4030 being reversely in accordance with the increase in 
complex viscosities. Medians and complex viscosities were about constant for 1P4030 
and 1P5025.   
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Fig. 4.35 TBF fluxes across hooves and complex viscosities of formulations with IPA/DMIS : 
water (1:1) across hooves; n = 3-6, *1P2836 revealed significantly different fluxes.   
 
4.9.3 Permeation across hooves from the series with POX/MCT : IPA/DMIS 
(1:1) 
From 1P2525 to 1P4040, fluxes were similar for the first two formulations and then 
increased at 1P3333 although the complex viscosities were about similar. A drop in 
complex viscosity of 1P4040 was followed by a slight decrease in 1P4040 flux (Fig. 
4.36). From this group, there was no linear or reciprocal correlation observed between 
fluxes and complex viscosities, possibly obscured by 1P3333’s high deviation. Again, 
* 
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one-way ANOVA could not be used to test this group since sample variances were 
unequal (Levene’s test, p<0.05). Since the post-hoc test according to Games-Howell 
revealed no differences between the formulations, fluxes within this group were 
considered as insignificantly different. Nevertheless, the low complex viscosity of 
1P4040 was in line with its fairly high TBF flux. In addition, this flux apparently 
correlated with the high IPA/DMIS content, similar to the group of POX/MCT : water at 
1:1. 
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Fig. 4.36 TBF fluxes across hooves and complex viscosities of formulations with POX/MCT : 
IPA/DMIS (1:1) across hooves; n = 3-6 
 
Table 4.8 Statistics of TBF fluxes across hooves 
Group 
Sample 
variances 
(Levene’s test) 
Alternative test 
Post-hoc test 
(Games-Howell’s 
test) 
POX/MCT : 
water (1:1) 
unequal W:  F(3,8.43) = 4.44, 
p=0.038 (different) 
B-F: F(3,14.83) = 1.53, 
p=0.249 (not different) 
no difference 
IPA/DMIS : 
water (1:1) 
unequal W:  F(3,5.61) = 24.56, 
p=0.001 (different) 
B-F: F(3,6.24) = 4.51, 
p=0.053 (not different) 
1P2836 was 
significantly 
different 
POX/MCT : 
IPA/DMIS (1:1) 
unequal W:  F(3,5.31) = 12.81, 
p=0.007 (different) 
B-F: F(3,5.29) = 5.12, 
p=0.051 (not different) 
no difference 
W: Welch’s test, B-F: Brown-Forsythe’s test 
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4.9.4 Compilation of permeation across hooves 
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Fig. 4.37 Compilation of TBF fluxes across hooves and complex viscosities of thermogelling 
formulations with different compositions; n = 3-8 
 
The reverse correlation between complex viscosities and fluxes was fairly evident if all 
data were displayed together as in Fig. 4.37. This relation was not obvious from each 
single group due to the high standard deviations from several formulations (1P3040, 
1P3333 and 1P3824). Statistical analysis revealed that only 1P2836 showed  
significantly different fluxes among all formulations. All means and medians from each 
formulation are summarized in Table 4.9.  
To analyze the relation between both parameters, medians and complex viscosities of 
the formulations are plotted in Fig. 4.38. Medians and complex viscosities of the 
formulations did not show a similarly good linear correlation as in the case of SC 
permeation. The correlation coefficient was r2 = 0.4616 for hooves whereas that for 
SC was r2 = 0.9157.   
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Table 4.9 Permeation data of TBF across hooves (n = 3-8): means, medians and amounts 
retained 
Formulation 
Mean 
x10-9 [g/cm²·s] 
Median 
x10-9 [g/cm²·s] 
TBF amount 
retained1 
[µg/cm2] 
POX/MCT: water (1:1)  
1P3040 
1P3333 
1P3824 
1P4412 
 
17.05 ± 18.48 
12.09 ± 11.75 
10.98 ±14.99 
0.17 ± 0.06 
 
10.84 
11.82 
0.04 
0.17 
 
22.4 ± 6.7  
12.7 ± 2.9 
14.0 ± 1.6  
10.8 ± 1.6 
IPA/DMIS : water (1:1) 
1P2836 
1P3333 
1P4030 
1P5025 
 
9.41 ± 1.79 
12.09 ± 11.75 
2.79 ± 3.64 
0.14 ± 0.19  
 
8.69 
11.82 
1.05 
0.09 
 
14.0 ± 1.2  
12.7 ± 2.9 
12.3 ± 1.0 
7.3 ± 0.5*  
POX/MCT: IPA/DMIS (1:1) 
1P2525 
1P3030 
1P3333 
1P4040 
 
0.44 ± 0.17 
0.41 ± 0.39 
12.09 ± 11.75 
6.98 ± 1.74 
 
0.41 
0.28 
11.82 
6.69 
 
13.9 ± 1.4  
18.6 ± 4.9 
12.7 ± 2.9 
11.3 ± 1.3 
1 
recovery of the extraction procedure was 100%; *1P5025 revealed significantly different amount (one-
way ANOVA at =0.05, followed by Games-Howell post-hoc test); 1P3333 is the intersection of the 
three examined lines 
 
 
Fig. 4.38 Medians of TBF fluxes across hooves and complex viscosities of thermogelling 
formulations containing TBF  
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Fig. 4.39 Medians of TBF fluxes across hooves from thermogelling formulations containing 
TBF -in dependency of IPA/DMIS contents- 
 
Previous permeation experiments from different bases showed that the presence of 
IPA/DMIS granted a benefit to TBF permeation across hooves. In this context, TBF 
flux from 1P2525 was 2.53-fold higher than that from POX hydrogel 20% although 
1P2525’s complex viscosity was 2.76-fold higher than POX hydrogel’s complex 
viscosity (5183 vs. 1878 Pa.s). The important role of IPA/DMIS for TBF permeation 
across hooves can be further explored through Fig. 4.39. In contrast, there were no 
apparent correlations between medians and the other components of the formulations 
(water or POX/MCT) if they were plotted together. Unless IPA/DMIS reached 25%, 
TBF did not permeate across hooves. Above 25%, TBF fluxes increased and reached 
a maximum flux at higher IPA/DMIS content of the formulation. In this case, a 
sufficient amount of IPA/DMIS was essential to initiate TBF permeation across 
hooves. This phenomenon was still evident even if the high standard deviations were 
considered. A possible mechanism of IPA/DMIS in promoting TBF permeation across 
hooves from these formulations has not been reported before. However, dimethyl 
sulfoxide, also a transdermal penetration enhancer, has been reported to increase 
econazole permeation into deeper nail layers. Yet, the high concentration used (99%) 
prohibits its further administration due to its irritant effect [38]. 
The role of water in the ungual permeation was not seen from this section. Water as a 
potent ungual penetration enhancer has been reported by Walters et al. [10,51]. They 
found that the homologous alcohols permeated to a higher extent from aqueous 
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solutions than from the neat liquids (undiluted). Hence, IPA/DMIS likely played a more 
important role than water in this study. 
Compared to the permeation across SC, the ringing formulations did not show a 
noticeable permeation enhancement across hooves. Actually there has not been any 
report associated with the use of LLC for ungual penetration enhancement. Since the 
lipid content of human nail, and accordingly hooves, is low (0.1-1%) [10], a 
modification of the ungual permeation process via LLC is rather unlikely. Therefore, 
the strategy in ungual penetration enhancement deals rather with the cleavage of the 
disulfide bonds within nail keratin and/or the increase in nail swelling [72].  
4.9.5 TBF amount retained in hooves 
TBF amounts retained in hooves after 12 h of permeation are displayed in Table 4.9. 
For a better visualization, all data were plotted together with the complex viscosities of 
the formulations in Fig. 4.40. Generally, TBF amounts retained in hooves were all 
about on the same level except for 1P3030 and 1P3040 which were relatively high, yet 
not statistically significant, and 1P5025 which was the lowest among all. Statistical 
analysis showed that 1P5025 was the only formulation which was significantly 
different from other formulations. 
 
 
Fig. 4.40 TBF amounts retained in hooves and complex viscosities of the thermogelling 
formulation (mean ± SD), *1P5025 revealed significantly different amount (one-way ANOVA at 
=0.05, followed by Games-Howell post-hoc test). 
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The relation between TBF amount retained in hooves and the complex viscosity of the 
formulation is not evident. As can be seen in Fig. 4.40, the amounts of TBF retained 
were generally constant although complex viscosities varied. A decrease in complex 
viscosity from 1P3030 to 1P3040, for example, did not influence the amount of TBF 
retained. This has been observed with other formulations as well. In addition, the 
influence of other components of the formulation on the amount of TBF retained was 
not evident either. 
4.10 Resume of TBF permeation across SC and hooves from 
thermogelling formulations with different compositions 
TBF permeation fluxes from 1P2525 across SC were 1.4-fold higher than those from 
Basiscreme DAC and Lamisil® Creme, yet not significantly different. Since TBF’s 
thermodynamic activity was the lowest in 1P2525, the nature of the thermogelling 
vehicle might play a major role for the permeation enhancement. A higher permeation 
flux was achieved by incorporating higher TBF contents into the vehicle. The latter 
was only possible due to the specific composition of the formulation. Furthermore, the 
enhancement factor is found to be specific for each composition (Table 4.4).  
DSC study on SC displayed comparable T2 and T3 shifts for all the vehicles 
examined. In other words, they showed a comparable influence on the melting of the 
lipid bilayer and to the disruption of protein-lipid association. These comparable results 
of T2 and T3 corresponded well with the permeation results in terms that there were 
no significantly different fluxes across SC from various vehicles either. Nonetheless, 
DSC thermograms revealed that 1P2525 eliminated T1 and T4 completely whilst 
Basiscreme DAC still showed a specific transition close to T1 which belonged to 
residues of the base itself. T4 was also evident from Lamisil® Creme. Summarizing all, 
the influence of the thermogelling formulation on the skin lipids seemed to be stronger 
than that from the other non-POX bases.  
1P2525 showed higher permeation fluxes across hooves compared to POX hydrogel 
20%, Basiscreme DAC and Lamisil® Dermgel. Fluxes from 1P2525 and POX hydrogel 
20% were significantly higher than those from Lamisil® Dermgel (p<0.05). POX-based 
formulations favored TBF permeation across hooves which characteristics are 
hydrophilic as well. Besides, the presence of other constituents in the thermogelling 
formulations improved TBF permeation, hinting at the synergistic action of all 
constituents.  
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The greatest benefit of the thermogelling formulations among other vehicles is the 
high amount of TBF retained both in SC and hooves after the permeation. Although 
the highest amount of TBF retained in hooves was given by POX hydrogel 20%, TBF 
amount retained both in SC and hooves from 1P2525 was significantly higher than 
that from Lamisil® Creme (p<0.05) (see p. 78). 
Permeation study from thermogelling formulations with different compositions arrived 
in the conclusion that high fluxes across SC can be achieved with increasing 
IPA/DMIS content. Indeed, a high content of IPA/DMIS reduced the complex viscosity 
of the formulation; thus, TBF permeation were favored. A reverse linear correlation 
between fluxes and complex viscosities was observed between 1000 to 8000 Pa·s. 
POX hydrogel 20% containing 1% TBF obeyed this relation as well. The viscosity of 
the formulation is not necessarily the rate limiting step of the percutaneous absorption; 
but it determines drug diffusion and drug release from the vehicle [37]. 1P4030, 
1P3824 and 1P4412 with their noticeably high viscosities gave higher fluxes than 
expected. The latter phenomenon might be the result of their ringing properties, 
possibly due to the existence of a liquid crystalline phase, e.g. a cubic system. The 
amount of TBF retained in SC was apparently dependent on the complex viscosity as 
well (r2 = 0.5123) whereas there was no direct correlation between each single 
constituent and the amount of TBF retained in SC. 
TBF permeation across hooves varied considerably for some formulations (1P3040, 
1P3333 and 1P3824) although there is still no explanation for this high standard 
deviation since TEER values of hooves used were checked prior to the permeation 
study. It can only be hypothesized that there was an unknown interaction between the 
formulations and the hooves. TBF only permeated when IPA/DMIS exceeded 25%. 
Below this content, medians were close to zero. TBF fluxes across hooves (see Fig. 
4.39) seemed to be constant between 33 and 40% of IPA/DMIS. 
As it has been shown in section 4.1.3, TBF solubility in various thermogelling 
formulations was not uniform. According to Fig. 4.4, TBF solubility ranged from less 
than 2% to 4%. Since most of the permeation experiments in this study were carried 
out with 1% TBF, TBF thermodynamic activity () in the formulations varied. 
Therefore, differences in TBF fluxes from the examined formulations might be also 
caused by differences in their  independent of a systematic variation of a simple 
component or a component mixture. For this assessment,  of TBF in the vehicles are 
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displayed in Table 4.10. As a basic calculation, a saturated TBF amount in a 
formulation (according to Fig. 4.4) gives the highest , i.e., it reaches unity. When a 
saturation condition was achieved with 4% TBF, a formulation containing 1% TBF 
gave of 0.25. 
Table 4.10 Thermodynamic activity of TBF in several thermogelling formulations 
Formulation TBF thermodynamic activity in the formulation 
1P2525 
1P2836 
1P3030 
1P3040 
1P3333 
1P3824 
1P4030 
1P4040 
1P4412 
1P5025 
0.5 
n.d. (app. <0.25) 
0.25 
n.d. (app. <0.25) 
0.25 
0.5 (app.) 
0.25 
n.d. (app. <0.25) 
<0.5 (app.) 
0.33 
n.d.: not known; app.: approximation according to Fig. 4.4 
 
The relation between TBF fluxes across SC and the respective is displayed in Fig. 
4.41, except for  of some formulations which were not determined. In terms of similar 
 two groups of formulations produced similar fluxes. The first group consisted of 
1P2525 and 1P3824 only. The second group encompassed 1P3030, 1P3333 and 
1P4030. This relation was not visible before. Meanwhile 1P3030 and 1P3333 had 
comparable complex viscosities, the viscosity of 1P4030 was much higher. This was 
also the case for 1P2525 and 1P3824. Therefore, the thermodynamic activity is able 
to explain the comparable fluxes from some thermogelling formulations. 
Exception is given by 1P5025; meanwhile its is between 0.25 and 0.5, its flux was 
far lower than that from all the other formulations. Although its viscosity was 
comparable with 1P4030, both fluxes were different. Regarding this, fluxes of 1P5025 
should have been higher than those of 1P3030 or 1P3333 or 1P4030. Since this is not 
the case, POX content of 1P5025, which was the highest among all, obviously played 
a more important role. As discussed before, assuming that TBF binding to the vehicles 
was comparable for all formulations, an increase in POX content would increase the 
tortuosity of the diffusion pathway and reduce Dapp of TBF [141]. 
Employing saturated system for the permeation study would probably be the best 
choice. However, this is not reflected by commercial TBF formulations which 
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commonly contain 1% TBF for topical application. Thereafter, by incorporating 1% 
TBF in all the cases, TBF permeation across SC was suggested to depend on several 
factors, i.e., viscosity of the formulation, TBF thermodynamic activity and the 
complexity of the gel network. 
 
Fig. 4.41 TBF fluxes across SC and its thermodynamic activity in the formulation 
 
A formulation with high solubilizing capacity for TBF will give a low ; this means a 
lower driving force for penetration. A compromise between drug solubility in the 
formulation and in the skin will enhance drug’s transdermal delivery [148]. This 
consideration is especially valid for DMIS, a liquid substance with a high solubilizing 
capacity. Lin and Nash [149] determined the solubility of various drugs with different 
physicochemical properties and showed that their solubilities in DMIS were always 
much higher than in water. The examined drugs were benzoic acid, camphor, 
ephedrine, lidocaine, methylparaben, testosterone and theophylline with DMIS 
solubility enhancement of 92-, 259-, 16-, 138-, 131-, 4165- and 1.6-fold, respectively 
(all compared to water). DMIS high capability in dissolving various drugs, especially 
non-polar drugs, is related to its low dielectric constant [150]. A single use of DMIS 
was not proven to be efficient as a penetration enhancer [148,151] but in combination 
with a penetration enhancer it could enhance the penetration and permeation of some 
drug [2]. Funke et al. [152] have shown that DMIS has only a negligible effect to the 
skin lipids by means of DSC measurements on the treated full skin of hairless mice. 
Rossi et al. [153] reported that DMIS supported the delivery of hydrophilic actives by 
increasing the polarity of SC. Besides, DMIS is able to reduce the contact angle of 
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some cosmetic oils; this is advantageous for the cosmetic purpose by spreading the 
constituents homogeneously [153]. 
As cosolvent, DMIS is prone to increase drug solubility in the formulation and this will 
reduce drug thermodynamic activity. But, in combination with a penetration enhancer, 
DMIS may increase drug partition coefficient, accordingly drug solubility, in the sub- 
stratum corneum region. This phenomenon is suggested from evidence of DMIS 
traversing the skin after a topical application [152,154]. This effect has been reported 
“solvent drag” in the literature, as in the case of ethanol [155] and propylene glycol 
[156,157]. A high drug accumulation in the skin is a benefit for the treatment of 
antifungal infection, acne, psoriasis etc. where a systemic effect is not desired [148]. 
The amounts of TBF retained in the SC after permeation from the thermogelling 
formulations correlated well with DMIS content. Formulation with high DMIS content 
tended to produce high accumulated amount in the SC, e.g. 1P3030 vs. 1P3040 or 
1P4030 vs. 1P4040 (Table 4.7). Finally, the thermogelling formulations revealed 
significantly higher amounts of TBF retained in the SC compared with non-POX based 
formulation.  
The relation between  and TBF fluxes across hooves has been explored as well. 
Unfortunately, due to the high variation in fluxes, no relation between both could 
clearly be drawn as in the case of permeation across SC. Since TBF flux across 
hooves was higher with an increased content of IPA/DMIS (compare Fig. 4.39), it is 
suggested that DMIS may play an important role. With its high solubilizing capacity 
and its hydrophilic property, DMIS diffuses as easily as water across hooves. 
However, the presence of water is a prerequisite for the action of an ungual 
penetration enhancer because pure organic solvents, e.g., ethanol and acetone 
cannot cause sufficient swelling of the nail, a common precondition of ungual 
permeation enhancement [11]. Walters et al. [51] reported that permeation rates of 
neat homologues alcohols were about 5-fold smaller than from their diluted aqueous 
solutions. In conjunction to this, the permeation enhancement of TBF across hooves 
along with high content of IPA/DMIS is a part of the synergistic action between water 
and DMIS.  
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4.11 Human nail plate model made of human hair keratin [114] 
In the next upcoming sections, the manufacture process and the physicochemical 
characterization of the keratin film will be discussed in detail. 
4.11.1 Keratin film manufacture 
The lyophilization of the dialysate yielded ~60% of the dry hair weight used in the 
keratin extraction procedure (section 3.2.8.1). This was in accordance with data 
reported by Nakamura et al. [55], who found more than 65% with the same method. 
However, this method was time-consuming in terms of determining the extraction 
efficiency. Therefore the Bradford method [115], a quicker method, was further 
performed to determine the protein content of the keratin dialysate using bovine serum 
albumin as standard. The protein content of the keratin dialysate was found to be 13 ± 
3.7 mg/mL. This refers to approximately 26% from initial hair weight being distinctly 
lower than what had been detected with the lyophilization method (~60%). However, 
the Bradford method is easier to perform and sufficiently reliable to monitor the 
recovery of the extraction process.  
With 2 mL of keratin dialysate mixture, different KF thicknesses of 90-120 µm were 
obtained. This range remained the same for different batches. However, as expected, 
this range decreased when the protein content in the keratin dialysate was lower, and 
vice versa. Variation in KF with similar thicknesses can be seen later on from the 
standard deviation of the marker Papp in the permeation study (without PE) in Table 
4.12.  
After evaporating the solvent from the keratin solution, a clear, translucent and 
brownish film was achieved. The subsequent curing process gave this film a water-
resistant property as well as mechanical stability due to an oxidation of disulfide bonds 
between keratin molecules. The intermediate product, finished keratin films and 
bovine hoof membranes are displayed in Fig. 4.42 (a-c). 
During dialysis, the keratin molecules aggregated together, changing the appearance 
of a clear solution into an opaque one, hinting at the growing size of keratin 
aggregates. Further solvent evaporation led to film formation. Curing was essential to 
oxidize the disulfide bonds between keratin molecules, and thus produced water-
resistant films.  
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The drying process and the plasticizer amount played an important role. A mild 
evaporation at 40 °C for 24 h was the optimum condition. A higher drying temperature 
led to a rapid evaporation and evoked trapped air bubbles, producing uneven films. 
Insufficient plasticizer (i.e., glycerol) resulted in brittle KF, whereas an excessive use 
led to a moist film. The optimum concentration for this purpose was found to be 1% 
glycerol. 
 
 
Fig. 4.42 (a) The intermediate products of keratin films before punching and curing; (b) Keratin 
films after curing; (c) Bovine hooves for the permeation study; membrane diameter = 15 mm; 
Teflon rings are shown in (a) [114] 
 
4.11.2 Water absorption profile from keratinous materials 
The water absorption profiles of all materials under study can be seen in Fig. 4.43. 
The water uptake of hoof was the greatest, by about 45%, followed by nail and keratin 
film, around 30% and 5%, respectively (referred to the initial dry weight). 
(a) 
(b) (c) 
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Fig. 4.43 Water absorption profiles from hooves, keratin films and human nail clippings – a 
comparison (n = 5) [114] 
4.11.3 SDS-PAGE 
The protein content of KF, its raw and intermediate materials were separated using 
SDS-PAGE and the respective protein bands were compared to those of human nail 
and bovine hoof extracts. The gel matrix after the separation is depicted in Fig. 4.44. 
All human keratin materials from hair and nail showed similar band profiles. Major 
fragments at approximately 42 and 52 kDa were clearly observed in both hair and nail. 
Further bands from nail extract (b) were situated at approximately 11, 16 and 24, 95 
and 135 kDa. The protein from hair extract (c) and its aqueous suspension after 
dialysis (a) showed similar major fragments, although the other bands were slightly 
diffuse. The finished KF (d) resembled the characteristic hair bands from hair extract 
in the same position. Curing altered the intensities of these protein bands (e) and 
increased the intensity of diffuse bands in the lower molecular weight area (10-26 
kDa), which hinted at fragment cleaving to smaller sizes. Hoof extract (f) showed a 
different profile to that of human hair and nail. Two diffuse major fragments were 
obvious at 20-26 and around 42 kDa. Another thin band appeared at 95 kDa. 
The major protein bands from KF at around 42 and 52 kDa were similar to those from 
human nail. This finding is in accordance with a previous study from Baden et al. who 
also found similar SDS-PAGE patterns for human keratinized tissues [53]. In addition, 
they also found that human hair and nail showed nearly equivalent water absorption 
profiles at various relative humidities.  
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Fig. 4.44 SDS-PAGE of (a) aqueous keratin suspension after dialysis; (b) human nail extract; 
(c) hair extract; (d), (e) keratin film before and after curing, respectively; (f) hoof extract; (g) 
molecular weight marker [114] 
 
Therefore and because of the discrepancy between human and bovine keratin, KF 
made of human hair is suggested as a strong candidate for a nail plate substitute. KF 
still retained its SDS-PAGE pattern after film formation while a reduction in intensity 
occurred after curing. This could hint at the denaturation of KF protein into smaller 
sizes, which appeared as diffuse bands throughout the lane. Reichl [12] investigated 
human hair keratin as cell culture/tissue engineering substrate and showed that the 
arrangement of the keratin filament in KF produced with this method did not resemble 
that in the native hair or nail. The arrangement was observed as a tightly packed and 
well-connected nanostructure of the keratin dialysate, as has been verified with cryo-
TEM micrographs [12]. This artificial arrangement explains the susceptibility of KF to 
all PEs. 
4.11.4 Finding the analogue of KF 
In order to find the thickness analogue of KF versus bovine hoof, permeation studies 
were carried out with SF, first. The permeation data showed that the KF of 120 µm 
thickness resembled hooves of 100 µm thickness, as can be seen in Fig. 4.45. The 
120 µm thick KF was further tested for the permeation of FD4 and RB and those 
permeability coefficients were then compared to the 100 µm thick bovine hoof again. A 
similar profile was shown by FD4, but a significant discrepancy (p<0.01) was obvious 
with RB (Table 4.12). Nevertheless, both bovine hooves and KFs revealed the same 
rank order of marker permeability coefficients (i.e., RB>SF>FD4).  
260 kDa
135 kDa
95 kDa
72 kDa
52 kDa
42 kDa
34 kDa
26 kDa
17 kDa
10 kDa
(a) (b) (c) (d) (e) (f) (g)
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Fig. 4.45 Permeation of SF in dependence of KF thickness (110-130 µm), comparison: 100 
µm thick hoof (n = 4-6) [114] 
 
The recoveries of the marker extraction process were between 63% and 100% (Table 
4.11). The actual accumulated amount for every marker can be seen in Table 4.13. A 
great affinity of keratin to the lipophilic RB is also obvious from this table. Both 
membranes retained more RB than the hydrophilic markers. KF bound more RB than 
hoof (42% vs. 26%, p<0.01) as well as SF (p<0.05). The accumulation of FD4 in hoof 
and KF was comparable and amounted to only 0.8% from the initial donor 
concentration.  
Table 4.11 Recovery of the extraction process 
Marker 
Recovery of extraction [%] 
Hoof KF 
SF 
RB 
FD4 
93 
63 
100 
82 
68 
77 
 
 
The KF/hoof ratios, in terms of Papp (without PE treatment) and accumulated amount, 
for every individual marker were about in the same magnitude. The KF/hoof ratios 
were about 1.2 for SF, 1.6-1.8 for RB and 0.7-0.98 for FD4 (see Table 4.12 and Table 
4.13). 
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Table 4.12 Papp of the markers [x 10
-7 cm/s] (mean ± SD) 
Marker Hoof 100 µm KF 120 µm KF/hoof ratio 
SF 
RB 
FD4 
5.00 ± 1.35 
  17.68 ± 2.22 
0.56 ± 0.15 
5.85 ± 1.12 
  32.29 ± 3.94 
0.41 ± 0.11 
1.2 
1.8** 
0.7 
**p<0.01; n = 4-12 
 
Table 4.13 Percentage of the accumulated marker in the membranes (mean ± SD) after 20 h 
permeation study (40 h for RB) 
Marker 
Accumulated amount 
in hoof 100 µm (%) 
Accumulated amount 
in KF 120 µm (%) 
KF/hoof 
ratio 
SF 
RB 
FD4 
1.52 ± 0.12 
          25.97 ± 5.73 
0.83 ± 0.06 
1.93 ± 0.16 
           42.13 ± 5.14 
0.82 ± 0.11 
1.27* 
1.62** 
0.98 
*p< 0.05; **p< 0.01; n = 3-6 
 
 
The search for a KF analogue revealed an optimal thickness of about 120 µm, 
compared to the 100 µm thick hoof. This was confirmed by the permeability 
coefficients of two markers (SF and FD4) as well as by their accumulated amounts in 
the membranes. A significant discrepancy was shown for RB, where its permeability 
coefficient across hoof was lower than that across KF (p<0.01). Again this discrepancy 
was shown for the RB accumulated amount as well. A strong binding of lipophilic RB 
to KF hinted at some specific binding of hair-type keratin compared to hoof keratin. 
This could be attributed to the different amino acid compositions from both materials, 
as reported by Baden et al. [53,158]. Furthermore, the graph shown in Fig. 4.46 
emphasizes that a large discrepancy between hoof and KF permeabilities could be 
expected when the solute is a lipophilic substance, although this explanation is in 
contrast to some literature reports [8,9,42,72]. 
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Fig. 4.46 Plot of permeability coefficients (Papp) and log octanol water partition coefficients 
(log P) of the markers [114] 
 
It has been acknowledged that human nail, hooves and accordingly KFs behave as 
hydrophilic membranes [9,10,42], where the permeation should not be controlled by 
the lipophilicity of the substance, but rather by its molecular weight [8,9,42,72]. Both 
SF and RB are not very different in their sizes (376 and 443, respectively), but SF is 
an acidic dye and RB is a basic one. Keratin, with a pI around 5 [54], is negatively 
charged in a neutral environment and supports the diffusion of a positively charged 
molecule, e.g., RB at pH 7.4. This explains the greater Papp of RB compared to SF 
across hoof and KF in this milieu as shown in Table 4.12. This phenomenon has been 
described by Mertin and Lippold before [9] and was attributed to the Donnan 
equilibrium phenomenon [7,159]. The electrostatic repulsion between the SF anion 
and the negative co-ion of keratin in this milieu at the membrane interface is 
responsible for its smaller Papp compared to RB.  
The amounts of SF and FD4 bound in both membranes were inconsiderable 
(maximum 1.9%) whereas the amount of bound RB was much higher. This was in 
agreement with the work of DeLauder and Kidwell [160], who found no binding 
between fluorescein and hair samples after exposure of 10 mg/mL dye in 10 mM 
phosphate buffer, pH 5.6 at 37 °C for 2 h. They found that  anionic substances such 
as SF could not be absorbed into hair due to the electrostatic repulsion at the hair 
interface, which was negatively charged in this milieu (pH>5). Rhodamine 6G, a 
cationic dye, was found to be almost completely absorbed in the hair samples after the 
same defined exposure. This finding supported once more the phenomenon of 
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Donnan equilibrium and confirmed the great influence of environmental pH to the 
diffusion of charged or dissociated molecules across nail or hoof.  
Interestingly, the ratio of KF/hoof from each marker was almost similar in terms of Papp 
and accumulated amount. As example, despite the discrepancy shown by RB 
between KF and hoof, the ratios remained constant for the permeated (Papp) and 
accumulated amount (ratio KF/hoof 1.6–1.8). This implies that KF and hoof were 
comparable by a factor, which was determined by the physicochemical properties of 
the marker. 
4.11.5 Influence of PE on permeability of the markers 
All the permeability coefficients after treatment with PEs can be seen in Table 4.14. 
The permeability coefficients of the three markers were generally higher in KFs 
compared to hooves after treatment with PEs. Exceptions, however, refer to SF after 
treatment with urea and RB after treatment with TA, where the Papp in hooves were 
higher than those in KFs.  
The Papp of SF across hooves and KFs increased after PE treatment. KF was more 
susceptible to PEs, especially after treatment with TA, as well as after PE combination 
and serial treatment. The ratios of KF versus hoof permeation after the application of 
PEs in the case of SF were at maximum 2.1-fold.  
All PEs increased FD4 permeability across KF although the urea impact was not 
significant. Interestingly, the single treatment of both TA and urea decreased FD4 
permeability across hooves, but its combination and serial treatment enhanced it. 
Papain was able to increase FD4 permeation across hooves as well. The highest ratio 
of KF versus hoof permeability was observed by TA treatment being 16.8-fold. 
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Table 4.14 Papp of the markers (mean ± SD) after treatments with PEs [x 10-7 cm/s] and its 
ratios [114] 
Marker PE Papp Hoof Papp KF 
Enhancement 
Factor 
(vs. no PE) 
KF/ 
hoof 
ratio 
Hoof KF 
SF no PE 5.00 ± 1.35 5.85 ± 1.12 - - 1.2 
 Urea 3d 22.49 ± 8.50 9.67 ± 2.80 4.5* 1.7* 0.4 
 TA 15h 55.63 ± 8.26 88.41 ± 14.15 11.1** 15.1** 1.6** 
 
Combination 
urea-TA 
53.62 ± 5.25 95.20 ± 7.51 10.7** 16.3** 1.8** 
 Serial urea-TA 45.82 ± 5.77 83.09 ± 11.16 9.2** 14.2** 1.8** 
 Papain 15h 9.78 ± 4.09 20.80 ± 3.62 2.0 3.6** 2.1* 
FD4 no PE 0.56 ± 0.15 0.41 ± 0.11 - - 0.7 
 Urea 3d 0.19 ± 0.08 0.51 ± 0.24 0.3** 1.2 2.7* 
 TA 15h 0.31 ± 0.04 5.20 ± 2.48 0.6** 12.7** 16.8** 
 
Combination 
urea-TA 
2.19 ± 1.53 6.87 ± 2.22 3.9** 16.8** 3.1* 
 Serial urea-TA 8.13 ± 5.19 11.60 ± 0.13 14.5** 28.3** 1.4 
 Papain 15h 1.62 ± 1.29 2.79 ± 1.19 2.9** 6.8* 1.7 
RB no PE 17.68 ± 2.22 32.29 ± 3.94 - - 1.8** 
 Urea 3d 9.62 ± 6.10 43.07 ± 11.26 0.5* 1.3* 4.5* 
 TA 15h 86.48 ± 28.92 68.32 ± 19.21 4.9** 2.1** 0.8 
 
Combination 
urea-TA 
17.02 ± 11.95 93.55 ± 15.26 1.0 2.9** 5.5** 
 Serial urea-TA 5.97 ± 2.11 119.10 ± 35.20 0.3** 3.7** 19.9** 
 Papain 15h 10.40 ± 5.83 59.90 ± 50.29 0.6* 1.9 5.8 
*p< 0.05; **p< 0.01; n = 3 – 12 
 
RB permeability across hooves increased after TA treatment, whilst the urea 
treatment, the serial treatment and papain reduced it. KF was susceptible to all 
treatments, although the papain treatment was not statistically significant. Remarkable 
differences between KF and hoof were observed with urea when its combination and 
serial treatment were applied (i.e., KF versus hoof ratios 4 - 19.9-fold).  
From the preliminary experimental set up papain was expected to be a potential PE 
because concentrations of 3% and 5% damaged both membranes within one hour 
(data not shown). Therefore, a papain concentration of 2% was chosen for the further 
permeation study. However, a penetration enhancement could not be shown for RB 
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across hooves. This phenomenon is not fully understood considering that there has 
not been reported any proof for the interaction of papain with other substances. 
4.11.6 Resume of marker permeability across KF and hoof 
The application of PE astonishingly did not always increase the permeability 
coefficient of tested marker. While the application of urea increased the Papp of SF 
across hooves, this was not the case for FD4 and RB. Again the Papp of SF and RB 
across hooves increased after treating hooves with TA, but this was not the case for 
FD4.  
4.11.6.1 Permeation across hoof 
PEs could increase the amount of permeated SF (up to 11.1-fold) across hooves. In 
the case of FD4 only papain, the combination and serial applications of urea-TA were 
effective. The permeability coefficient of RB increased after treating hooves with TA 
only. 
4.11.6.2 Permeation across KF 
All PEs increased marker permeability coefficients, although for both urea and papain, 
the impact on FD4 and RB permeation was not significant, respectively. 
4.11.6.3 KF versus hoof  
In the case of SF permeation, hooves and KF permeability differed only up to 2.1-fold 
when PE treatment was performed. Greater discrepancies of 16.8- and 19.9-fold were 
found for FD4 and RB permeation when TA and serial application were used, 
respectively. KF versus hoof ratios of 2- to 3-fold were observed when urea and its 
combination with TA were applied to FD4. Urea and its combination with TA resulted 
in about 5-fold ratios for RB. Fig. 4.46 shows the relation between permeability (Papp) 
and octanol/water partition coefficient of the markers (log P) under study. As a note, 
Fig. 4.46 is actually not intended to explain a dependency of the markers’ partition 
coefficients (lipophilicities) on their permeation coefficients, as it was clear that both 
parameters were independent in terms of permeation across nail and hoof. Rather, 
this plot is an effort to explore the behavior of the tested membranes, especially their 
response to markers with different physicochemical properties.  
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4.12 Microbiological assay 
This assay was aimed to assess the efficacy of the formulation quantitatively by 
measuring the growth inhibition of T. rubrum after TBF application on the human nail 
model bovine hoof or keratin film. The nail model hoof/ keratin film simulates the nail  
plate in place of a real application of the formulation. The efficacy of the formulation is 
a function of the growth inhibition after incubation of the membrane with the 
formulation. An aseptic condition is essential for conducting this assay since any 
microbial contamination will influence the growth of T. rubrum. For that reason, all 
steps must be done in an aseptic condition under a laminar air flow. Furthermore, 
safety issues must be seriously considered since human pathogenic fungi produce 
spores and these can further transmit the disease. 
T. rubrum strain DSM 19959 was chosen since this strain grows faster (within 10-15 
days) than other strain, e.g., T. mentagrophytes which needs more than one month to 
grow. T. rubrum preferably colonizes skin and can be isolated thereof while T. 
mentagrophytes is mainly isolated from nails. Actually, skin fungus generally grows 
faster than nail fungus. That is probably why the clinical manifestations of the skin 
fungal infection are usually more acute than nail fungal infection is, which is rather 
chronic and hard to be cured. 
First of all, the membranes were treated with TBF loaded formulation to allow for TBF 
diffusion -vertical penetration and permeation- across the membrane. Subsequent to 
the permeation across the membrane, TBF also diffuses laterally within the agar. Both 
residual TBF within the membrane and TBF diffused into the agar should be able to 
inhibit the growth of T. rubrum. For this purpose, only one side of the membrane was 
treated. The untreated side faced the agar medium which had previously been 
inoculated with T. rubrum. It is important to restrict the treated area so that the 
formulation will not flow over the boundary of the membrane during the incubation. 
Any spread of the formulation would enlarge the treated area in an uncontrolled 
manner. The use of the donor-part of the Franz diffusion cell which was affixed 
together with the silicon paste was successful to control the treated area. 
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Fig. 4.47 Agar plates after 9 days of incubation: (a) hoof blank, (b) keratin film blank, (c) hoof 
after 24 h treatment with 1P3030, (d) keratin film after 24 h treatment with1P4412 
 
Results showed that T. rubrum colonized not only the medium surface, but also the 
membrane as there were fungal colonies at the border of the membranes as depicted 
in Fig. 4.47 (a-b). The colonization of the membrane was further recognized as a 
visual alteration: hoof turned brownish (a), keratin film turned pale (b). This alteration 
hinted at the digestion of keratin by T. rubrum. 
The diameter of an inhibition zone could be measured initially after 9 days of 
incubation. Otherwise, no distinct border could be observed as a zone of inhibition. 
Examples of inhibition zones can be seen in Fig. 4.47 (c) and (d). By means of this 
assay, the power of the formulation in inhibiting the fungal growth could be 
distinguished, e.g., between 1P3030 and 1P4412 across hoof and keratin film, 
respectively. Collecting the diameters of inhibition zones from the examined 
formulations revealed a ranking of their efficacies. 
1P3030, 1P2525 and 1P4412 were chosen since they revealed different permeation 
fluxes and the amounts of TBF retained in hooves. Consequently, TBF diffusion rates 
from these formulations were expected to be different as well. In addition, standard 
deviations were low and their semisolid consistencies enabled convenient applications 
(a) (b) 
(d) (c) 
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in this assay. A zone of inhibition could be observed even after 1 h of treatment 
with1P3030 as displayed in Fig. 4.48. As expected, the diameters initially increased up 
to 5-h-treatment interval. Surprisingly, the diameters decreased after 15 h of treatment 
and then increased again after 24 h of treatment. This fluctuation was more distinct 
from hooves than from keratin films where the inhibition diameters of keratin films after 
5 and 15 h were similar. It is still unclear why hooves’ diameters of inhibition suddenly 
dropped after 15 h of incubation before it increased again after 24 h incubation. 
However, since the deviation from each time point was larger compared to the 
fluctuation observed within the sampling time, there were no significant differences 
between the treatment times for both membranes (one way ANOVA, alpha = 0.05, 
p>0.05).    
 
Fig. 4.48 Diameter of inhibition zone (mean ± SD) on day 9 after treatment with 1P3030 for 1, 
5, 15 and 24 h  (n = 3)  
 
In order to compare the effects of different formulations in more detail, diameters of 
inhibition zones from the three chosen formulations across hooves and keratin films 
were measured after 24 h incubation. The diameters of inhibition zones from both 
membranes are depicted in Fig. 4.49 and Fig. 4.50. Generally, no significant 
differences could be observed from the three formulations across hooves or keratin 
films (one way ANOVA, alpha = 0.05, p>0.05). A trend was shown by hooves where 
the diameters of inhibitions increased along with increase in POX/MCT content from 
25% to 30% and remained constant up to 44%. The inhibition diameters from keratin 
films revealed no distinct trend since the shortest diameter resulted from 1P3030. The 
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inhibition diameters resulting from TBF diffusion across hooves were against the 
expectation.  
 
Fig. 4.49 Diameter of inhibition zone (mean ± SD) on day 9 after 24 h-treatment of hooves 
with 1P2525, 1P3030 and 1P4412 after 24 h (n = 3) 
 
 
Fig. 4.50 Diameter of inhibition zone (mean ± SD) on day 9 after 24 h-treatment of keratin 
films with 1P2525, 1P3030 and 1P4412 (n = 3) 
 
With increasing POX/MCT content, the median of the permeation flux decreased 
whereas the amount of TBF retained in hooves increased first and then decreased 
again (compare section 4.9.4 and 4.9.5). As a consequence, it was expected that the 
ranking of the inhibition zones would be either 1P2525>1P3030>1P4412 (from the 
permeation data) or 1P3030>1P2525>1P4412 (from the amount of TBF retained). 
Normalized diameters were calculated as compensation for slight differences in Franz 
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cell donor’s orifice by dividing the diameter per opening area of the Franz cell. 
Nevertheless, in both cases of hooves and keratin films, diameters of inhibition and 
the normalized ones delivered similar trends and fluctuations.  
From the result of the microbiological assay, it could be deduced that there was no 
distinct difference in the diameter of the inhibition zone observed from the chosen 
formulations. However, this assay showed that TBF was released from the formulation 
and permeated across hooves and keratin films although the formulation was given in 
a finite dose and in a short treatment of 24 h at maximum. Albeit different from the 
trend of the permeation flux, the presence of a diameter of inhibition zone indicated 
that this assay works but demands an improvement.  
Improvement of the assay could be done by quantifying the amount of fungus spores 
seeded on the agar plate. By doing this, a more reliable and reproducible result is 
expected. Clinical and Laboratory Standards Institute/ CLSI (formerly NCCLS), a 
nonprofit educational organization in the United States, published a method M38-A2 
which is applicable for the antifungal susceptibility test for molds or filamentous fungi. 
The inoculum is prepared from a conidial or sporangiospores suspension which is 
later adjusted to 0.4 - 5·104 cfu/mL to give a reproducible result. The optical density 
(OD) of the suspension is then measured spectrophotometrically at wavelength 530 
nm. RPMI-1640 medium is recommended for diluting the suspension which is 
afterwards seeded on the agar plate for the assay purpose. Without standardization, 
the fungal amount which was seeded on the agar plate would vary so that as 
expected, the growth inhibition may vary as well. Yet, this procedure is time 
consuming and out of the scope of the current study. Still, without quantifying the 
spores amount seeded on the agar plate for the microbiological assay, a proof of 
concept was successful in demonstrating the efficacy of the formulations loaded with 
TBF. 
4.13 Final Discussion 
One aim of this work was the further characterization of the poloxamer 407-based 
thermogelling formulation with the highlight of TBF incorporation as a representative of 
a lipophilic drug. This study was carried out based on the previous work of Grüning [2] 
and van Hemelrijck [3] who had investigated the physicochemical properties of this 
vehicle and the incorporation of the hydrophilic 5-ALA for the photodynamic therapy 
purpose. As expected, upon the incorporation of a lipophilic drug, the behavior of this 
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vehicle was different from that upon the incorporation of a hydrophilic drug. Besides 
the characterization of the formulations, this work also emphasized the permeation of 
TBF from various formulations, including  thermogelling formulations, across human 
stratum corneum and bovine hooves. The stability of TBF during the storage at 20 °C 
was investigated as well. Finally, to ensure that TBF in the formulation can inhibit the 
growth of the fungal infection causative, T. rubrum, microbiological assays were 
carried out. For this purpose, bovine hooves and keratin films made of human hair 
were employed as nail plate models. 
4.13.1 Physicochemical characterization of thermogelling formulations 
containing TBF 
The physicochemical properties of POX-based thermogelling formulations changed 
upon TBF incorporation in a different manner from 5-ALA incorporation. TBF 
increased the gelation temperature of the vehicle and thus extended the area of the 
liquid formulations in a phase diagram at room temperature as shown in Fig. 4.1. 
Despite the large increase in gelation temperature, the complex viscosity of the 
formulations remained the same up to 2% TBF addition. The increase in gelation point 
upon TBF addition was unexpected insofar as most chloride ions tend to decrease 
POX gelation temperature. Hence, terbinafine cation is suggested to give a greater 
influence on affecting POX gelation process compared to its chloride anion. 
The influence of 5-ALA on the ringing effect and the isotropy of the vehicle has not yet 
been explored but TBF shifted the area of systems with ringing effect and extended 
the area of anisotropic systems in the phase diagram. Grüning and Müller-Goymann 
[5] mentioned that the shear moduli of these ringing formulations were too low 
(magnitude of 103 Pa) to be categorized as cubic system which generally reaches 104-
106 Pa [126]. However, SAXD measurements disclosed the existence of the cubic 
system for the original thermogel P2525 [6]. The intensity of the reflections of this 
cubic structure (Pn3m) of P2525 was weakened upon the addition of TBF and was 
amplified upon higher temperature. Unfortunately, the structures of other ringing 
formulations 1P4020 and 1P5015 could not be elucidated due to their high primary 
peaks.  
The ability of the vehicle in dissolving up to 4% TBF is a benefit since a maximum 
thermodynamic activity of TBF in the formulation can be achieved. A higher drug 
thermodynamic activity will be followed by a higher flux rate. Above the saturation 
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concentration in the vehicle, the permeation flux will be independent of the drug 
concentration and the vehicle used. Accordingly, a drug with similar thermodynamic 
activities in different vehicles should give similar fluxes as well [84]. TBF incorporation 
of more than 1% was not possible in Basiscreme DAC or Lamisil® Creme or Lamisil® 
DermGel. The high solubility of TBF in the POX-based formulations was dependent on 
the IPA/DMIS and POX/MCT contents in the formulations. The maximum TBF 
solubility can only be achieved in the area of the phase diagram with POX/MCT 30-
50% and IPA/DMIS 30-40%. Outside this area, TBF solubility was less than 4% (Fig. 
4.4). 
4.13.2 Stability study of TBF 
In this study, UV spectrograms of aqueous TBF solutions remained unchanged up to 
48 h. TBF stability was lower in higher pH, e.g., in neutral and pH 7.4 than in acidic 
medium (pH 5.8). Furthermore, the electrolytes in PBS gave a negative influence on 
TBF stability compared to water. As expected, a higher storage temperature increased 
the degradation rate rapidly in line with the Arrhenius equation.  
As described in the literature, a TBF suspension can apparently decrease TBF’s 
degradation rate. TBF contents remained above 95% within 28 days of storage at 4° 
and 25 °C in an extemporaneous suspension prepared in a mixture of sweetened 
vehicles [161]. The initial TBF concentrations in both temperatures were 26.5 and 27.7 
mg/mL, respectively. These concentrations were much higher than TBF concentration 
examined in this study which was 50 µg/mL (see section 3.2.3.3). Therefore, 
degradation seems to occur faster from a diluted aqueous TBF solution than from a 
saturated solution, i.e., a suspension. Unfortunately, TBF stability in various 
pharmaceutical solvents has not been reported in literature so far. Since TBF is 
commonly administered perorally as tablet, the need of such stability studies is 
obviously not that urgent.  
In contrast to TBF’s poor stability in aqueous solutions, TBF was proven to be stable 
in the thermogelling formulations up to 1 month (TBF content ≥95%). Despite high 
water contents (20-50%) and TBF’s complete dissolution in all examined formulations, 
the thermogelling vehicle could maintain TBF stability within one month. A suggested 
location of TBF within the POX micelles might be advantageous for the protection from 
degradation. Within the micelles, a direct contact with water can be avoided. The 
incorporation of a hydrophobic drug into a poloxamer-based vehicle may enhance its 
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stability against degradation. As a general rule, poloxamers with higher PPO contents 
offer higher protection, e.g., camptothecin was more stable against hydrolysis with 
Pluronic®  L92 than with Pluronic® F127 [162]. The ability of poloxamer hydrophobic 
core to protect drugs from degradation has been observed from indomethacin in 
Pluronic® F68 and F127 [163] as well as from simvastatin in various Pluronics and 
Tetronics [164].   
4.13.3 TBF permeation across SC 
TBF fluxes from 1P2525 were about 1.4-fold higher than those from Basiscreme DAC 
loaded with 1% TBF or from the marketed product Lamisil® Creme, yet not statistically 
significant (p>0.05). This minor enhancement was in line with their comparable effect 
on SC skin lipids which was measured by means of DSC. 1P2525 was however still 
more effective than other vehicles by eliminating T1 and T4 transitions completely. 
The thermogelling characteristics of the formulation as well as the thermodynamic 
activity of TBF were suggested to play an important role in TBF delivery. 
Thermodynamic activities are in agreement with higher drug content in the formulation 
and thus higher flux.  
TBF permeation enhancement was not pronounced when compared to 5-ALA. The 
flux of the latter was 7.5-fold higher from the thermogel than from Basiscreme DAC. 
As reason, it is suggested that both drugs, i.e., a hydrophilic and a lipophilic one, are 
differently located within the POX gel network. Nevertheless, POX-based formulation 
still offers an advantage by revealing the highest TBF amount retained in SC after 
permeation. This amount plays an important role for the complete cure of fungal 
infection since the fungal burden is mainly located in SC. 
Thermodynamic activity of TBF in the formulation can be used to further explain the 
influence of different vehicle compositions on the TBF fluxes. Since the TBF 
concentration was fixed at 1%, its thermodynamic activity varied within the examined 
formulations due to different saturation limits. Yet, it could be shown that formulations 
with similar thermodynamic activities exhibited about similar fluxes (Fig. 4.41). Finally, 
the most appropriate vehicle for delivering TBF was decided for from a compromise 
between flux, viscosity of the formulation and stability during storage. So far, it was 
shown that viscositiy and thermodynamic activity played important roles in delivering 
TBF from the thermogelling formulations across SC. Therefore, both parameters can 
be a useful tool in predicting/ calculating TBF permeation across SC.  
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DMIS, a solvent for transdermal formulation, was proven to be advantageous in 
improving the amount of TBF retained in SC. Although TBF permeations across SC 
were not pronounced compared to other non-POX vehicles, DMIS presence in the 
thermogelling formulations was prone to increase TBF accumulation in SC. The 
hydrophilic property and the high solubilizing capability of DMIS in combination with a 
postulated penetration into the skin are considered to be responsible for this solvent 
drag effect. 
4.13.4 TBF permeation across hooves 
Different from the permeation across SC, TBF fluxes from POX-based formulations 
across hooves were remarkably higher than those from other non-POX vehicles 
(p<0.05). Bovine hoof served in this study as a human nail plate model. TBF was 
delivered across hooves and its fluxes were higher from 1P2525 than from POX 
hydrogel hinting at a synergistic effect of all constituents. In contrast, the amount of 
TBF retained in hooves was ~4-fold higher from POX hydrogel than that from 1P2525. 
The high water content in POX hydrogel seemed to provoke TBF binding to hooves’ 
keratin. 
High experimental standard deviations from the permeation across hooves made a 
conclusion difficult to be drawn. However, the influence of viscosity and IPA/DMIS 
content on TBF fluxes was apparent (Fig. 3.36 and 3.37). Interesting to note that TBF 
permeated only when IPA/DMIS exceeded 25%; below this concentration, medians of 
fluxes remained at about zero. IPA/DMIS was proven in this study as ungual 
penetration promoter. The amounts of TBF retained in hooves at the end of the 
permeation experiment did not depend on the composition of the formulations. As an 
exception, only 1P5025 revealed a significantly low TBF amount retained in hooves 
whereas TBF amounts from 1P3030 and 1P3040 were relatively high, yet not 
significantly different. It might be possible that those amounts retained after 12 h of the 
permeation experiment could not be distinguished due to an insufficient experiment 
time.  
A different anatomical organization of the nail from that of the skin requires different 
strategies for permeation enhancement in both cases. The lipid-protein-partitioning 
theory from Barry [30] explains that skin penetration enhancers work via one or up to 
three main mechanisms: alteration of intercellular skin lipids or skin protein, increase 
of the drug partition into skin or any combination of them. Human nail has been 
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described as a hydrophilic gel membrane in contrast to skin that behaves as a 
lipophilic partition membrane [8-10,42]. Therefore, hydrophilicity, drug molecular size 
and molecular charge are important parameters for the passive diffusion across nail 
[40] unlike skin permeation where drug lipophilicity plays a major role.  
In this study, POX-based thermogelling formulations have been shown to be a 
potential vehicle for delivering TBF across both SC and hooves. The high amounts of 
TBF retained after the permeation, especially in hooves, are a great benefit for the 
fungal infection treatment. Therefore, this formulation could be a promising substitute 
and adjuvant in mycosis therapy of dermatophyte infections. 
4.13.5 Human nail plate model made of human hair keratin versus bovine hoof 
[114] 
Keratin belongs to the family of water-insoluble proteins [165]. Furthermore, it is 
insoluble in many solvents and even robust against digestion of enzymes, such as 
pepsin and trypsin. The keratin extraction requires reducing agents which turn keratin 
into a more soluble form via cleavage of the keratin disulfide bonds [43]. The Shindai 
solution is appropriate to extract the keratin from human hair to produce the keratin 
film (KF) under study. Blond or gray hair was the best raw material for KF production 
because colored hair may influence or disturb the extraction process (according to the 
preliminary study), due to the rich content in melanin. Bleaching could however be 
applied before extraction to diminish this problem.  
There are two major protein groups of hair and nail keratin, i.e., low-sulfur and high-
sulfur proteins. The former has higher apparent MW in the range of 55-76 kDa 
whereas the latter is in the range of 26.5-43 kDa [40,54]. Human hair and nail share 
similar proteins in both groups although their amino acid and half-cystine contents are 
slightly different [53]. At least seven proteins are common to hair and nail in the high-
sulfur group with additional proteins for nail at MW 38.5 and 32 kDa. On the other 
hand, six proteins in the low-sulfur group have been identified in both materials 
including additional proteins at MW 61 kDa in hair and 72 or 76 kDa in nail [54]. Both 
groups were evident in our study from the hair and nail samples. However, to identify 
each single keratin protein, further application of two-dimensional electrophoresis in 
different pH is needed. The thick bands at around 52 kDa presented the low-sulfur 
proteins group meanwhile those at around 42 kDa belong to the high-sulfur proteins 
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group. Additional bands from each keratin group were shown distinctly by the nail 
extract compared to hair or KF at e.g., 76 kDa.   
Cooper and Sun [166] listed some bovine proteins in previous reports. Hoof keratin 
comprises proteins with MW of 48, 50, 51, 52, 54, 56, 58, 60, 63 and 68 kDa. In 
addition to this, Kvedar et al. [167] found specific keratin proteins in bovine hoof, 
labeled as a1-a4 and b2 with MW of 44-58 kDa and pI 5.2-6. These descriptions can 
however not explain the thick band with MW 20-26 kDa appeared from the hoof 
extract lane (f) in the present study. On the other hand, the additional band at around 
42 kDa belongs to the protein group which is about similar to human keratin from hair 
and nail. A more detailed discussion to bovine hoof keratin contents and its 
immunoblotting assay are given in ref. [166,167].     
Penetration enhancers (PE) were previously found to be penetrant specific [72], and 
this is confirmed by our study. A careful conclusion must be made if the tested 
substance is a large or a lipophilic molecule. The different water uptakes from hoof 
and KF and their different inner structures (natural vs. artificial) were possibly 
responsible for all discrepancies found after PE application. Hoof with the water 
uptake up to 45%, in contrast to KF (5%), is accordingly able to retain the PE solution 
within the matrix longer; this would retain the matrix acidity/ alkalinity after PE 
application as well. This environment will affect the solute permeation across the 
membrane. Human nail absorbs water up to around 30% and this is between the 
water uptake values observed for hoof and KF. Just considering the water uptake 
only, one would underestimate the permeability of KF in comparison to nail. This was 
actually not the case, as indicated by an even higher KF permeability compared to 
hoof, despite its low water uptake. 
KF is supposed to be less susceptible to urea, which works via an increase in 
hydration. This was indeed seen for all markers across KF, where the increases after 
urea application were the lowest among other PE applications. However, the different 
water uptake between hoof and KF did not contribute to any distinct difference when 
the hydrophilic marker was applied. Finally, KF was very susceptible to TA, a common 
permanent waving agent [168]. 
To cleave disulfide bonds in hair, TA must reach the cortex through the hair cuticle 
[169]. Following this, Cannell [168] explained the reaction mechanism as follows: 
kSSk + RSH ↔ kSH + kSSR 
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In this step, hair keratin disulfide bond (kSSk) is cleaved upon addition of thiol 
compound (RSH) and produces a cysteine residue (kSH) and the mixed disulfide of 
the thiol compound with the hair keratin (kSSR). Upon contact with the second thiol 
molecule, a second cysteine residue and the symmetrical disulfide of the thiol RSSR 
are formed: 
kSSR + RSH ↔ kSH + RSSR 
In the final step, the application of an oxidizing agent restores hair disulfide cross-links 
(kSSk) via the following reaction: 
kSH + HSk         →  kSSk + H2O 
To explain the synergistic works of TA and urea, TA as waving agent is usually 
employed in alkaline pH of about 9-10 to maximize disulfide bonds cleavage by the 
thiolate ion [168-170]. At acidic pH, heat is required to carry out the waving process. In 
low pH, the dominant species in the system is the un-ionized molecule HS-CH2-
COOH. The presence of thiolate ion –S-CH2-COO
- in alkaline pH plays the main role 
for the reduction of the keratin disulfide bonds [170]. This explains the Papp increases 
across KF upon application of serial urea-TA or in combination with urea where the 
environments of these systems were less acidic. Meanwhile the pH of 5% TA solution 
was 1.63, in combination with urea the pH increased to 2.93. The pH increases of TA 
solutions were followed by Papp increases across KF except those for SF which were 
comparable.  
Single, serial or combination of TA did not give any differences to SF’s Papp across 
hooves meanwhile urea incorporation or serial application reduced RB’s Papp across 
hooves. Urea in aqueous solution acts as electron donor and keratin is negatively 
charged in this milieu due to the alkaline pH. Theoretically, this alkaline environment 
should actually support RB permeation as in the case of its permeation without PE at 
pH 7.4. However, this was not proven. Thereafter, the electrostatic repulsion with urea 
molecule at the diffusion interface when RB is entering hooves, could be responsible 
for this phenomenon. This phenomenon was not seen in KF where urea application 
led to permeation enhancements for all markers.  
Interestingly, although the water uptake of hooves was high, the application of urea 
did not always increase the permeation of markers, which can be seen with FD4 and 
oxidizing agent 
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RB. The permeated amounts of FD4 and RB decreased, respectively, suggesting the 
unsuitability of urea as PE in these cases.  
Papain was proven to be a potential PE, with a concentration of 2% still showing 
permeation enhancements across both membranes. The mechanism of papain in 
increasing diffusion was not clear until now. Quintanar-Guerrero et al. [123] suggested 
a passage formation by papain and salicylic acid, whereas Mohorčič et al. [122] 
proposed a hydrolysis of the keratin network by a keratinolytic enzyme, as was shown 
by keratinase in their study. KF was found to be more susceptible to papain compared 
to hooves indicating that keratin bonds in KF were more fragile than the ones in hoof. 
There is unfortunately no universal ungual PE for all penetrants. In fact, the 
permeation of the penetrant is strongly depending on the PE concentration, treatment 
duration and the physicochemical character of the penetrant itself. Brown et al. [72] 
reported that all tested PEs (TA, urea H2O2, sequential and reversal TA-urea) showed 
no universal enhancements to all their tested substances (caffeine, methylparaben 
and terbinafine HCl). Caffeine as a model of a small hydrophilic drug did not show any 
enhanced penetration after the sequential application of 15% urea-H2O2 followed by 
5% TA, but in the present study SF did. Indeed one should consider the influence of 
environmental pH to the dissociation of penetrant as well. Mertin and Lippold [9] found 
that benzoic acid permeated to a higher extent across nail at pH 2.0 than at pH 7.4. 
Vice versa, this was also the case for pyridine, a basic substance, which permeated to 
a higher extent and faster at pH 7.4 than at pH 2.0. This phenomenon indicated that 
the undissociated form facilitated the permeation across nail. 
4.13.6 Microbiological assay 
The microbiological assay conducted in this study revealed that TBF was released 
from the formulation before it further penetrated and permeated across the nail plate 
model. This was a preliminary study to evaluate the efficacy of the formulation against 
T. rubrum in vitro. SC would be an interesting model as well since this fungus infects 
human skin as well. However, the handling of SC for this purpose would be difficult 
due to its thickness which is about 8 µm only (from the abdomen part) [171]. 
Nevertheless, hoof and keratin film are valuable models since this fungus colonizes 
the nail plate. The evidence that TBF was delivered across the nail plate model could 
be ascertained from the inhibition on fungal growth. 
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Two main points can be drawn from this microbiological assay. First, hooves and 
keratin films showed similar inhibition profiles over the treatment and incubation time 
applied. Yet, hooves were slightly more permeable than keratin films for TBF despite 
their similar thicknesses (100 µm). This is evident from the higher diameter of the 
inhibition zone exhibited by hooves. The second point emphasizes that the 
formulations examined did not show any significant difference in their inhibition zones 
although the amounts of TBF retained in hooves after permeation were different. The 
use of a fungal suspension with defined number of spores in high dilution could 
probably improve the result of this assay, i.e., deliver distinct differences in growth 
inhibition.  
TBF has proven successful to inhibit the growth of dermatophytes and some other 
causative pathogens of onychomycosis in vitro when applied as solution [172-176]. 
This growth inhibition has been shown from formulations containing TBF as well [110]. 
Unfortunately, the latter study was carried out without any representative barrier. An 
attempt to mimic the real infection condition has been performed by adding nail 
powder into the medium as a representative nutrient for T. rubrum in a pathological 
condition [177,178]. The MIC value (minimum inhibitory concentration) of antifungal 
agents increased upon the addition of nail powder hinting at a reduction in cidal 
activity in an in vivo situation. For that reason, the MIC values reported in the literature 
e.g., [69] will not reflect the efficacy of the antifungal agents when these actives are 
not tested under a representative condition, e.g., upon the presence of keratin as the 
essential nutrient of dermatophytes. Hence, the existence of a barrier (skin/ nail plate) 
for this assay plays an important role since in the real infection, the drug must be able 
to diffuse across the keratinous material (skin or nail plate) which is the main site of 
the infection. 
  
Chapter 5 
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Succeeding the previous work of Grüning on poloxamer 407-based formulations as 
vehicles for 5-ALA in photodynamic therapy, this study aimed at the incorporation of 
TBF as a lipophilic antifungal agent into thermogelling poloxamer formulations and the 
physicochemical characterization thereof. Permeation across human stratum 
corneum, bovine hooves and a nail plate model as well as stability studies during 
storage were conducted within the framework of this study. 
In contrast to 5-ALA which is hydrophilic, the lipophilic TBF changed the 
characteristics of the vehicles to likewise different extents. TBF increased the area of 
the liquid systems of the phase diagram which was likely due to the insufficient 
networking of POX micelles. Furthermore, the incorporation of TBF into these systems 
moved the area of the systems with ringing effect to higher POX/MCT contents. The 
anisotropic systems were found in an area with POX/MCT contents higher than 70%. 
This area was broader after TBF addition (2% in this study). Solubility of TBF varied in 
these systems, depending on the composition of the formulation, ranging from less 
than 2% to 4%. Gelation temperature of the POX-based formulations increased to a 
higher temperature after the addition of TBF. In contrast, TBF addition did not give any 
pronounced change in complex viscosity of the formulation. It is suggested that TBF 
cation has a more dominant role than its chloride anion in altering the physical 
properties of the formulations.  
SAXD diffractograms hinted at a structural change upon addition of TBF. The cubic 
structure Pn3m which was shown by P2525 (the original composition of the 
thermogelling formulation) intensified with increasing temperature, e.g., from 20 to 40 
°C, and weakened upon TBF incorporation (e.g., from 1% to 3%). All of these 
evidences suggest that TBF rather disorganizes and perturbs the networking of  POX 
micelles. 
The stability study revealed that TBF in selected thermogelling formulations was 
stable only up to one month at 20 °C. Since TBF showed a larvated incompatibility 
with DMIS, an alternative solubilizer would be necessary.  
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Permeations of TBF from the thermogelling formulations across stratum corneum and 
hooves showed that this vehicle gave advantages over other non-POX formulations in 
terms of TBF fluxes and the amount of TBF retained in both membranes. The 
permeation enhancement across the stratum corneum was not significantly increased 
by factor 1.4; yet, the amount of TBF retained in the stratum corneum was significantly 
higher than that from the standards of comparison (1.3- and 2.2-fold higher than from 
Basiscreme DAC and Lamisil® Creme, respectively). In conjunction to the fungal 
infection treatment, a high drug accumulation in the infected site is valuable for a 
complete eradication of the fungus.  
While TBF permeation across stratum corneum was apparently dependent on the 
complex viscosity of the formulation that across hooves correlated well rather with the 
IPA/DMIS content. Furthermore, a synergistic action of water with DMIS is suggested 
to be responsible for the high TBF diffusion across hooves. The efficacy of TBF from 
this formulation in inhibiting the growth of T. rubrum has been proven in vitro by 
means of a microbiological assay although this assay needs further improvement. 
Nevertheless, a representative biological barrier has been employed for this 
experiment. A suitable and representative model for skin or nail infection will permit 
the translation of the in vitro result to the in vivo pathological condition. 
A nail plate model made of human hair keratin has been successfully manufactured. 
The produced keratin film (KF) was appropriate for permeation experiments with 
regard to its mechanical stability and water-resistant property. This model showed 
similarity with bovine hooves in terms of permeability for different hydrophilic markers; 
the amounts of markers retained within both membranes were comparable as well. 
The study involving lipophilic drug and any application of ungual penetration enhancer 
must be carefully interpreted because the use of KF could overestimate the 
permeated amount in comparison to bovine hoof. Although the water uptake of this 
keratin film was lower than that from hooves, this film was more susceptible to the 
penetration enhancers. Therefore, a further improvement is still needed upon testing 
lipophilic substances and increasing film strength as well as a further comparative 
study with human nail. 
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